Sentence,class,file
"87:012707. http://dx.doi.org/10.1103/PhysRevE.87.012707 Fischer, M.J., D. Balasuriya, P. Jeggle, T.A.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1007/s00424-014-1497-z Fodor, A.A., and R.W.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"279:19046– 19050. http://dx.doi.org/10.1074/jbc.M402560200 Gentle, J.E.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1007/978-0-387-98144-4 Göbel, U., C. Sander, R. Schneider, and A. Valencia.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1002/prot.340180402 Grandl, J., S.E.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nn.2552 Guda, P., P.E.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.cell.2009.07.038 Hille, B.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
http://dx.doi.org/10.1038/ nature08542,Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.ympev .2014.06.016 Pless, S.A., A.P.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"4:1784. http://dx.doi.org/10.1038/ncomms2761 Price, M.N., P.S.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1371/journal.pone.0009490 Quenouille, M.H.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1214/aoms/1177729989 Reeds, J.A.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1214/aos/1176344248 Roberts, E., J. Eargle, D. Wright, and Z. Luthey-Schulten.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"7:382. http://dx.doi.org/10.1186/ 1471-2105-7-382 Ryu, S., B. Liu, J. Yao, Q. Fu, and F. Qin.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"27:12797– 12807. http://dx.doi.org/10.1523/JNEUROSCI.2324-07.2007 Shao, J., and D. Tu.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1007/978-1-4612-0795-5 Shao, J., and C.F.J.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1214/ aos/1176347263 Shem-Ad, T., O. Irit, and O. Yifrach.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1371/journal .pone.0082253 Söding, J.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1093/ bioinformatics/bti125 Starace, D.M., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature02270 Su, Z., X. Zhou, W.J.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1073/ pnas.0708584104 Süel, G.M., S.W.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"33:1– 67. http://dx.doi.org/10.1214/aoms/1177704711 Weigt, M., R.A. White, H. Szurmant, J.A.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"9:30. http://dx.doi.org/10.1186/1744-8069-9-30 Yan, Z., X.C.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.07.022 Yifrach, O., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi .org/10.1016/S0092-8674(02)01013-9 Yu, F.H., and W.A.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
http://dx.doi.org/10.1016/ S0896-6273(04)00116-3,OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
Online supplemental  material is available at http://www.jgp.org/cgi/content/full/jgp  .201411314/DC1.,Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"1828:1587– 1597. http://dx.doi.org/10.1016/j.bbamem.2012.09.007 Bannister, R.A., H.M. Colecraft, and K.G.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1085/jgp.201010461 Béguin, P., K. Nagashima, T. Gonoi, T. Shibasaki, K. Takahashi, Y.  Kashima, N. Ozaki, K. Geering, T. Iwanaga, and S. Seino.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/ 10.1038/35079621 Béguin, P., Y.J.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"282:11509– 11520. http://dx.doi.org/10.1074/jbc.M606423200 Beqollari, D., C.F.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.bpj.2014.03.033 Beqollari, D., C.F.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc .M209501200 Cheng, W., X. Altafaj, M. Ronjat, and R. Coronado.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi .org/10.1073/pnas.0504334102 Cherednichenko, G., A.M. Hurne, J.D.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1073/ pnas.0403485101 Cui, Y., H.S.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.bpj.2013.11.4503 Jhun, B.S., J. O-Uchi, W. Wang, C.H.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1096/fj.12-211334 Lee, C.S., A. Dagnino-Acosta, V. Yarotskyy, A. Hanna, A. Lyfenko,  M. Knoblauch, D.K.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc .M509566200 Lu, X., L. Xu, and G. Meissner.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1111/j.1600- 0854.2007.00599.x Meza, U., D. Beqollari, C.F.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.bbrc .2013.08.044 Murata, M., E. Cingolani, A.D. McDonald, J.K. Donahue, and   E. Marbán.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1161/01.RES.0000138449.85324.c5 Nabhani, T., X. Zhu, I. Simeoni, V. Sorrentino, H.H.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/ S0006-3495(02)75487-8 Nakai, J., R.T. Dirksen, H.T.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1038/380072a0 Nakai, J., T. Tanabe, T. Konno, B. Adams, and K.G.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc .273.39.24983 Ono, F., G. Mandel, and P. Brehm.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.0851-04.2004 Papadopoulos, S., V. Leuranguer, R.A. Bannister, and K.G.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc.M405317200 Prosser, B.L., E.O.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.biocel.2008.08.004 Dayal, A., J. Schredelseker, C. Franzini-Armstrong, and M. Grabner.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi .org/10.1016/j.ceca.2010.04.003 Dayal, A., V. Bhat, C. Franzini-Armstrong, and M. Grabner.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1085/jgp.200709831 DiFranco, M., P. Tran, M. Quiñonez, and J.L.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1113/jphysiol.2010.202804 El-Hayek, R., and N. Ikemoto.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc .M114.615526 Fajloun, Z., R. Kharrat, L. Chen, C. Lecomte, E. Di Luccio, D. Bichet,  M. El Ayeb, H. Rochat, P.D.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/S0014-5793(00)01239-4 Finlin, B.S., S.M.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1074/jbc.M604867200 Flynn, R., and G.W.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi .org/10.4161/chan.4.6.12865 García, J., T. Tanabe, and K.G.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1085/jgp .103.1.125 Gregg, R.G., A. Messing, C. Strube, M. Beurg, R. Moss, M. Behan,  M. Sukhareva, S. Haynes, J.A.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.01.022 Rebbeck, R.T., Y. Karunasekara, P.G.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.biocel .2013.12.001 Ríos, E., and G. Brum.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1038/325717a0 Romberg, C.F., D. Beqollari, U. Meza, and R.A. Bannister.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.4161/chan.27686 Schneider, M.F., and W.K.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/ 10.1038/242244a0 Schredelseker, J., V. Di Biase, G.J.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"284:1242– 1251. http://dx.doi.org/10.1074/jbc.M807767200 Sheridan, D.C., O. Moua, N.M. Lorenzon, and K.G.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(96)79446-8Szpyt, J., N. Lorenzon, C.F.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1038/336134a0 Tanabe, T., K.G.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1038/346567a0 Wang, Z.M., M.L.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1172/ JCI66091 Xu, X., F. Zhang, G.W.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi .org/10.1096/fj.14-264499 Yang, T., and H.M. Colecraft.",Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1016/j.bbamem.2012  .10.005 Yang, T., Y. Suhail, S. Dalton, T. Kernan, and H.M. Colecraft.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi.org/10.1038/ nchembio.2007.42 Yang, T., X. Xu, T. Kernan, V. Wu, and H.M. Colecraft.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
"http://dx.doi .org/10.1113/jphysiol.2010.187203 Yang, T., A. Puckerin, and H.M. Colecraft.",OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
http://dx.doi.org/10.1371/journal.pone.0037079,Non-OADS,/arxiv_data1/oa_pdf/49/c6/JGP_201411314.PMC4485024.pdf
© 2015 Lockless  This article is distributed under the terms of an Attribution–Noncommer- cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"After six months it is available under a Creative Com- mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1038/nsmb.1531 Alam, A., and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1038/nsmb.1537 Alam, A., and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1113/jphysiol .1984.sp015352 Baconguis, I., and E. Gouaux.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature11375 Baukrowitz, T., and G. Yellen.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/science.271.5249.653 Begenisich, T., and P. De Weer.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.06.031 Blatz, A.L., and K.L.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp.84.1.1 Boudker, O., R.M.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature05455 Brohawn, S.G., J. del Mármol, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/ science.1213808 Cao, Y., X. Jin, H. Huang, M.G.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/ nature12056 Chekhlov, A.N.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1023/B:RUCO.0000008393.57920.7d Chekhlov, A.N.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(86)83546-9 Gao, X., F. Lu, L. Zhou, S. Dang, L. Sun, X. Li, J. Wang, and Y. Shi.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/science.1173654 Gouaux, E., and R. Mackinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1021/bi00869a041 Guo, R., W. Zeng, H. Cui, L. Chen, and S. Ye.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp.201411192 Harding, M.M.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1107/S0907444902003712 Heginbotham, L., and R. MacKinnon.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/S0006-3495(93)81244-X Heginbotham, L., T. Abramson, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/science.1279807 Heginbotham, L., Z. Lu, T. Abramson, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"66:1061– 1067. http://dx.doi.org/10.1016/S0006-3495(94)80887-2 Hess, P., and R.W.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1038/309453a0 Hille, B.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1085/jgp.72.4.409 Hodgkin, A.L., and R.D.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1113/jphysiol.1955.sp005291 Horn, R., B. Roux, and J. Åqvist.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.bpj .2014.03.039 Imai, S., M. Osawa, K. Takeuchi, and I. Shimada.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1021/ cr00068a003 Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/ 417515a Jiang, Y., A. Lee, J. Chen, V. Ruta, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature01580 Kauffmann, E., J.M.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1126/science.1198785 Clarke, O.B., A.T. Caputo, A.P.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.cell.2010.05.003 Cordero-Morales, J.F., L.G.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nsmb1069 Cordero-Morales, J.F., V. Jogini, S. Chakrapani, and E. Perozo.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/ j.bpj.2011.01.073 Cram, D.J., and S.P.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1021/ja00271a032 Craven, K.B., and W.N.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1146/annurev.physiol.68.040104.134728 Derebe, M.G., D.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1021/ed062p954 Dixit, P.D., and D. Asthagiri.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp.201010533 Dobler, M., and R.P.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/ science.280.5360.69 Dutzler, R., E.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.07.006 Eisenman, G., and O. Alvarez.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"15:562– 567. http://dx.doi.org/10.1016/0006-291X(64)90505-4 Morais-Cabral, J.H., Y. Zhou, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/35102000 Neupert-Laves, K., and M. Dobler.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1085/jgp.92.5.569 Nimigean, C.M., and T.W.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp.201010551 Nishida, M., M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601828 Noskov, S.Y., and B. Roux.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.bpc .2006.05.033 Noskov, S.Y., and B. Roux.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp.200609633 Noskov, S.Y., S. Bernèche, and B. Roux.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1038/nature02943 Nyblom, M., H. Poulsen, P. Gourdon, L. Reinhard, M. Andersson,  E. Lindahl, N. Fedosova, and P. Nissen.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/science.1243352 Piasta, K.N., D.L.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/jgp .201110684 Picollo, A., M. Malvezzi, J.C. Houtman, and A. Accardi.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nsmb.1704 Ressl, S., A.C. Terwisscha van Scheltinga, C. Vonrhein, V. Ott, and  C. Ziegler.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"20:634– 640. http://dx.doi.org/10.1038/nsmb.2548 Roux, B., S. Bernèche, B. Egwolf, B. Lev, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"4:2721. http://dx.doi.org/10.1038/ ncomms3721 Schlösser, A., M. Meldorf, S. Stumpe, E.P.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/0022-2836(67)90370-1 Kim, I., and T.W.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"269:410– 412. http://dx.doi.org/10.1126/science.7618108 Kuo, A., J.M.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/ science.1085028 Lam, Y.L., W. Zeng, D.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/ jgp.201411191 Liao, J., H. Li, W. Zeng, D.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10 .1126/science.1215759 Liu, S., and S.W.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1085/jgp.201210855 Lockless, S.W., M. Zhou, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1371/journal .pbio.0050121 Long, S.B., E.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1126/science.1116269 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1038/nature06265 Luzhkov, V.B., and J. Aqvist.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1016/S0167-4838(01)00213-8 Mari, S.A., J. Pessoa, S. Altieri, U. Hensen, L. Thomas, J.H.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10 .1073/pnas.1314356110 McCoy, J.G., and C.M.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/j.bbamem.2011 .09.007 Miller, A.N., and S.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
http://dx.doi.org/10.1126/science.1213274,Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"1788:1024– 1032. http://dx.doi.org/10.1016/j.bbamem.2009.01.008 Shi, N., S. Ye, A. Alam, L. Chen, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature04508 Slesinger, P.A., N. Patil, Y.J.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80050-1 Spalding, B.C., O. Senyk, J.G.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1085/ jgp.110.5.539 Steinrauf, L.K., J.A.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1021/ja00379a008 Tao, X., J.L.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10 .1126/science.1180310 Thompson, A.N., I. Kim, T.D.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/ nsmb.1703 Uysal, S., V. Vásquez, V. Tereshko, K. Esaki, F.A.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1021/ja0631955 Varma, S., and S.B.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/ j.jmb.2007.11.059 Varma, S., D.M.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10 .1007/BF01871214 Vieira-Pires, R.S., A. Szollosi, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature12055 Wang, Y., A.C. Chamberlin, and S.Y.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1126/science.1164440 Whorton, M.R., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1016/j.cell.2011.07.046 Yamashita, A., S.K.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi .org/10.1038/nature03978 Ye, S., Y. Li, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nsmb.1865 Zhou, X., E.J.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/nature12811 Zhou, Y., and R. MacKinnon.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1016/ j.jmb.2003.09.022 Zhou, Y., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1021/bi049876z Zhou, Y., J.H.",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1038/35102009 Zilman, A.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/ 10.1016/j.bpj.2008.09.058 Zilman, A., S. Di Talia, T. Jovanovic-Talisman, B.T.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
"http://dx.doi.org/10.1371/journal.pcbi .1000804 Zimmermann, I., and R. Dutzler.",OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
http://dx.doi.org/10.1371/journal.pbio.1001101,Non-OADS,/arxiv_data1/oa_pdf/ee/7d/JGP_201511371.PMC4485025.pdf
© 2015 Karlin  This article is distributed under the terms of an Attribution–Noncommer- cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"After six months it is available under a Creative Com- mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
The online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201511380/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1074/jbc.M111.243923 Bao, L., and D.H. Cox.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1085/jgp.200509346 Benjamin, B.A., and E.A.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"234:107– 122. http://dx.doi.org/10.1016/j.jtbi.2004.11.013 Berridge, M.J., M.D.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1038/nrm1155 Bezprozvanny, I., J. Watras, and B.E.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1038/351751a0 Bidasee, K.R., L. Xu, G. Meissner, and H.R.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1074/jbc.M208372200 Boettcher, A.J., J. Wu, C. Kim, J. Yang, J. Bruystens, N. Cheung, J.K.  Pennypacker, D.A.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1016/j.str.2010.12.005 Brenner, R., G.J.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10 .1038/35038011 Brini, M., and E. Carafoli.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1101/cshperspect.a004168 Bulley, S., Z.P.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.112.277145 Butler, A., S. Tsunoda, D.P.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/ 10.1126/science.7687074 Chipperfield, A.R., and A.A. Harper.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/ S0079-6107(00)00024-9 Colyer, J.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
http://dx.doi.org/10.1111/j.1749-6632.1998.,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1126/science.1193270 Desch, M., K. Sigl, B. Hieke, K. Salb, F. Kees, D. Bernhard, A.  Jochim, B. Spiessberger, K. Höcherl, R. Feil, et al.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
http://dx.doi.org/10.1074/jbc.272.44.27787The model makes two types of predictions.,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/ 10.1038/16483 Ase, A.R., R. Raouf, D. Bélanger, E. Hamel, and P. Séguéla.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"120:267– 305. http://dx.doi.org/10.1085/jgp.20028605 Horrigan, F.T., J. Cui, and R.W.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1085/ jgp.114.2.277 Huang, J., H. Zhou, S. Mahavadi, W. Sriwai, and K.S.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ ajpcell.00103.2006 Jaggar, J.H., V.A.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1007/s11302-012-9314-7 Kang, T.M., and D.W. Hilgemann.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1111/j.1469-7793.1998.199br.x Knot, H.J., N.B.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.211br.x Launikonis, B.S., J. Zhou, D. Santiago, G. Brum, and E. Ríos.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1085/jgp.200609545 Leo, M.D., J.P. Bannister, D. Narayanan, A. Nair, J.E.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10 .1085/jgp.201110626 Liu, Q.H., Y.M.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1165/rcmb.2008-0323OC Loukin, S., X. Zhou, Z. Su, Y. Saimi, and C. Kung.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/ 10.1161/01.RES.0000147311.54833.03 Earley, S., T.J. Heppner, M.T.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1152/ajpheart.01286.2006 Earley, S., T. Pauyo, R. Drapp, M.J. Tavares, W. Liedtke, and J.E.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart.00241.2009 Enouri, S., G. Monteith, and R. Johnson.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10 .1152/ajpregu.00491.2010 Francis, S.H., M.A.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1152/physrev.00030.2010 Garland, C.J., P .L.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1111/j.1476-5381.2011.01224.x Gold, M.G., F. Stengel, P.J.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1021/bi00189a057 Hill, A.J., J.M.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1101/cshperspect.a004549 Hines, K.E., T.R.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/j.cardiores.2007.06.002 Nishizuka, Y.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1007/s00424-010-0850-0 Quayle, J.M., M.T.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.4161/chan.2.5.6897 Rizzuto, R., and T. Pozzan.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/physrev.00004.2005 Rubart, M., J.B. Patlak, and M.T.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/ 10.1085/jgp.107.4.459 Sachse, G., J. Faulhaber, A. Seniuk, H. Ehmke, and O. Pongs.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1113/jphysiol.2014.272880 Saleh, S.N., A.P.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1113/ jphysiol.2006.119305 Santana, L.F., and M.F.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.07.008 Saucerman, J.J., and A.D. McCulloch.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart.00198.2011 Schöfl, C., G. Brabant, R.D.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1172/JCI32726 Sharif-Naeini, R., J.H.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/j.cell.2009.08.045 Shaw, L., M.A.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1016/j.cardiores.2005.12.016 Sobie, E.A., K.W.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1085/jgp .117.5.447 McCarron, J.G., G. Osol, and W. Halpern.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/ 10.1152/ajpheart.01003.2006 Meens, M.J., N.J. Mattheij, P.B.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"166:297– 308. http://dx.doi.org/10.1111/j.1476-5381.2011.01774.x Moore, E.D., T. Voigt, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1529/ biophysj.104.044123 Moosmang, S., V. Schulla, A. Welling, R. Feil, S. Feil, J.W.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1093/emboj/ cdg583 Murthy, K.S.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1016/j.neuint.2004.03.014 Narayanan, D., A. Adebiyi, and J.H.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart .01146.2011 Nausch, L.W., A.D. Bonev, T.J. Heppner, Y. Tallini, M.I.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart.00773.2011 Navedo, M.F., G.C.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1085/jgp.200609519 Navedo, M.F., G.C.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart.00450.2007 Neher, E. 1998.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80983-6 Nelson, C.P., R.D.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"91:694– 702. http://dx.doi.org/10.1093/cvr/cvr137 Nelson, M.T., H. Cheng, M. Rubart, L.F. Santana, A.D. Bonev, H.J.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
http://dx.doi.org/ 10.1126/science.270.5236.633,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/S0006-3495(02) 75149-7 Stull, J.T., P.J.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1111/ j.1365-201X.1998.tb10699.x Takahashi, S., H. Lin, N. Geshi, Y. Mori, Y. Kawarabayashi, N.  Takami, M.X.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.156083 Taylor, C.W., and D.L.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10 .1016/j.bpj.2008.11.045 van Breemen, C., N. Fameli, and A.M. Evans.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1113/jphysiol .2012.246348 Vandamme, J., D. Castermans, and J.M.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10 .1152/physrev.00018.2008 Xu, L., and G. Meissner.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1016/ S0006-3495(04)74155-7 Yang, J., J.W.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1152/ajpheart.00216.2004 Yang, L., G. Liu, S.I.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi .org/10.1161/CIRCRESAHA.107.156976 Yang, Y.D., H. Cho, J.Y.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1038/nature07313 Yue, C., C.Y.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1159/000235964 Zhang, J.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"http://dx.doi.org/10.1074/jbc.M800447200 Zhou, X.B., I. Wulfsen, E. Utku, U. Sausbier, M. Sausbier, T.  Wieland, P. Ruth, and M. Korth.",OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
http://dx.doi.org/ 10.1038/20200,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/JGP_201511380.PMC4485026.pdf
"101 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Hyperglycemia increases the  expression levels of sclerostin in a  reactive oxygen species- and tumor  necrosis factor-alpha-dependent  manner Jiho Kang1, Kanitsak Boonanantanasarn1,2, Kyunghwa Baek3, Kyung Mi Woo1,  Hyun-Mo Ryoo1, Jeong-Hwa Baek1,*, Gwan-Shik Kim1,* 1Department of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National    University, Seoul, Korea 2Department of Anatomy, Faculty of Dentistry, Mahidol University, Bangkok, Thailand 3Department of Pharmacology, College of Dentistry, Gangneung-Wonju National University, Gangneung,    KoreaResearch Article J Periodontal Implant Sci 2015;45:101-110 http://dx.doi.org/10.5051/jpis.2015.45.3.101 Purpose:  Sclerostin, an inhibitor of Wnt/ β-catenin signaling, exerts negative effects on  bone formation and contributes to periodontitis-induced alveolar bone loss.",Non-OADS,/arxiv_data1/oa_pdf/57/47/jpis-45-101.PMC4485060.pdf
Abnormal cal - This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/57/47/jpis-45-101.PMC4485060.pdf
ORCID Jiho Kang http://orcid.org/0000-0001-7789-9251 Kanitsak Boonanantanasarn http://orcid.org/0000-0001-9288-         0786 Kyunghwa Baek http://orcid.org/0000-0002-6290-0392 Kyung Mi Woo http://orcid.org/0000-0002-2782-1189 Hyun-Mo Ryoo http://orcid.org/0000-0001-6769-8341 Jeong-Hwa Baek http://orcid.org/0000-0002-2032-1683 Gwan-Shik Kim http://orcid.org/0000-0002-1175-572X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/57/47/jpis-45-101.PMC4485060.pdf
"111 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Effect of fibroblast growth factor on  injured periodontal ligament and  cementum after tooth replantation in  dogs Sang-Joun Yu1, Jung-Seok Lee2, Ui-Won Jung2, Joo-Cheol Park3,   Byung-Ock Kim1, Seong-Ho Choi2,* 1Department of Periodontology, School of Dentistry, Chosun University, Gwangju, Korea 2Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry,    Yonsei University, Seoul, Korea 3Department of Oral Histology-Developmental Biology and Dental Research Institute, School of Dentistry,    Seoul National University, Seoul,  KoreaResearch Article J Periodontal Implant Sci 2015;45:111-119 http://dx.doi.org/10.5051/jpis.2015.45.3.111 Purpose:  The purpose of this animal study was to perform a histological and histomorpho - metric analysis in order to elucidate the effect of fibroblast growth factor-2 (FGF-2) on in - jured periodontal ligament (PDL) and cementum after tooth replantation in dogs.",Non-OADS,/arxiv_data1/oa_pdf/2c/c3/jpis-45-111.PMC4485061.pdf
[5] reported that substantial ankylosis and inflammatory root  resorption develop if the periodontal ligament (PDL) is exposed for some time (≥18 min - This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/c3/jpis-45-111.PMC4485061.pdf
ORCID Sang-Joun Yu http://orcid.org/0000-0001-8818-549X Jung-Seok Lee http://orcid.org/0000-0003-1276-5978 Ui-Won Jung http://orcid.org/0000-0001-6371-4172 Joo-Cheol Park http://orcid.org/0000-0002-3162-7557 Byung-Ock Kim http://orcid.org/0000-0001-8952-617X Seong-Ho Choi http://orcid.org/0000-0001-6704-6124   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/c3/jpis-45-111.PMC4485061.pdf
"6Department of Public Health Sciences, Korea University, Seoul, Korea 7Department of General Dentistry, Boston University School of Dental Medicine, Boston, MA, USA 8Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea 9Dental Research Institute, Seoul National University School of Dentistry, Seoul, KoreaResearch Article J Periodontal Implant Sci 2015;45:120-126 http://dx.doi.org/10.5051/jpis.2015.45.3.120 Purpose:  With the significance of stable adhesion of alveolar bone and peri-implant soft  tissue on the surface of titanium for successful dental implantation procedure, the purpose  of this study was to apply microgrooves on the titanium surface and investigate their ef - fects on peri-implant cells and tissues.",Non-OADS,/arxiv_data1/oa_pdf/bd/ae/jpis-45-120.PMC4485062.pdf
Since  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/jpis-45-120.PMC4485062.pdf
ORCID Hyo-Jung Lee http://orcid.org/0000-0002-0439-7389 Jaden Lee http://orcid.org/0000-0001-6937-9416 Jung-Tae Lee http://orcid.org/0000-0001-5383-3004 Ji-Soo Hong http://orcid.org/0000-0001-5698-0894 Bum-Soon Lim http://orcid.org/0000-0003-3112-0227 Hee-Jung Park http://orcid.org/0000-0002-6789-9247 Young-Kwang Kim http://orcid.org/0000-0002-1984-206X Tae-Il Kim http://orcid.org/0000-0003-4087-8021   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/ae/jpis-45-120.PMC4485062.pdf
"81 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 A clear 'wake-up call' from Korea  Tae-Il Kim  Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea  Editorial J Periodontal Implant Sci 2015;45:81-81 http://dx.doi.org/10.5051/jpis.2015.45.3.81 Received:  Jun.",Non-OADS,/arxiv_data1/oa_pdf/14/ac/jpis-45-81.PMC4485063.pdf
ORCID  Tae-Il Kim http://orcid.org/0000-0003-4087-8021 This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/ac/jpis-45-81.PMC4485063.pdf
"82 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Early radiographic diagnosis of peri- implantitis enhances the outcome of  peri-implantitis treatment: a 5-year  retrospective study after non-surgical  treatment Hee-Yung Chang1,†, Shin-Young Park2,†, Jin-Ah Kim2, Young-Kyun Kim3,   Hyo-Jung Lee2,* 1Department of Periodontology, School of Dentistry, Wonkwang University, Iksan, Korea 2Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital,    Seongnam, Korea 3Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang    Hospital, Seongnam, KoreaResearch Article J Periodontal Implant Sci 2015;45:82-93 http://dx.doi.org/10.5051/jpis.2015.45.3.82 Purpose:  This retrospective study evaluated the relationship between the timing of peri- implantitis diagnosis and marginal bone level after a 5-year follow-up of non-surgical peri- implantitis treatment.",Non-OADS,/arxiv_data1/oa_pdf/29/82/jpis-45-82.PMC4485064.pdf
Bacterial accu - This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/82/jpis-45-82.PMC4485064.pdf
ORCID Jin-Ah Kim http://orcid.org/0000-0001-9746-4546 Shin-Young Park http://orcid.org/0000-0002-3776-4130 Young-Kyun Kim http://orcid.org/0000-0002-7268-3870 Hee-Yung Chang http://orcid.org/0000-0001-7074-4791 Hyo-Jung Lee http://orcid.org/0000-0002-0439-7389   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/29/82/jpis-45-82.PMC4485064.pdf
"94 Copyright © 2015 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 In vivo  comparison between the effects  of chemically modified hydrophilic and  anodically oxidized titanium surfaces  on initial bone healing Hyo-Jung Lee1,†, Il-Hyung Yang2,†, Seong-Kyun Kim3, In-Sung Yeo3,   Taek-Ka Kwon4,* 1Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital,    Seongnam, Korea 2Department of Orthodontics and Dental Research Institute, Seoul National University School of Dentistry,    Seoul, Korea 3Department of Prosthodontics and Dental Research Institute, Seoul National University School of    Dentistry, Seoul, Korea 4Department of Prosthetic Dentistry, St. Vincent Hospital, Catholic University of Korea, Suwon, KoreaResearch Article J Periodontal Implant Sci 2015;45:94-100 http://dx.doi.org/10.5051/jpis.2015.45.3.94 Purpose:  The aim of this study was to investigate the combined effects of physical and  chemical surface factors on in vivo  bone responses by comparing chemically modified hy - drophilic sandblasted, large-grit, acid-etched (modSLA) and anodically oxidized hydropho - bic implant surfaces.",Non-OADS,/arxiv_data1/oa_pdf/22/8b/jpis-45-94.PMC4485065.pdf
This product  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/8b/jpis-45-94.PMC4485065.pdf
ORCID Hyo-Jung Lee http://orcid.org/0000-0002-0439-7389 Il-Hyung Yang http://orcid.org/0000-0001-6398-4607 Seong-Kyun Kim http://orcid.org/0000-0001-8694-8385 In-Sung Yeo http://orcid.org/0000-0002-6780-2601 Taek-Ka Kwon http://orcid.org/0000-0003-2961-6135 ACKNOWLEDGEMENTS This work was supported by the Seoul National University Bun - dang Hospital Research Fund ( Grant no.,Non-OADS,/arxiv_data1/oa_pdf/22/8b/jpis-45-94.PMC4485065.pdf
Cardiac natriuretic peptides and obesity1–12 4:R25 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity2–12 4:R26 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity3–12 4:R27 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity4–12 4:R28 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity5–12 4:R29 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity6–12 4:R30 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity7–12 4:R31 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity8–12 4:R32 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity9–12 4:R33 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity10–12 4:R34 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity11–12 4:R35 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
Cardiac natriuretic peptides and obesity12–12 4:R36 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0018/C2092015 The authors Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/87/db/ec-04-R25.PMC4485177.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/ott-8-1341.PMC4485179.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1341–1343OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1341Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8448 0Could erlotinib treatment lead to acute  cardiovascular events in patients with lung  adenocarcinoma after chemotherapy failure?,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/ott-8-1341.PMC4485179.pdf
"EGFR mutation was not found and Correspondence: Tulay Kus Department of internal Medicine,  Division of Medical Oncology, Gaziantep  University, Tr-27310 Gaziantep, Turkey email drtulaykus83@hotmail.co mJournal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2015 Volume: 8 Running head verso: Kus et al Running head recto: Erlotinib and acute cardiovascular events DOI: http://dx.doi.org/10.2147/OTT.S84480",Non-OADS,/arxiv_data1/oa_pdf/a6/c3/ott-8-1341.PMC4485179.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a6/c3/ott-8-1341.PMC4485179.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/ott-8-1341.PMC4485179.pdf
J Clin Imaging Sci 2015;5:29.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2015/5/1/29/157853Belgian scientist Andreas Vesalius in 1543.,Non-OADS,/arxiv_data1/oa_pdf/9d/cc/JCIS-5-29.PMC4485185.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/32/158907 Abstract As a result of their practice of medicine, forensic pathologists create a wealth of data  regarding the causes of and reasons for sudden, unexpected or violent deaths.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
"J Pathol Inform 2015, 1:32  http://www.jpathinformatics.org/content/6/1/32all medical specialties that transforms health care by  analyzing, implementing, and evaluating information  and communication systems to improve patient  care, enhance access to care, advance individual and  population health outcomes, and strengthen the  clinician‑patient relationship”[1] CI is commonly confused  with Information Technology (IT), yet there is a distinct  difference between these two fields.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
"J Pathol Inform 2015, 1:32  http://www.jpathinformatics.org/content/6/1/32certificate.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
"J Pathol Inform 2015, 1:32  http://www.jpathinformatics.org/content/6/1/32a significant role in the death.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
"J Pathol Inform 2015, 1:32  http://www.jpathinformatics.org/content/6/1/32ability of forensic pathologists to effectively transform  the data they are collecting into actionable information  that would better inform public health and public safety  agencies.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
"J Pathol Inform 2015, 1:32  http://www.jpathinformatics.org/content/6/1/32systems need to be developed.",Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.acgme.org/acgmeweb/Portals/0/PFAssets/ ProgramRequirements/381_clinical_informatics_02032014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.ncjrs.gov/pdffiles1/ovw/241903.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.bjs.gov/ content/pub/pdf/meco04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.propublica.org/article/ the‑real‑csi‑americas‑patchwork‑system‑of‑death‑investigation.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.cdc.gov/violenceprevention/ nvdrs/.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available from: http://www.nij.gov/ journals/256/pages/missing‑persons.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/JPI-6-32.PMC4485186.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.,Non-OADS,/arxiv_data1/oa_pdf/21/3a/JCIS-5-30.PMC4485187.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/91/40/JCIS-5-31.PMC4485188.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/34/158911,Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/34means that the burden of work that each pathologist  shoulders becomes heavier, with shortened time of review  of individual cases, often resulting in false diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/34section 3, we discuss P‑SSD and compare it with other  software packages.",Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/34the supervised data and images are stored in the database.",OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/34Detecting the cancerous area Support system for pathological diagnosis can detect  cancerous areas in tissue.",Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/34one virtual slide in P‑SSD and NDP .view.",Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
Available from: http://www.ganjoho.jp/pro/ statistics/en/table_download.html.,OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
"J Pathol Inform 2015, 1:34  http://www.jpathinformatics.org/content/6/1/348.",Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
Available from: http://www.gimp.org.,Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
Available from: http://www.imagej.nih.,Non-OADS,/arxiv_data1/oa_pdf/81/05/JPI-6-34.PMC4485189.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36studies limited to evaluating a protein’s location in at  most a small number of tissues.",Non-OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
Mechanize‑0.2.5 (https://pypi.python.org/pypi/ mechanize/) is used for stateful interaction with the  HPA website.,OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"Pygame (http://www.pygame.org/) is used  for the graphical user interface (GUI) to display images  and to manage user input, including game controller  input.",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
BeautifulSoup 4.3.2 (http://www.crummy.com/ software/BeautifulSoup/) is used to parse HTML pages  retrieved from the HPA website.,OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
The HPASubC tools are freely available and can be  downloaded from https://github.com/cornish/HPASubC.,OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36the image_scorer.py script using score values of 0–6  that can be based on any user parameters like stain  intensity.",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36the following values ‑ 0: Non SMC or EC staining, 1:  Clean EC, 2: Predominant EC, 3: Both EC and SMC,  4: Predominant SMC, 5: Clean SMC.",Non-OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36list contains 6,701 proteins with an ENSG ID.",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36organ system.",Non-OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Full list of 703 proteins we identified that are present exclusively in ECs and/or  SMCs but not in cardiac myocytes ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Contd...Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
"J Pathol Inform 2015, 1:36  http://www.jpathinformatics.org/content/6/1/36Supplemental T able 1: Contd... ENSGID Gene ID T otal cores % + cores (%) EC to SMC In Kim et al.?",OADS,/arxiv_data1/oa_pdf/6e/79/JPI-6-36.PMC4485190.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/33/158910 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.158910 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33identify cellular components, extracellular structures,  and lumen with relative ease.",OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33Clustering was halted when only 10 independent clusters  remained, which served as the 10 basis groups for the  remainder of the analysis.",OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33belonged to another class was selected to represent that  class.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33of points from each other.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33 Figure 6: Classification confidence.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33that exhibited certainty levels >1 and 0.92 for pixels that  exhibited certainty levels >0.5.",OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33The algorithm can then proceed to classify all pixels in  the image based on the SVM decision tree framework.",OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
"J Pathol Inform 2015, 1:33  http://www.jpathinformatics.org/content/6/1/33pathology).",Non-OADS,/arxiv_data1/oa_pdf/a6/98/JPI-6-33.PMC4485192.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/35/158912,Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"J Pathol Inform 2015, 1:35  http://www.jpathinformatics.org/content/6/1/35including: Offsite readings of computed tomography  images for appendicitis,[2] stroke diagnosis,[3] directly  observed therapy for sickle cell patients[4] and in  ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"The study  attempted to answer the question, “ Are images taken  using a mobile phone adequate for diagnosis?” METHODS The images and video overviews were taken by one of the  authors (PF), a pathologist experienced in telelpathology,  with an iPhone 5 smartphone (8‑megapixel  back‑illuminated sensor, autofocus) attached to an  Olympus BX 41 microscope using a Universal Camera  Phone/Microscope Adapter (http://www.thingiverse.",Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"J Pathol Inform 2015, 1:35  http://www.jpathinformatics.org/content/6/1/35as previously described.",Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"J Pathol Inform 2015, 1:35  http://www.jpathinformatics.org/content/6/1/35consultations while two had previously sent telepathology  consults.",Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"J Pathol Inform 2015, 1:35  http://www.jpathinformatics.org/content/6/1/35Likert scale scores for image quality, adequacy of images  for diagnosis, confidence in diagnosis and usefulness of  video overviews had modes of 3, 4, 4 and 3, respectively.",OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
"J Pathol Inform 2015, 1:35  http://www.jpathinformatics.org/content/6/1/35in developed countries through academic institutions  and organizations need to develop to create networks  of referral centers and to provide smartphone adapters.",Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
Available  from: https://www.gsmaintelligence.com/analysis/2014/9/ smartphone-forecasts-and-assumptions-20072020/443/.,Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
Zaiontz C. Available from: http://www.real-statistics.com/reliability/ intraclass-correlation/.,OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
Available  from: http://www.idc.com/prodserv/smartphone-os-market-share.jsp.,Non-OADS,/arxiv_data1/oa_pdf/43/ab/JPI-6-35.PMC4485193.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/39/159232,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39to obtain accurate diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39The emergence of digital pathology gave rise to many  computational methods modeled on popular pathological  grading systems such as the Nottingham, Gleason, and  Fuhrman grading systems.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39T able 1: Images cropped from TCGA breast cancer data Image Slide identification Nottingham grade (1-3) Bounding box ( xmin, ymin) (xmax, ymax) and  pixel resolution MPP bc001 TCGA‑A2‑A0CM‑01Z‑00‑DX1.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39DESCRIPTION OF BREAST , RENAL CLEAR  CELL AND RENAL PAPILLARY CELL  CANCER DATASETS Four whole slide images of breast cancer with  Nottingham grading of 2 and 3 (two images each) were  downloaded from the TCGA website.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39Throughout this paper, we processed the data with  different color spaces independently.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39Figure 1:  (a) How the s × s pixels image patch is divided into blocks.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39Hx yc xyiii ,( ,) () =∑  (4) αi are the weights assigned by AdaBoost.",OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39nucleoli pattern.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39 Figure 4:  The figure shows the order of the ten most prominent  nucleoli patterns to be presented to the pathologist for the prostate  cancer dataset Breast Cancer Dataset There were 12 images in this dataset; we performed  12‑fold cross validation, training on 11 images and testing  on the remaining image.",OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39 Figure 6:  The figure shows the order of the ten most prominent nucleoli patterns to be presented to the pathologist for the breast cancer dataset only one cascade with XCA, HPG or EHPG classifiers  and an image patch size of s × s = 24 × 24.",OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39 Figure 8: The figure shows the order of the ten most prominent nucleoli patterns to be presented to the pathologist for the renal clear  cell cancer dataset were then compared with the final result of combining 32  cascades.",OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39 Figure 10: The figure shows the order of the 10 most prominent nucleoli patterns to be presented to the pathologist for the renal cell  papillary cancer dataset pixels per cascade on the prostate dataset.",OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
"J Pathol Inform 2015, 1:39  http://www.jpathinformatics.org/content/6/1/39surgical pathology practice.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
Available from: http://www.eprints.dcs.warwick.ac.uk/476/.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
Available from: http://www.miaab.org/miaab‑2008‑papers/15‑miaab‑2008‑ paper‑14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
Available from: http://www.imagej.nih.gov/ij/docs/ menus/process.html#find‑maxima.,OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
Available from: http://www.imagej.nih.gov/ ij/.,OADS,/arxiv_data1/oa_pdf/9f/f8/JPI-6-39.PMC4485194.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/37/159214 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.159214 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37same interoperability issues plaguing EMR and related  systems, issues promoting the formation of data siloes.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"We can explore further whether  answers to research queries can be obtained from the  1 http://www.w3.org/TR/owl‑semantics/, http://www.w3.org/TR/owl2‑ primer/",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37combined body of data that could not be obtained from  the two component bodies of data considered separately.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37AUXILIARY ONTOLOGIES RELEVANT TO  THE FIELD OF IMAGING In this section, we focus on candidate reference  ontologies in the image and image processing domain.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37Besides supporting tagging, the OA model allows for  integration with ontologies through structured bodies  defined by a collection of statements using ontology  terms.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
This ontology  provides resources to represent the types of entities  Figure 2: Structure of a typical investigation as viewed by Ontology  for Biomedical Investigations (from http://obi-ontology.org/page/ Investigation),Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37relevant to obtaining information for example about the  kinds of samples stored in a biobank, about who runs or  owns the biobank, who are the contact persons, and so  forth.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
The merged owl file  can be retrieved from https://github.com/biobanking/ biobanking2.,OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"The past several years, however, have seen an increased  interest in promoting features of the DICOM standard  3  http://ncorwiki.buffalo.edu/index.php/Ontology_and_Imaging_Infor ‑ matics Figure 3: Central ontologized minimum information about  biobank data sharing classes (from http://www.jbiomedsem.com/ content/4/1/23/figure/F1)",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37to further automate compliance, conformance testing,  and interoperability.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
The recent encoding of the  DICOM standard document into Extensible Markup  Language (XML) (http://medical.nema.org/medical/ dicom/current/source/docbook/) represents one step  toward transforming the standard into an ontology  framework to support the development of next‑generation  image management systems.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37incompatible positions.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"[61,62] The ontology is expressed  in XML Schema and has had several independent  software implementations,[63,64] including large‑scale image  repositories (http://cellimagelibrary.org, http://jcb‑dataviewer.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"The whole OME data model is divided into multiple  branches, including an image, and an equipment branch,  as illustrated in Figures 7 and 8 below (taken from the  overview at http://www.openmicroscopy.org/).",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
A portion of the  ontology is available in OWL at http://www.itee.uq.edu.au/ eresearch/projects/fusion/ome [Figure 6] (Hunter et al.[65]).,OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"Unfortunately, this lacks an upper‑level architecture of  the sort that would allow integration with other clinical  or image‑related ontologies [Figure 9].The Quantitative Imaging Biomarker Ontology The National Institutes of Health defines a “biomarker” as  a characteristic “that is objectively measured as an indicator  Figure 6: Fragment of RadLex hierarchical structure in RadLex  (from http://bioportal.bioontology.org/ontologies/RADLEX) Figure 7: Image branch of the Open Microscopy Environment data  model (from http://www.openmicroscopy.org) Figure 8: Instrument branch of the Open Microscopy Environment  data model (from http://www.openmicroscopy.org)",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37of normal biological processes, pathological changes, or  pharmacologic responses to a therapeutic intervention.”  The quantitative imaging biomarker alliance (QIBA) has  been established by the RSNA to advance quantitative  imaging in clinical care and to facilitate imaging as a  source of biomarkers in clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"However,  both textual and associated image content is available  at http://www.gamuts.net/, and an example of the textual  content, including hyperlinks to further relevant textual  and image content, is provided in Figure 11.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37The ontologies in effect provide extensions of the  general‑purpose DOLCE ontology for the domain  of datasets, including image datasets.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"However, it is important that all work invested in the  development of the ontology should be performed in a  4  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903726/ Figure 11: Sample Radiology Gamuts Ontology content from http:// www.gamuts.net/x/25403 Figure 12: Fragment from the OntoNeuroLOG-dataset processing  ontology in bioportal",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37consistent way–which implies the need for encompassing  general framework.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37Image Processing Parameters Once an image is generated, it can be processed in a  multitude of ways.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37Datasets, algorithms, and outcomes data are not easy to  share between different research groups and institutions.",OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/376.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.goo.gl/nuzIwB.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available  from: http://www.openannotation.org/spec/core/20130208/index.html.,OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.w3.org/RDF/.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available  from: http://www.goo.gl/nuzIwB.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.obi‑ontology.org/page/Main_ Page.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.obi‑ontology.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: https://www.code.google.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.ceur‑ws.org/Vol‑833/paper48.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available from: http://www.ihe.net.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"J Pathol Inform 2015, 1:37  http://www.jpathinformatics.org/content/6/1/37A, Davidson D, Baldock R, editors.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
"Laboratoire de Recherche en Informatique  d’Amiens (LaRIA), 2005‑8, Available from: http://hal.archives‑ouvertes.fr/hal‑ 00012203 [Last accessed on 2014, 15 Jul].",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/JPI-6-37.PMC4485195.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/38/159215,Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38interpreting pathologists.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38process.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38The total number of unique features across all reports  that we extracted was 4,211,995, and the average number  of unique features per report was about 1302.",OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38which these particular findings were flagged, are shown  in Table 1.",OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38T able 2: Performance of several procedure, laterality, and result findings from the evaluation set (N:324)  and processed by the final version of the NLP systema Code Name TPbFPbFNbTNbFrequencycPrecision Sensitivity Specificity Accuracy Fscore Procedure Breast FNA 5 0 1 134 3.40% 1.000 0.833 1.000 0.993 0.909 Breast Closed percutaneous  biopsy/Core biopsy, NOS79 9 0 52 54.01% 0.898 1.000 0.852 0.936 0.946 Breast Core biopsy, small  diameter 2 1 0 137 0.93% 0.667 1.000 0.993 0.993 0.800 Breast Open biopsy, NOS 4 3 0 133 2.47% 0.571 1.000 0.978 0.979 0.727 Breast Re‑excisional biopsy 2 1 0 137 2.47% 0.667 1.000 0.993 0.993 0.800 Breast Excisional biopsy 0 2 1 137 3.70% 0.000 0.000 0.986 0.979 0.000 Mastectomy 3 0 1 136 4.32% 1.000 0.750 1.000 0.993 0.857 Lumpectomy 7 2 2 129 8.64% 0.778 0.778 0.985 0.971 0.778 Breast Reduction 0 0 2 138 0.93% 0.000 0.000 1.000 0.986 0.000 Breast mass or tissue, NOS 7 3 2 128 6.79% 0.700 0.778 0.977 0.964 0.737 Omit 24 1 1 114 10.19% 0.960 0.960 0.991 0.986 0.960 Laterality Both 10 0 0 130 5.86% 1.000 1.000 1.000 1.000 1.000 Left 49 3 1 87 39.51% 0.942 0.980 0.967 0.971 0.961 Right 71 3 0 66 43.52% 0.959 1.000 0.957 0.979 0.979 Not Specified 1 3 0 136 0.93% 0.250 1.000 0.978 0.979 0.400 Result Invasive cancer, NOS 0 3 0 137 1.23% 0.000 0.000 0.979 0.979 0.000 Invasive ductal 63 3 4 70 28.09% 0.955 0.940 0.959 0.950 0.947 Invasive lobular 1 0 1 138 4.01% 1.000 0.500 1.000 0.993 0.667 Invasive Ductal and Invasive  Lobular0 1 0 139 1.23% 0.000 0.000 0.993 0.993 0.000 Metastatic from breast 0 3 9 128 7.41% 0.000 0.000 0.977 0.914 0.000 Ductal CIS 0 0 45 95 26.23% 0.000 0.000 1.000 0.679 0.000 Lobular CIS 0 0 1 139 1.54% 0.000 0.000 1.000 0.993 0.000 Ductal and Lobular CIS 0 0 2 138 0.62% 0.000 0.000 1.000 0.986 0.000 Papillary 0 0 6 134 2.47% 0.000 0.000 1.000 0.957 0.000 Comedo 0 0 3 137 2.47% 0.000 0.000 1.000 0.979 0.000 Ductal atypical hyperplasia 1 0 5 134 5.25% 1.000 0.167 1.000 0.964 0.286 Lobular atypical hyperplasia 0 0 1 139 1.23% 0.000 0.000 1.000 0.993 0.000 Ductal and Lobular atypical  hyperplasia0 0 2 138 0.62% 0.000 0.000 1.000 0.986 0.000 Ductal hyperplasia 14 2 7 117 15.12% 0.875 0.667 0.983 0.936 0.757 Fibroadenoma 4 0 5 131 8.64% 1.000 0.444 1.000 0.964 0.615 Calcifications 0 0 15 125 11.73% 0.000 0.000 1.000 0.893 0.000 Microcalcification 0 0 32 108 22.22% 0.000 0.000 1.000 0.771 0.000 Angiolymphatic Invasion 0 0 2 138 0.93% 0.000 0.000 1.000 0.986 0.000 Benign 29 7 47 57 50.00% 0.806 0.382 0.891 0.614 0.518 Lymph nodes 0 0 10 130 7.10% 0.000 0.000 1.000 0.929 0.000 Sentinel lymph node 0 0 9 131 4.94% 0.000 0.000 1.000 0.936 0.000 Lymph nodes and Sentinel  Lymph nodes0 0 9 131 4.32% 0.000 0.000 1.000 0.936 0.000 Negative FNA 1 0 3 136 2.16% 1.000 0.250 1.000 0.979 0.400 Insufficient FNA 0 0 2 138 0.62% 0.000 0.000 1.000 0.986 0.000 Suspicious for malignancy 0 0 1 139 0.31% 0.000 0.000 1.000 0.993 0.000 aNote the following: true positive (TP), eqv.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38research and analysis); and (4) creating a method to flag  reports for manual review.",OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38scope of projects similar to this one, NLP cannot be  expected to perform well when applied to an existing,  complex manual process.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/3820.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38Appendix 1 NegEx T ype With and without [PSEU] None [PREN] No increase [PSEU] No suspicious change [PSEU] No significant change [PSEU] No change [PSEU] No interval change [PSEU] No definite change [PSEU] No significant interval change [PSEU] Not extend [PSEU] Not cause [PSEU] Not drain [PSEU] Not certain if [PSEU] Not certain whether [PSEU] Gram‑negative [PSEU] Without difficulty [PSEU] Not necessarily [PSEU] Not only [PSEU] Absence of [PREN] Cannot [PREN] Cannot see [PREN] Checked for [PREN] Declined [PREN] Declines [PREN] Denied [PREN] Denies [PREN] Denying [PREN] Evaluate for [PREN] Fails to reveal [PREN] Free of [PREN] Negative for [PREN] Never developed [PREN] Never had [PREN] No [PREN] No abnormal [PREN] No cause of [PREN] No complaints of [PREN] No evidence [PREN] No new evidence [PREN] No other evidence [PREN] No evidence to suggest [PREN] No findings of [PREN] No findings to indicate [PREN] No mammographic evidence of [PREN] No new [PREN] No radiographic evidence of [PREN] No sign of [PREN] No significant [PREN] No signs of [PREN] No suggestion of [PREN] No suspicious [PREN] Not [PREN] Contd ...Appendix 1: Continued NegEx T ype Not appear [PREN] Not appreciate [PREN] Not associated with [PREN] Not complain of [PREN] Not demonstrate [PREN] Not exhibit [PREN] Not feel [PREN] Not had [PREN] Not have [PREN] Not know of [PREN] Not known to have [PREN] Not reveal [PREN] Not see [PREN] Not to be [PREN] Patient was not [PREN] Previous [PREN] Rather than [PREN] Resolved [PREN] Suspicious for [PREN] T est for [PREN] T o exclude [PREN] Unremarkable for [PREN] With no [PREN] Without [PREN] Without any evidence of [PREN] Without evidence [PREN] Without indication of [PREN] Without sign of [PREN] Rules out [PREN] Rules him out [PREN] Rules her out [PREN] Rules the patient out [PREN] Rules out for [PREN] Rules him out for [PREN] Rules her out for [PREN] Rules the patient out for [PREN] Ruled out [PREN] Ruled him out [PREN] Ruled her out [PREN] Ruled the patient out [PREN] Ruled out for [PREN] Ruled him out for [PREN] Ruled her out for [PREN] Ruled the patient out for [PREN] Ruled out against [PREN] Ruled him out against [PREN] Ruled her out against [PREN] Ruled the patient out against [PREN] Did rule out [PREN] Did rule out for [PREN] Did rule out against [PREN] Did rule him out [PREN] Contd ...",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38Appendix 1: Continued NegEx T ype Did rule her out [PREN] Did rule the patient out [PREN] Did rule him out for [PREN] Did rule her out for [PREN] Did rule him out against [PREN] Did rule her out against [PREN] Did rule the patient out for [PREN] Did rule the patient out against [PREN] Can rule out [PREN] Can rule out for [PREN] Can rule out against [PREN] Can rule him out [PREN] Can rule her out [PREN] Can rule the patient out [PREN] Can rule him out for [PREN] Can rule her out for [PREN] Can rule the patient out for [PREN] Can rule him out against [PREN] Can rule her out against [PREN] Can rule the patient out against [PREN] Adequate to rule out [PREN] Adequate to rule him out [PREN] Adequate to rule her out [PREN] Adequate to rule the patient out [PREN] Adequate to rule out for [PREN] Adequate to rule him out for [PREN] Adequate to rule her out for [PREN] Adequate to rule the patient out for [PREN] Adequate to rule the patient out against [PREN] Sufficient to rule out [PREN] Sufficient to rule him out [PREN] Sufficient to rule her out [PREN] Sufficient to rule the patient out [PREN] Sufficient to rule out for [PREN] Sufficient to rule him out for [PREN] Sufficient to rule her out for [PREN] Sufficient to rule the patient out for [PREN] Sufficient to rule out against [PREN] Sufficient to rule him out against [PREN] Sufficient to rule her out against [PREN] Sufficient to rule the patient out against [PREN] Versus [PREN] vs [PREN] Or [PREN] Differential diagnosis [PREN] Rule out [PREP] r/o [PREP] ro [PREP] Rule him out [PREP] Rule her out [PREP] Rule the patient out [PREP] Rule out for [PREP] Rule him out for [PREP] Contd ...Appendix 1: Continued NegEx T ype Rule her out for [PREP] Rule the patient out for [PREP] Be ruled out for [PREP] Should be ruled out for [PREP] Ought to be ruled out for [PREP] May be ruled out for [PREP] Might be ruled out for [PREP] Could be ruled out for [PREP] Will be ruled out for [PREP] Can be ruled out for [PREP] Must be ruled out for [PREP] Is to be ruled out for [PREP] What must be ruled out is [PREP] Unlikely [POST] Free [POST] Was ruled out [POST] Is ruled out [POST] Are ruled out [POST] Have been ruled out [POST] Has been ruled out [POST] Absent [POST] Not identified [POST] Not seen [POST} Not present [POST] Versus [POST] Vs [POST] Or [POST] Did not rule out [POSP] Not ruled out [POSP] Not been ruled out [POSP] Being ruled out [POSP] Be ruled out [POSP] Should be ruled out [POSP] Ought to be ruled out [POSP] May be ruled out [POSP] Might be ruled out [POSP] Could be ruled out [POSP] Will be ruled out [POSP] Can be ruled out [POSP] Must be ruled out [POSP] Is to be ruled out [POSP] But [CONJ] However [CONJ] Nevertheless [CONJ] Yet [CONJ] Though [CONJ] Although [CONJ] Still [CONJ] Aside from [CONJ] Except [CONJ] Apart from [CONJ] Secondary to [CONJ] As the cause of [CONJ] Contd ...",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
"J Pathol Inform 2015, 1:38  http://www.jpathinformatics.org/content/6/1/38Appendix 1: Continued NegEx T ype As the source of [CONJ] As the reason of [CONJ] As the etiology of [CONJ] As the origin of [CONJ] As the cause for [CONJ] As the source for [CONJ] As the reason for [CONJ] As the etiology for [CONJ] As the origin for [CONJ] As the secondary cause of [CONJ] As the secondary source of [CONJ] As the secondary reason of [CONJ] As the secondary etiology of [CONJ] As the secondary origin of [CONJ] As the secondary cause for [CONJ] As the secondary source for [CONJ] As the secondary reason for [CONJ] As the secondary etiology for [CONJ] As the secondary origin for [CONJ] As a cause of [CONJ] As a source of [CONJ] As a reason of [CONJ] As an etiology of [CONJ] As a cause for [CONJ] As a source for [CONJ] As a reason for [CONJ] As an etiology for [CONJ] As a secondary cause of [CONJ] As a secondary source of [CONJ] As a secondary reason of [CONJ] As a secondary etiology of [CONJ] As a secondary origin of [CONJ] As a secondary cause for [CONJ] As a secondary source for [CONJ] As a secondary reason for [CONJ] As a secondary etiology for [CONJ] As a secondary origin for [CONJ] As an cause of [CONJ] As an source of [CONJ] As an reason of [CONJ] Contd ...Appendix 1: Continued NegEx T ype As an etiology of [CONJ] As an origin of [CONJ] As an cause for [CONJ] As an source for [CONJ] As an reason for [CONJ] As an etiology for [CONJ] As an origin for [CONJ] As an secondary cause of [CONJ] As an secondary source of [CONJ] As an secondary reason of [CONJ] As an secondary etiology of [CONJ] As an secondary origin of [CONJ] As an secondary cause for [CONJ] As an secondary source for [CONJ] As an secondary reason for [CONJ] As an secondary etiology for [CONJ] As an secondary origin for [CONJ] Cause of [CONJ] Cause for [CONJ] Causes of [CONJ] Causes for [CONJ] Source of [CONJ] Source for [CONJ] Sources of [CONJ] Sources for [CONJ] Reason of [CONJ] Reason for [CONJ] Reasons of [CONJ] Reasons for [CONJ] Etiology of [CONJ] Etiology for [CONJ] Trigger event for [CONJ] Origin of [CONJ] Origin for [CONJ] Origins of [CONJ] Origins for [CONJ] Other possibilities of [CONJ] PREN: Prenegation (negation that affects following word),  POST:  Postnegation (negation that affects preceding word),  PSEU:  Pseudonegation (look like negation, but aren’t), PREP: Prepossible  (uncertainty that affects following word), POSP: Postpossible (uncertainty that  affects preceding word), CONJ: Interrupts negation/uncertainty",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/JPI-6-38.PMC4485196.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2015/5/1/32/157860REVIEW ARTICLE Received : 16‑04‑2015 Accepted : 26‑04‑2015 Published : 29‑05‑2015 Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.157860,Non-OADS,/arxiv_data1/oa_pdf/53/5f/JCIS-5-32.PMC4485197.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/47/main.PMC4485478.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.014 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/47/main.PMC4485478.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/47/main.PMC4485478.pdf
Evaluation onEBioMedicine 2 (2015) 190 –191 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.01.008 .,OADS,/arxiv_data1/oa_pdf/12/11/main.PMC4485479.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.012 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/11/main.PMC4485479.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/12/11/main.PMC4485479.pdf
EBioMedicine http://dx.doi.org/10.1016/j.ebiom.2015.01.008 .,OADS,/arxiv_data1/oa_pdf/12/11/main.PMC4485479.pdf
EBioMedicine http://dx.doi.org/10.1016/j.ebiom.2015.01.006 .EBioMedicine 2 (2015) 104 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.01.006 .,OADS,/arxiv_data1/oa_pdf/cc/ae/main.PMC4485480.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.017 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/ae/main.PMC4485480.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/ae/main.PMC4485480.pdf
EBioMedicineEBioMedicine 2 (2015) 91 http://dx.doi.org/10.1016/j.ebiom.2015.02.002 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/00/3b/main.PMC4485484.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/3b/main.PMC4485484.pdf
Disclosure The authors have no relevant con ﬂicts of interest to disclose.EBioMedicine 2 (2015) 184 –185 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.01.003 .,Non-OADS,/arxiv_data1/oa_pdf/2b/b3/main.PMC4485487.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.019 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/2b/b3/main.PMC4485487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/b3/main.PMC4485487.pdf
(2015) conﬁrms the feasibility of exploring how CFTR might work with different mutationsEBioMedicine 2 (2015) 100 –101 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2014.12.005 .,OADS,/arxiv_data1/oa_pdf/5a/e9/main.PMC4485492.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.013 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/5a/e9/main.PMC4485492.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/e9/main.PMC4485492.pdf
EBioMedicine http://dx.doi.org/10.1016/j.ebiom.2014.12.005 .,OADS,/arxiv_data1/oa_pdf/5a/e9/main.PMC4485492.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/88/hyv056.PMC4485603.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3141–3152Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3141Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8612 6custom fractional factorial designs to  develop atorvastatin self-nanoemulsifying and  nanosuspension delivery systems – enhancement  of oral bioavailability Fahima M hashem1 Majid M al-sawahli2 Mohamed nasr1 Osama aa ahmed3,4 1Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, helwan University,   cairo, egypt; 2holding company  for Biological Products and Vaccines  (Vacsera), giza, egypt; 3Department  of Pharmaceutics and industrial  Pharmacy, Faculty of Pharmacy, King  abdulaziz University, Jeddah, saudi  arabia; 4Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, Minia University, Minia,   egyptAbstract:  Poor water solubility of a drug is a major challenge in drug delivery research and  a main cause for limited bioavailability and pharmacokinetic parameters.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
"On the other hand, ATR increases high-density lipoproteins in patients  with a wide variety of dyslipidemias.2,3 Recently, attention has been drawn toward self-nanoemulsifying drug delivery  systems (SNEDDS) and solid nanosuspensions (NS) for improving the oral correspondence: Osama aa ahmed Department of Pharmaceutics and  industrial Pharmacy, Faculty of Pharmacy,  King abdulaziz University, PO Box  80200, Jeddah 21589, saudi arabia Tel +966 2 640 0000 ext 22251 email oaahmed@kau.ed u.sa Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hashem et al Running head recto: Development of nanostructured atorvastatin carriers DOI: http://dx.doi.org/10.2147/DDDT.S86126",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
"Avail- able from: http://ec.europa.eu/environment/chemicals/lab_animals/ legislation_en.ht m. Accessed December 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/f8/dddt-9-3141.PMC4485649.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/40/main.PMC4485673.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.05.0022213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/40/main.PMC4485673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/40/main.PMC4485673.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/ef/main.PMC4485674.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.05.0032213-3232/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/bd/ef/main.PMC4485674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/ef/main.PMC4485674.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/38/main.PMC4485679.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.03.056 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/83/38/main.PMC4485679.pdf
This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/38/main.PMC4485679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/ba/main.PMC4485680.pdf
Inﬂammatory markers were raised http://dx.doi.org/10.1016/j.ijscr.2015.02.010 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/67/ba/main.PMC4485680.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/ba/main.PMC4485680.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/83/main.PMC4485681.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.003 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/83/main.PMC4485681.pdf
"45 (January (1)) (2010) 236–240, http://dx.doi.org/10.1016/j.jpedsurg.2009.10.039 .",OADS,/arxiv_data1/oa_pdf/d1/83/main.PMC4485681.pdf
"177 (September (1)) (2012) 127–130,http://dx.doi.org/10.1016/j.jss.2012.03.009 , Epub 2012 Mar 30.",OADS,/arxiv_data1/oa_pdf/d1/83/main.PMC4485681.pdf
"46 (June (6)) (2011) 1121–1125,http://dx.doi.org/10.1016/j.jpedsurg.2011.03.038 .",OADS,/arxiv_data1/oa_pdf/d1/83/main.PMC4485681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/23/main.PMC4485682.pdf
2 ) conﬁrmed the presence of http://dx.doi.org/10.1016/j.ijscr.2015.04.021 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/23/main.PMC4485682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/50/main.PMC4485683.pdf
"Thesepta orientation was in the antero-posterior direction (horizontaltype), so we decided to divide into smaller two osteotomy above http://dx.doi.org/10.1016/j.ijscr.2015.05.001 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/main.PMC4485683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/53/main.PMC4485684.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.004 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/53/main.PMC4485684.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/53/main.PMC4485684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC4485686.pdf
The approach http://dx.doi.org/10.1016/j.ijscr.2015.04.010 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC4485686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/3f/main.PMC4485687.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.04.020 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/3f/main.PMC4485687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/be/main.PMC4485688.pdf
"After micro- catheter embolization, en-bloc resection of the zygoma including http://dx.doi.org/10.1016/j.ijscr.2015.04.032 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/be/main.PMC4485688.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/37/main.PMC4485689.pdf
"Dur-ing exploration, it was discovered that the soft tissue of the rectum http://dx.doi.org/10.1016/j.ijscr.2015.04.023 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/da/37/main.PMC4485689.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/5a/main.PMC4485690.pdf
Limited contusions of the superior and middle lobe ofthe right lung were also described without any intra-abdominal http://dx.doi.org/10.1016/j.ijscr.2015.05.002 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/5a/main.PMC4485690.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.04.037 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"Case Rep. 4 (2013) 818–821, http://dx.doi.org/ 10.1016/j.ijscr.2013.07.006 (Epub 20.07.13).",OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"10 (2012)66, http://dx.doi.org/10.1186/1477-7819-10-66 [7] E. Fülöp, S. Marcu, D. Milutin, A. Borda, Gastrointestinal stromal tumors: review on morphology: diagnosis and management, Rom.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"456 (2010) 111–127, http://dx.doi.org/10.1007/ s00428-010-0891-y (Epub 18.02.10).",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"30 (2013) 8–12, http://dx.doi.org/10.4103/0970- 9371.107505[11] M. Benesch, Gastrointestinal Stromal Tumor, in: D. Schneider, I.B.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
Available from: < http://www.cap.org />.,Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"6 (2008) 76, http://dx.doi.org/10.1186/ 1477-7819-6-76 [15] E.D.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"32 (2008) 210–218, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"15 (2012) 74–81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"Case Rep. 5 (10) (2014) 681–685,http://dx.doi.org/10.1016/j.ijscr.2014.05.009 (Epub 15.08.14).",OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"Case Rep. 2013(December (12)) (2013), http://dx.doi.org/10.1093/jscr/rjt103 , pii: rjt103.",OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"11 (August) (2013) 172, http://dx.doi.org/10.1186/1477-7819- 11-172 [31] R. Colovi ´c, M. Micev, S. Mati ´c, N. Colovi ´c, N. Grubor, H.D.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"12 (May) (2014) 153, http://dx.doi.org/10.1186/1477-7819-12-153 [34] Z.M.",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"20 (October (37))(2014) 13632–13636, http://dx.doi.org/10.3748/wjg.v20.i37.13632[35] A. Nakano, Y. Akutsu, K. Shuto, M. Uesato, T. Kono, I. Hoshino, N. Akanuma, T. Maruyama, Y. Isozaki, H. Matsubara, Giant esophageal gastrointestinalstromal tumor: report of a case, Surg.",OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
"Cases 2 (January (1))(2014) 9–11, http://dx.doi.org/10.12998/wjcc.v2.i1.9 .",Non-OADS,/arxiv_data1/oa_pdf/44/c0/main.PMC4485691.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC4485692.pdf
The resected mass was http://dx.doi.org/10.1016/j.ijscr.2015.05.009 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC4485692.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/90/main.PMC4485692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/27/main.PMC4485693.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.007 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/27/main.PMC4485693.pdf
"Not all patients showedclinical beneﬁts from PPV; therefore, wetried to identify prognostic or predictive biomarkers in patients with aCRC who © Tetsuro Sasada, Shiro Kibe, Yoshito Akagi, and Kyogo Itoh *Correspondence to: Tetsuro Sasada; Email: tsasada@kcch.jpSubmitted: 12/31/2014; Accepted: 01/01/2015 http://dx.doi.org/10.1080/2162402X.2015.1005512 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Cancer Immunol Immunother2013; 62:919-29; PMID:23197273; http://dx.doi.org/ 10.1007/s00262-012-1379-1 2.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Curr Med Chem 2014; 21:2332-45; PMID:24524766; http://dx.doi.org/10.2174/0929867321666140205132936 3.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
J Clin Oncol 2011; 29:337-44; PMID:21149665; http://dx.doi.org/10.1200/JCO.2010.29.7499 4 .,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Cancer Immunol Immunother 2010; 59:1001-9;PMID:20146063; http://dx.doi.org/10.1007/s00262- 010-0822-4 5.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Cancer Immunol Res 2014; 2:1154-62; PMID:25351849; http://dx.doi.org/10.1158/2326-6066.CIR-14-0035 6.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Cancer Immu-nol Immunother 2011; 60:433-42; PMID:21221967; http://dx.doi.org/10.1007/s00262-010-0960-8 7.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Improved endpoints for cancer i m m u n o t h e r a p yt r i a l s .JN a t lC a n c e rI n s t2 0 1 0 ;102:1388-97; PMID:20826737; http://dx.doi.org/ 10.1093/jnci/djq310 8.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
Cancer 2012; 118:3208-21; PMID:22071976; http://dx.doi.org/10.1002/cncr.26636 9.,Non-OADS,/arxiv_data1/oa_pdf/69/5d/koni-04-05-1005512.PMC4485709.pdf
"These data also © Hatice Ozbilge, Charles LeVea, Allen Y Chung, Qingsheng Li, and Nejat K Egilmez *Correspondence to: Nejat K Egilmez; Email: nejat.egilmez@louisville.eduSubmitted: 12/18/2014; Accepted: 12/20/2014 http://dx.doi.org/10.1080/2162402X.2014.1002724 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Gastroenterology 2010; 138:2101-14; PMID:20420949; http://dx.doi.org/ 10.1053/j.gastro.2010.01.058 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Curr Cancer Drug Targets 2011; 11:451-64; PMID:21247378; http://dx.doi.org/10.2174/ 156800911795538066 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Cytokine Growth Factor Revi 2010; 21:331-44; PMID:21115385; http://dx.doi.org/10.1016/j.cytogfr.2010.09.002] 4.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Curr Opin Oncol 2013; 25:637-45; PMID:24076584; http://dx.doi.org/10.1097/CCO.00000000000000065.,OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Immunol Rev 2008; 223:114-31; PMID:18613832; http://dx.doi.org/10.1111/j.1600- 065X.2008.00635.x 6.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Nature 1997; 386:410-4; PMID:9121559; http://dx.doi.org/10.1038/386410a0 7.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Cancer Res 2014; 74:5377-85; PMID:25228656; http://dx.doi.org/ 10.1158/0008-5472.CAN-14-09188.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Sci Trans Med 2012; 4:164ra59; PMID:23241743; http://dx.doi.org/10.1126/ scitranslmed.3004566 9.,OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Pathol Res Pract 2008;204 (7):479-90; PMID:18538487; http://dx.doi.org/10.1016/j.prp.2008.03.004 10.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
Nat Med 2009; 15:1016-22; PMID:19701202; http://dx.doi.org/10.1038/nm.2015 www.tandfonline.com e1002724-3 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/5f/96/koni-04-04-1002724.PMC4485710.pdf
"Autologous in vitro acti- vated T cells were transduced using a © Antonio Bertoletti, Maurizia Brunetto, Mala K Maini, Ferruccio Bonino, Waseem Qasim, and Hans Stauss *Correspondence to: Antonio Bertoletti; Email: antonio@duke-nus.edu.sgSubmitted: 12/30/2014; Revised: 01/06/2015; Accepted: 01/08/2015 http://dx.doi.org/10.1080/2162402X.2015.1008354 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Nat Gen 2012; 44:765-9; PMID: 22634754; http://dx.doi.org/10.1038/ng.2295 2.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Gastroenterology 2009; 137:682-90; PMID:19394336; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Mol Ther 2009; 19:620-6; PMID: 21157437; http://dx.doi.org/10.1038/mt.2010.272 4.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
J Immu- nol 2014:1401703; PMID: 25539815; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
J Hepatol 2011; 55:103-10;PMID:21145860; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Gastroenterology 2013; 145:456-65; PMID:23639914; http://dx.doi.org/10.1053/j.gastro.2013.04.047 7.,Non-OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
J Hepatol2015; 62:486-92; PMID:25308176; http://dx.doi.org/ 10.1016/j.jhep.2014.10.001 8.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Mol Ther Nucleic Acids 2013; 2:e114; PMID:23941866; http://dx.doi.org/10.1038/mtna.2013.43 9.,Non-OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
J Hepatol 2012; 57:974-9; PMID:22771712; http://dx.doi.org/ 10.1016/j.jhep.2012.06.033 10.,OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Gastroenterology 2008; 134:1890-9; PMID:18424269; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/dd/koni-04-06-1008354.PMC4485715.pdf
Approximately30 000 patients were diagnosed with FL in 2010 (http://seer.can-cer.gov/seertools).,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
"However, it is possible that the macro-phage signature found in immune response 1 patients may corre- late with the presence of macrophages with antitumor functions (i.e., so-called M1 macrophages), and those in the immune © Xiao Liu, Girish Venkataraman, Jiaying Lin, Kazuma Kiyotani, Sonali Smith, Magdeline Montoya, Yusuke Nakamura, and Justin Kline *Correspondence to: Yusuke Nakamura; Email: ynakamura@bsd.uchicago.edu; Justin Kline; Email: jkline@medicine.bsd.uchicago.eduSubmitted: 11/18/2014; Revised: 12/20/2014; Accepted: 12/23/2014 http://dx.doi.org/10.1080/2162402X.2014.1002728 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2005; 23:5019–26; PMID:15983392; http://dx.doi.org/10.1200/JCO.2005.04.503 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2008; 26:5165–9;PMID:18838711; http://dx.doi.org/10.1200/ JCO.2008.16.0283 3.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Blood 2004; 104:1258–65; PMID:15126323; http://dx.doi.org/10.1182/blood-2003-12-4434 4.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
N Engl J Med 2004; 351:2159–69; PMID:15548776; http://dx.doi.org/ 10.1056/NEJMoa041869 5.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
N Engl J Med 1984; 311:1471–5; PMID:6548796; http://dx.doi.org/10.1056/NEJM198412063112303 6.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Clin Oncol 2014; 32:1797–803; PMID:24799467; http://dx.doi.org/10.1200/JCO.2012.43.9273 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2006; 24:5052–9; pub- lished online EpubNov 1 (10.1200/JCO.2006.06.4642); PMID:17033038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2006; 24:5350–7; PMID:17135637; http://dx.doi.org/10.1200/JCO.2006.06.4766 9.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Blood 2005; 106:2169–74;PMID:15933054; http://dx.doi.org/10.1182/blood- 2005-04-1565 10.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2007; 25:390–8;PMID:17200149; http://dx.doi.org/10.1200/ JCO.2006.06.1648 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Blood 2010; 115:289–95; PMID:19901260; http://dx.doi.org/10.1182/blood-2009-07-235598 12.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Invest 2014; 124:2246–59; PMID:24667641; http://dx.doi.org/10.1172/JCI73639 13.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Oncoimmunology2014; 3(12): e968467; http://dx.doi.org/10.4161/ 21624011.2014.968467 14.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Proc Nat Acad Sci USA 2005; 102:18538–43; PMID:16344461; http://dx.doi.org/10.1073/ pnas.0509182102 17.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Cancer 1996; 77:1303–10;PMID:8608507; http://dx.doi.org/10.1002/(SICI)1097- 0142(19960401)77:7%3c1303::AID-CNCR12%3e3.0.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Nature Immunol 2013;14:1155–65; http://dx.doi.org/10.1038/ni.2710 20.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Nature Rev Immunol 2006; 6:883–94; http://dx.doi.org/10.1038/nri1977 21.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Science 2003; 299:1057–61; PMID:12522256; http://dx.doi.org/10.1126/science.1079490 22.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Nature Immunol 2005; 6:1142–51; http://dx.doi.org/10.1038/ni1263 23.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
NatureImmunol 2005; 6:331–7; http://dx.doi.org/10.1038/ ni1179 24.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Nature Rev Immunol 2006; 6:295– 307; http://dx.doi.org/10.1038/nri1806 25.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Clinical Can Res 2008; 14:3156–67; http://dx.doi.org/10.1158/1078- 0432.CCR-07-4696 26.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Exp Med 2001; 194:823–32; PMID:11560997; http://dx.doi.org/10.1084/jem.194.6.82327.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Invest 2005; 115:3623–33; PMID:16308572; http://dx.doi.org/10.1172/ JCI25947 28.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
"Nature Med2004; 10:942–9; PMID:15322536; http://dx.doi.org/ 10.1038/nm1093 30. deLeeuw RJ, Kost SE, Kakal JA, Nelson BH.",OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Clin Can Res 2012; 18:3022–9; http://dx.doi.org/10.1158/1078-0432.CCR-11-3216 31.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Haematologica 2008; 93:193– 200; PMID:18223287; http://dx.doi.org/10.3324/ haematol.11702 33.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Immunity 2009; 30:636–45; PMID:19464986; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Blood 2011; 118:5371–9; PMID:21856865; http://dx.doi.org/ 10.1182/blood-2011-04-345777 3 5 .,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
Ann Rev Immunol 2004; 22:329–60; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Invest 2012; 122:3424–31; PMID:23023713; http://dx.doi.org/10.1172/ JCI63186 37.,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
J Clin Oncol 2014; 32:1757–9; PMID:24799493; http://dx.doi.org/10.1200/ JCO.2013.53.8439 e1002728-12 Volume 4 Issue 5 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/f2/f3/koni-04-05-1002728.PMC4485720.pdf
"Expression of multipletumor-associated antigens provides targets for humoral and © L Vassilev, T Ranki, T Joensuu, E J €ager, J Karbach, C Wahle, K Partanen, K Kairemo, T Alanko, R Turkki, N Linder, J Lundin, A Ristim €aki, M Kankainen, A Hemminki, C Backman, K Dienel, M von Euler, E Haavisto, T Hakonen, J Juhila, M J €aderberg, P Priha, A Vuolanto, and S Pesonen *Correspondence to: S Pesonen; Email: sari.pesonen@oncos.comSubmitted: 12/19/2014; Revised: 02/05/2015; Accepted: 02/06/2015 http://dx.doi.org/10.1080/2162402X.2015.1017702 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460; http://dx.doi.org/10.1056/NEJMoa020177 2.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Gynecol Oncol 2008; 108:415-20; PMID:18037158; http://dx.doi.org/ 10.1016/j.ygyno.2007.10.016 3 .,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Proc Natl Acad Sci USA2005; 102:18538-43; PMID:16344461; http://dx.doi.org/ 10.1073/pnas.0509182102 4.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Nat Med 2004; 10:942-9; PMID:15322536; http://dx.doi.org/10.1038/nm1093 5.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Cancer Res 2013; 73:6900-12; PMID:23975756; http://dx.doi.org/ 10.1158/0008-5472.CAN-13-15506.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
J Transl Med 2013; 11:147; PMID:23763830; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Oncoimmunol 2014; 3:e27668;PMID:25101220; http://dx.doi.org/10.4161/onci.27668 9.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
J Cancer Res Clin Oncol 2003; 129:397-409; PMID:12836015; http://dx.doi.org/10.1007/s00432-003-0445-7 11.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Ann Oncol 2005; 16(4):590-6; PMID:15699022; http://dx.doi.org/ 10.1093/annonc/mdi11212.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Nature 2002; 415:331-5;PMID:11797011; http://dx.doi.org/10.1038/415331a 13.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Natur e Rev Microbiol 2010; 8:62-73; PMID:19966816; http://dx.do i.org/10.1038/nrmicro2240 14.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
J Clin Invest 2014; 124(11):4843-56;PMID:25271627; http://dx.do i.org/10.1172/JCI75894 15.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Mol Ther 2010; 18:1874-84; PMID:20664527; http://dx.doi.org/ 10.1038/mt.2010.161 16.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Blood 2012; 119:3383-3393; PMID:22323450; http://dx.doi.org/10.1182/blood-2011-11-370130 18.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Curr Opin Immunol 2014; 27:1-7; PMID:24413387; http://dx.doi.org/10.1016/j.coi.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Cancer Immunol Immunother 2007;56:641- 648; PMID:16960692; http://dx.doi.org/10.1007/ s00262-006-0225-8 20.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Mol Ther 2011; 19:1737- 46; PMID:21673660; http://dx.doi.org/10.1038/ mt.2011.11321.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Am J Surg 1999; 177:55- 60; PMID:10037309; http://dx.doi.org/10.1016/ S0002-9610(98)00299-2 22.,OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139 23.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
J Rranslat Med 2012; 10:1-4; PMID:22214470; http://dx.doi.org/10.1186/1479- 5876-10-1 24.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
Hum Pathol 2003; 34:605-609; PMID:12827615; http://dx.doi.org/10.1016/S0046-8177(03)00177-1 25.,Non-OADS,/arxiv_data1/oa_pdf/fb/bb/koni-04-07-1017702.PMC4485730.pdf
"Indeed, (pre)neoplastic cells create a tolerant microenvi-ronment by activating a plethora of immunosuppressivemechanisms, including the modulation of antigen-presenting ©S t/C19ephanie A Demoulin, Joan Somja, Ana €elle Duray, Samuel Gu /C19enin, Patrick Roncarati, Philippe O Delvenne, Michael F Herfs, and Pascale M Hubert *Correspondence to: Pascale M Hubert; Email: p.hubert@ulg.ac.beSubmitted: 08/21/2014; Revised: 12/16/2014; Accepted: 01/08/2015 http://dx.doi.org/10.1080/2162402X.2015.1008334 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
JAMA 2000; 283:1031-7; PMID:10697063; http://dx.doi.org/10.1001/jama.283.8.1031 2.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Sci 2007; 98:874-81;PMID:17433037; http://dx.doi.org/10.1111/j.1349- 7006.2007.00470.x 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Dermatol Sci 2011; 63:173-83;PMID:21715145; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cytokine Growth Factor Rev 2008; 19:65-77; PMID:18061513; http://dx.doi.org/10.1016/j.cytogfr.2007.10.008 6.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Genes Immun 2013; 14:336-45; PMID:23698708; http://dx.doi.org/10.1038/gene.2013.29 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Prostate 2008; 68:92-104; PMID:18008334; http://dx.doi.org/ 10.1002/pros.20678 8.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer ImmunolImmunother 2012; 61:289-93; PMID:22237887; http://dx.doi.org/10.1007/s00262-011-1181-5 14.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Proc Natl Acad Sci USA 2011; 108:18049- 54; PMID:22006331; http://dx.doi.org/10.1073/ pnas.1110076108 15.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Adv Dermatol 2007; 23:307-33; PMID:18159907; http://dx.doi.org/ 10.1016/j.yadr.2007.07.014 16.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Immunol 2005; 174:2220-7; PMID:15699155;http://dx.doi.org/10.4049/jimmunol.174.4.2220 17.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Nat Immunol 2009; 10:488-95; PMID:19349986; http://dx.doi.org/10.1038/ni.1724 18.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Cell 2012; 21:402-17; PMID:22439936; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Immunol Cell Biol 2013; 91:545-55; PMID:24018532; http://dx.doi.org/10.1038/icb.2013.38 20.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Scand J Immunol 2004; 59:600-6; PMID:15182256; http://dx.doi.org/10.1111/j.1365-3083.2004.01453.x 22.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Int J Gynecol Cancer 2012; 22:1130-7; PMID:22872166;http://dx.doi.org/10.1097/IGC.0b013e318262aa53 23.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Nat Med 2006; 12:1372-9;PMID:17143276; http://dx.doi.org/10.1038/nm1518 24.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Oncol Rep 2011; 25:1545-8; PMID:21455582; http://dx.doi.org/ 10.3892/or.2011.1235 25.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Bone Miner Res 2000; 15:1321-9; PMID:10893680; http://dx.doi.org/10.1359/jbmr.2000.15.7.1321 26.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Immunol Immunother 2009; 58:603-14; PMID:18802697; http://dx.doi.org/ 10.1007/s00262-008-0584-427.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Future Oncol 2013; 9:1609-22; PMID:24156322; http://dx.doi.org/10.2217/fon.13.115 28.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Trends Endocrinol Metab 2011; 22:188-94; PMID:21470874; http://dx.doi.org/ 10.1016/j.tem.2011.02.007 30.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Am J Obstet Gynecol 2003 189:1660-5;PMID:14710094; http://dx.doi.org/10.1016/S0002- 9378(03)00852-4 31.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Int J cancer 1991; 48:533-9; PMID:1646176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Leukoc Biol 2013;93:343-52; PMID:23136258; http://dx.doi.org/ 10.1189/jlb.0812397 33.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Eur Cytokine Netw 2008; 19:81-8; PMID:18632421; http://dx.doi.org/ 10.1684/ecn.2008.0125 34.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Immunol 2002; 169:3606-12; PMID:12244151; http://dx.doi.org/ 10.4049/jimmunol.169.7.3606 36.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
J Exp Med 2007; 204:3119-31; PMID:18086861; http://dx.doi.org/10.1084/jem.20071724 37.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Immunol Rev 2010; 234:120-41; PMID:20193016; http://dx.doi.org/10.1111/j.0105- 2896.2009.00886.x 38.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Immunol Immun- other 2005; 54:307-14; PMID:15599732; http://dx.doi.org/10.1007/s00262-004-0593-x 40.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
22; PMID:23521696; http://dx.doi.org/10.1111/ imm.12101 41.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Clin Cancer Res 2009; 15:6341-7; PMID:19825956; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1652 42.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Transpl Immunol 2003; 11:245- 58; PMID:12967778; http://dx.doi.org/10.1016/ S0966-3274(03)00058-3 43.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Exp Mol Pathol 2012; 93:294-301; PMID:23018130; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Blood 2007; 110:211-9; PMID:17356131; http://dx.doi.org/10.1182/blood- 2006-10-052506 45.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Blood 2006; 107:2037-44; PMID:16293609; http://dx.doi.org/10.1182/blood- 2005-07-2760 46.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Biochem Biophys Res Commun 2012; 429:156-62; PMID:23142594; http://dx.doi.org/10.1016/j.bbrc.2012.10.12247.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
PloS One 2009; 4:e6846; PMID:19718269;http://dx.doi.org/10.1371/journal.pone.0006846 48.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Biochim Biophys Acta 2014;1845(2):182-201; PMID:24440852; http://dx.doi.org/ 10.1016/j.bbcan.2014.01.004 49.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Scand J Immu- nol 2013; 78:1-7; PMID:23298229; http://dx.doi.org/ 10.1111/sji.12019 50.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Nature 2007; 446:690-4;PMID:17377533; http://dx.doi.org/10.1038/ nature05656 51.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cell Res 2008; 18:858-70; PMID:18645583; http://dx.doi.org/10.1038/cr.2008.84 52.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Lett 2014; 353:194-200; PMID:25079688; http://dx.doi.org/ 10.1016/j.canlet.2014.07.034 53.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
PloS One2012; 7:e41127; PMID:22952578; http://dx.doi.org/ 10.1371/journal.pone.004112754.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Oncologist 2011; 16:136-45;PMID:21285392; http://dx.doi.org/10.1634/ theoncologist.2010-0154 55.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Eur J Immunol 2010; 40:3075-84; PMID:21061438; http://dx.doi.org/10.1002/eji.201040571 56.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Exp Hem-atol 2012; 40:268-78; PMID:22245566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Immunol Immunother1998; 47:81-9; PMID:9769116; http://dx.doi.org/ 10.1007/s002620050507 59.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
Cancer Immunol Immunother 2009; 58:39-47; PMID:18438663; http://dx.doi.org/10.1007/s00262-008-0522-5 www.tandfonline.com e1008334-13 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/koni-04-06-1008334.PMC4485731.pdf
"We found that normal monocytes were converted to © Zhe (Jenny) Zhang, Peggy A Bulur, Ahmet Dogan, Dennis A Gastineau, Allan B Dietz, and Yi Lin *Correspondence to: Yi Lin; Email: Lin.Yi@mayo.eduSubmitted: 10/10/2014; Revised: 12/04/2014; Accepted: 12/05/2014 http://dx.doi.org/10.1080/2162402X.2014.996470 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Leuk Lym- phoma 2014; 55:988-98; PMID:23865835; http://dx.doi.org/10.3109/10428194.2013.8259033.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Curr Hematol Malig Rep 2009; 4:196-201; PMID:20425408; http://dx.doi.org/10.1007/s11899- 009-0026-1 4.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Clin Oncol 2011; 29:1803-11; PMID:21483013; http://dx.doi.org/10.1200/ JCO.2010.33.3252 5.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Blood 2011; 117:872-81; PMID:21063024; http://dx.doi.org/10.1182/blood-2010-05-283820 6.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Nat Rev Cancer 2013; 13:739-52; PMID:24060865; http://dx.doi.org/ 10.1038/nrc3581 7.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
PMID:24203443; http://dx.doi.org/10.1007/s12026- 013-8455-2 8.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Neuro Oncol 2010; 12:631-44; PMID:20179016; http://dx.doi.org/10.1093/neuonc/ noq001 9.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Cancer Immunol Immunother 2013; 62:1421-30; PMID:23764929; http://dx.doi.org/10.1007/s00262-013-1447-1 11.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Exp Dermatol 2014; 23:202-4; PMID:24495013; http://dx.doi.org/10.1111/exd.12336 12.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Br J Haematol 2012; 156:674-6; PMID:22050346; http://dx.doi.org/10.1111/j.1365- 2141.2011.08902.x 13.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Immunother Cancer 2013; 1:7; PMID:25512872; http://dx.doi.org/10.1186/2051-1426-1-7 14.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Int J Lab Hematol 2014; 36:350-55; PMID:24636145; http://dx.doi.org/10.1111/ijlh.,OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Eur J Immunol 2010; 40:22-35; PMID:19941314; http://dx.doi.org/ 10.1002/eji.200939903 16.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Mod Pathol 2004; 17:109-16; PMID:14657946; http://dx.doi.org/10.1038/modpathol.3800039 17.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Blood 1997; 90: 935- 43; PMID:9242521; http://dx.doi.org/0006-4971/97/9003-0142 18.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Immunol 2000; 165:3951-8; PMID:11034403; http://dx.doi.org/10.4049/ jimmunol.165.7.3951 19.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Cell Stress Chaperones 2014; 19:135-44; PMID:23775284; http://dx.doi.org/ 10.1007/s12192-013-0440-0 20.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Eur J Immunol 2007; 37:2812-24; PMID:17823891; http://dx.doi.org/ 10.1002/eji.200636993 21.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Cancer Res 2011; 71:318- 27; PMID:21224361; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-1778 22.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Prog Mol Subcell Biol 2002; 28:205-18; PMID:11908061; http://dx.doi.org/ 10.1007/978-3-642-56348-5_11 23.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Clin Oncol 2014; 32:3059-68; PMID:25113753; http://dx.doi.org/10.1200/JCO.2013.54.8800 25.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Clin Oncol 2007; 25:579-86;PMID:17242396; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
J Cell Biochem 2008; 103:270-83; PMID:17516511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Pathol Int 2008; 58:529-32; PMID:18705775; http://dx.doi.org/10.1111/j.1440-1827.2008.02268.x 29.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Histopathology 2012; 60:313-9; PMID:22211289; http://dx.doi.org/10.1111/j.1365- 2559.2011.04096.x 30.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Clin Cancer Res 2007; 13:2855-64; PMID:17504983; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2090 31.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Int J Radiat Oncol Biol Phys 2008; 70:543-53; PMID:17980509; http://dx.doi.org/ 10.1016/j.ijrobp.2007.08.061 32.,OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Cancer Res 2003; 63:6174-7; PMID:14559800; http://dx.doi.org/10.1182/blood-2003-08-2873 33.,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
Blood 2012; 119:2844-53; PMID:2323454; http://dx.doi.org/ 10.1182/blood-2011-10-388538 e996470-8 Volume 4 Issue 4 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/56/00/koni-04-04-996470.PMC4485750.pdf
"1,7We, therefore, reasoned that immunogenic chemotherapies inducing strong CD8CT–cell-dependent effector © Alison M McDonnell, W Joost Lesterhuis, Andrea Khong, Anna K Nowak, Richard A Lake, Andrew J Currie, and Bruce WS Robinson *Correspondence to: Alison M McDonnell; Email: alison.mcdonnell@uwa.edu.auSubmitted: 12/28/2014; Revised: 12/29/2014; Accepted: 12/30/2014 http://dx.doi.org/10.1080/2162402X.2015.1005501 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
Clin Dev Immunol 2010; 2010: 539519;PMID:20976125; http://dx.doi.org/10.1155/2010/ 539519 2.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
Oncoimmunology 2012; 1: 1084–94; PMID:23170256; http://dx.doi.org/10.4161/onci.20924 4.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
OncoImmunology 2012; 1: 840–6; PMID:23162751; http://dx.doi.org/10.4161/onci.20493 5.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
J Immunol 2000; 165: 6047–55; PMID:11086036; http://dx.doi.org/10.4049/jimmunol.165.11.6047 6.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
Semin Immunopathol 2011; 33: 353–67; PMID:21274535; http://dx.doi.org/10.1007/s00281- 011-0246-z 9.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
Immunity 2013; 38: 729– 41; PMID:23562161; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
PLoS One 2013; 23: 8(4): e61895; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6c/0a/koni-04-05-1005501.PMC4485774.pdf
"© Jonathan Pol, Norma Bloy, Aitziber Buqu /C19e, Alexander Eggermont, Isabelle Cremer, Catherine Saut /C18es-Fridman, Jer ^ome Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer, and Lorenzo Galluzzi*Correspondence to: Lorenzo Galluzzi; Email: eadoc@vodafone.it; Guido Kroemer; Email: kroemer@orange.fr Submitted: 10/06/2014; Accepted: 10/06/2014http://dx.doi.org/10.4161/2162402X.2014.974411 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"Literature Update During the last 13 months, the results of no less than 60 clinical trials investigating the safety and efﬁcacy of recombinant/puriﬁedTAAs or peptides thereof as therapeutic interventions in cancerpatients have been published in the peer-reviewed scientiﬁc litera-ture (sources http://www.ncbi.nlm.nih.gov/pubmed and http://meetinglibrary.asco.org/abstracts).",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"187-189 Ongoing Trials When this Trial Watch was being redacted (September 2014), ofﬁcial sources listed no less than 19 clinical trials initiated afterSeptember 1 st, 2013 to evaluate the safety and efﬁcacy of recom- binant/puriﬁed TAAs or peptides thereof as anticancer vaccines in patients (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"Of note, both NCT01989572 and NCT01989559are listed as “Completed” on http://www.clinicaltrials.gov.",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"As for the clinical trials listed in our 2 previous Trial Watches dealing with this topic, 47,48the following studies have changed status since the publication of the latter: NCT01854099, nowlisted as “Withdrawn;” NCT00624182 and NCT01264731,now listed as “Suspended;” NCT00455572, NCT00977145 andNCT01058850, now listed as “Terminated;” NCT00480025,NCT00643097, NCT00694551, NCT00819806,NCT00821652, NCT01149343, NCT01222221, NCT01250470, NCT01355393, NCT01425749, NCT01437605, NCT01462838, NCT01507103,NCT01580696, NCT01592617, NCT01606241 andNCT01632332, and now listed as “Active, not recruiting;”NCT00911560, NCT00960752, NCT01220128, NCT01307618, NCT01479244, NCT01526473,NCT01532960, NCT01570036 and NCT01922921, nowlisted as “Recruiting;” NCT00626015, NCT00655161, NCT00773097, NCT00841399, NCT00854789, NCT01639885 and NCT01673217, now listed as “Completed”(source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"NCT00455572,NCT00977145 and NCT01058850 were all terminated owingto issues with patient accrual (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"Tothe best of our knowledge, the results of NCT00655161,NCT00854789, NCT01639885 and NCT01673217 have notbeen released yet (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Immunol 2002; 3:991-8;PMID:12407406; http://dx.doi.org/10.1038/ni1102- 991 4.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Adv Immunol 2006; 90:1-50; PMID:16730260; http://dx.doi.org/ 10.1016/S0065-2776(06)90001-7 5.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Curr Opin Immunol 2007;19:203-8; PMID:17292599; http://dx.doi.org/ 10.1016/j.coi.2007.02.001 6.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunity 2004; 21:137-48; PMID:15308095;http://dx.doi.org/10.1016/j.immuni.2004.07.017 7.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/ science.1224922 8.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"Motz GT, Coukos G. The parallel lives of angiogene- sis and immunosuppression: cancer and other tales.Nat Rev Immunol 2011; 11:702-11; PMID:21941296; http://dx.doi.org/10.1038/nri3064 9.",OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Immunol Immunother 2007; 56:1687-700; PMID:17571260; http://dx.doi.org/10.1007/s00262-007-0343-y 10.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Annu Rev Immunol 2007; 25:267-96; PMID:17134371; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141609 11.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Rev Vaccines 2012; 11:1315-7; PMID:23249231; http://dx.doi.org/10.1586/erv.12.107 12.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Survivin the battle against immunosuppression.Oncoimmunology 2012; 1:240-1; PMID:22720256; http://dx.doi.org/10.4161/onci.1.2.18180 15.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Annu Rev Immunol 2009; 27:83-117;PMID:19007331; http://dx.doi.org/10.1146/ annurev.immunol.021908.132544 16.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2012; 12:265-77;PMID:22437871; http://dx.doi.org/10.1038/nrc3258 17.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
NatRev Cancer 2012; 12:237-51; PMID:22437869; http://dx.doi.org/10.1038/nrc3237 18.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Annu Rev Immunol 1994; 12:337-65; PMID:8011285; http://dx.doi.org/10.1146/ annurev.iy.12.040194.002005 20.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1643-4; PMID:23264922; http://dx.doi.org/10.4161/onci.21717 22.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Clin Cancer Res 2014; 20:1125-34; PMID:24323902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunother Cancer 2013;1:11; PMID:24829748; http://dx.doi.org/10.1186/ 2051-1426-1-11 24.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:768-9; PMID:22934277;http://dx.doi.org/10.4161/onci.19727 25.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Res 2012; 72:1081-91; PMID:22237626; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3722 26.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Mol Cell Biol 2011; 12:385-92; PMID:21527953; http://dx.doi.org/10.1038/nrm3115 27.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
CellDeath Differ 2011; 18:1403-13; PMID:21072053; http://dx.doi.org/10.1038/cdd.2010.145 28.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Mol Cell Biol 2010; 11:220-8; PMID:20177397;http://dx.doi.org/10.1038/nrm2858 29.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Can-cer 2003; 3:701-8; PMID:12951589; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nature 2005; 434:907- 13; PMID:15829965; http://dx.doi.org/10.1038/ nature03485 31.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Proc Natl Acad Sci U S A 2014;111:403-8; PMID:24344295; http://dx.doi.org/ 10.1073/pnas.1306549111 32.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Mol Syst Biol 2011; 7:533; PMID:21952136; http://dx.doi.org/10.1038/msb.2011.68 33.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Mol Oncol 2011; 5:164-82; PMID:21376678; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Biol Ther2006; 5:1226-7; PMID:17021387; http://dx.doi.org/ 10.4161/cbt.5.9.3343 39.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Exp Med 2004; 199:815-24; PMID:15024047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Blood 2013; 121:2836-44; PMID:23390195; http://dx.doi.org/10.1182/blood-2012-09-452078 41.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Immunol 2007; 7:790- 802; PMID:17853902; http://dx.doi.org/10.1038/nri2173 42.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Rev Vaccines2007; 6:591-603; PMID:17669012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
N Engl J Med 2011; 364:2119-27; PMID:21631324; http://dx.doi.org/ 10.1056/NEJMoa1012863 47.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1557-76; PMID:23264902; http://dx.doi.org/10.4161/ onci.22428 49.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Clin Oncol 2014; 11:509-24; PMID:25001465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Annu Rev Immunol 2004; 22:329-60; PMID:15032581; http://dx.doi.org/10.1146/annurev.immunol.22.012703.104803 51.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Curr Opin Immunol 2014; 27:16-25;PMID:24531241; http://dx.doi.org/10.1016/j.coi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nature 2012; 482:405-9; PMID:22318517; http://dx.doi.org/ 10.1038/nature10803 54.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1607-9; PMID:23264909;http://dx.doi.org/10.4161/onci.2145655.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486 56.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:995-6; PMID:23162784; http://dx.doi.org/10.4161/onci.20011 57.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunol 2013; 190:5588-99; PMID:23630363; http://dx.doi.org/10.4049/jimmunol.1203216 61.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
PLoS One 2013; 8:e52940; PMID:23308126; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nature 2014; 512:324-7; PMID:25043048; http://dx.doi.org/10.1038/nature13387 64.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Rev Vaccines 2013; 12:253-62; PMID:23496665; http://dx.doi.org/10.1586/ erv.13.27 65.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Clin Oncol 2005; 23:7536- 45; PMID:16157940; http://dx.doi.org/10.1200/JCO.2005.03.047 66.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cell Death Differ 2014; 21:50-8; PMID: 23744294; http://dx.doi.org/10.1038/cdd.2013.60 67.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunity 2013; 39:74-88; PMID:23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014 71.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:28-37; PMID:22720209; http://dx.doi.org/ 10.4161/onci.1.1.17938 75.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Immunol 2002; 2:85-95; PMID:11910899; http://dx.doi.org/10.1038/nri724 77.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Immunol Immunother 2014;63:779-86; PMID:24756419; http://dx.doi.org/ 10.1007/s00262-014-1551-x 78.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Immunol Immunother 2013; 62:639-52; PMID:23143746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:287-357;PMID:22737604; http://dx.doi.org/10.4161/onci.18628 81.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2012; 12:860-75; PMID:23151605; http://dx.doi.org/10.1038/nrc3380 82.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Mol CellBiol 2012; 13:780-8; PMID:23175281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Hepatol 2013; 59:583-94; PMID:23567086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Trends Immunol 2013; 34:471-81; PMID:23891238; http://dx.doi.org/10.1016/j.it.2013.06.005 86.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunotherapy 2011; 3:731-3; PMID:21668310; http://dx.doi.org/10.2217/imt.11.62 87.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
N Engl J Med 2007; 356:1908-10; PMID:17494923; http://dx.doi.org/10.1056/NEJMp078053 88.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Lancet 2009; 374:301- 14; PMID:19586656; http://dx.doi.org/; http://dx.doi.org/10.1016/S0140-6736(09)61248-4 89.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Biosci Biotechnol Biochem 2013; 77:766-70; PMID:23563546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2013; 11:97; PMID:23578144; http://dx.doi.org/10.1186/1479- 5876-11-97 106.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Dev Comp Immunol 2013; 41:68-76; PMID:23583523; http://dx.doi.org/ 10.1016/j.dci.2013.04.004 107.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Invest New Drugs 2014; 32:235-42; PMID:23609828; http://dx.doi.org/10.1007/s10637-013-9960-9 e974411-8 Volume 4 Issue 4 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Gas-tric Cancer 2014; 17:173-80; PMID:23613128; http://dx.doi.org/10.1007/s10120-013-0258-6 109.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Int J Oncol2013; 43:1019-26; PMID:23903757; http://dx.doi.org/ 10.3892/ijo.2013.2044 111.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Immunol Immunother 2013; 62:1599-608; PMID:23934022; http://dx.doi.org/10.1007/s00262-013-1461-3 113.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Clin Oncol 2013; 31:4311-8; PMID:24145345; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2013; 11:291; PMID:24237633; http://dx.doi.org/ 10.1186/1479-5876-11-291 116.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Hum Vaccin Immun- other 2014; 10:338-43; PMID:24252799; http://dx.doi.org/10.4161/hv.27217 117.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
BMC Cancer 2013; 13:613; PMID:24373380; http://dx.doi.org/ 10.1186/1471-2407-13-613 120.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Int J Oncol 2014;44:662-8; PMID:24398900; http://dx.doi.org/ 10.3892/ijo.2013.2242 122.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Br J Haematol 2014; 164:366-75; PMID:24422723;http://dx.doi.org/10.1111/bjh.12637 123.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Immu- nol Immunother 2014; 63:381-94; PMID:24487961; http://dx.doi.org/10.1007/s00262-013-1516-5 124.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunother 2014; 37:105-14; PMID:24509173; http://dx.doi.org/10.1097/CJI.0000000000000020 126.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2014; 12:61; PMID:24606884; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2014; 12:63; PMID:24612787; http://dx.doi.org/10.1186/ 1479-5876-12-63 130.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med2014; 12:84; PMID:24708624; http://dx.doi.org/ 10.1186/1479-5876-12-84 131.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunopharmacol Immunotoxicol 2014; 36:224-36; PMID:24773550; http://dx.doi.org/10.3109/08923973.2014.913617 132.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Clin Oncol 2014; 32:2050-8; PMID:24888813; http://dx.doi.org/10.1200/JCO.2013.54.0526 134.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Breast Cancer Res2014; 16:R70; PMID:24992895; http://dx.doi.org/ 10.1186/bcr3685 139.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunother Cancer 2014; 2:23; PMID:25126421; http://dx.doi.org/10.1186/2051- 1426-2-23 142.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
PMID:25130084; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Immunol 2014; 15:266-74; PMID:24487322; http://dx.doi.org/10.1038/ni.2822 144.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Immunol 2014; 15:798-807; PMID:25137454; http://dx.doi.org/10.1038/ni.2940 145.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Front Immunol 2014; 5:132; PMID:24817867; http://dx.doi.org/10.3389/ﬁmmu.2014.00132 146.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Vaccine 2014; 32:2241-50;PMID:24530151; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2013; 11:88; PMID:23557172; http://dx.doi.org/10.1186/ 1479-5876-11-88 148.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"Evid Based Com- plement Alternat Med 2013; 2013:981717; PMID:23840274; http://dx.doi.org/10.1155/2013/ 981717 149. de Vos van Steenwijk PJ, van Poelgeest MI, Ram- wadhdoebe TH, Lowik MJ, Berends-van der Meer DM, van der Minne CE, Loof NM, Stynenbosch LF, Fathers LM, Valentijn AR, et al.",OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
The long-termimmune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.Cancer Immunol Immunother 2014; 63:147-60; PMID:24233343; http://dx.doi.org/10.1007/s00262- 013-1499-2 150.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunother 2014; 37:84-92; PMID:24509171; http://dx.doi.org/10.1097/ CJI.0000000000000017 151.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2008; 8:351-60; PMID: 18418403; http://dx.doi.org/10.1038/nrc2373 153.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Front Immunol 2014;5:308; PMID:25071769; http://dx.doi.org/10.3389/ ﬁmmu.2014.00308 154.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efﬁcacy of a subunit malaria vaccine.Infect Immun 2004; 72:949-57; PMID:14742540; http://dx.doi.org/10.1128/IAI.72.2.949-957.2004 158.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Rev Vaccines 2002; 1:111-8; PMID:12908518;http://dx.doi.org/10.1586/14760584.1.1.111 159.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2013; 2:e22691; PMID:23524510; http://dx.doi.org/10.4161/onci.22691 160.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunol 2000; 164:1625-33; PMID:10640784; http://dx.doi.org/ 10.4049/jimmunol.164.3.1625 161.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Vaccine 1999; 17:1201-5; PMID:10195633; http://dx.doi.org/ 10.1016/S0264-410X(98)00341-7 162.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunity1994; 1:751-61; PMID:7895164; http://dx.doi.org/ 10.1016/S1074-7613(94)80017-0 163.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 1989; 244:707-12; PMID:2470152; http://dx.doi.org/ 10.1126/science.2470152 164.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 1987; 235:177-82; PMID: 3798106; http://dx.doi.org/10.1126/science.3798106 165.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Int J Cancer 1991;49:650-5; PMID:1682277; http://dx.doi.org/ 10.1002/ijc.2910490504 167.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Mod Pathol 2013; 26:610-1; PMID:23542524; http://dx.doi.org/10.1038/modpathol.2013.38168.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Mod Pathol 2012;25:938-48; PMID:22388760; http://dx.doi.org/ 10.1038/modpathol.2012.36 169.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 2013; 339:959-61; PMID:23348503; http://dx.doi.org/10.1126/science.1230062 172.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Science 2013; 339:957-9; PMID:23348506; http://dx.doi.org/ 10.1126/science.1229259 173.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Clin Cancer Res 2007; 13:5991-4; PMID:17947459; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0686 175.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2008; 6:24; PMID:18471305; http://dx.doi.org/10.1186/1479- 5876-6-24 176.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Int J Cancer 1994; 59:78-82; PMID:7927908; http://dx.doi.org/ 10.1002/ijc.2910590116 179.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Drug Discov 2013; 12:829-46; PMID:24113830; http://dx.doi.org/10.1038/nrd4145 184.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nature 2014; 507:519-22; PMID:24531764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Clin Invest 2014; 124:188-97; PMID:24292708; http://dx.doi.org/ 10.1172/JCI69856 186.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Clin Invest 2013; 123:2509-22; PMID:23635779;http://dx.doi.org/10.1172/JCI67250 187.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Res 2014;74:436-45; PMID:24302580; http://dx.doi.org/ 10.1158/0008-5472.CAN-13-1265 188.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Curr Mol Med 2012; 12:1183-97; PMID:22804241; http://dx.doi.org/ 10.2174/156652412803306684 193.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Front Immunol 2012; 3:63; PMID:22566944; http://dx.doi.org/10.3389/ﬁmmu.2012.00063 194.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Rev Vaccines 2008; 7:1019-30; PMID:18767951; http://dx.doi.org/10.1586/14760584.7.7.1019 195.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncogene 2012; 31:1869-83; PMID:21892204; http://dx.doi.org/ 10.1038/onc.2011.384 196.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Dalton Trans 2010; 39:8113-27; PMID:20593091; http://dx.doi.org/10.1039/c0dt00292e 197.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Bio- chem Pharmacol 1999; 58:1625-9; PMID:10535754;http://dx.doi.org/10.1016/S0006-2952(99)00250-6 198.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Gynecol Oncol 2013; 129:251-7; PMID:23280089; http://dx.doi.org/ 10.1016/j.ygyno.2012.12.035199.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Cancer 2014; 5:86-97; PMID:24494026;http://dx.doi.org/10.7150/jca.7963 200.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Int J Cancer 1997; 74:193-8; PMID:9133455; http://dx.doi.org/10.1002/(SICI)1097-0215(19970422)74:2%3c193::AID-IJC10%3e3.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Gynecol Oncol 2013; 131:493-8; PMID:23863359; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2009; 9:445-52; PMID:19461669; http://dx.doi.org/10.1038/nrc2639 204.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Curr Cancer Drug Targets 2009; 9:938-52; PMID:20025603; http://dx.doi.org/10.2174/156800909790192374 205.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Res 2012; 72:5435-40; PMID:23090118; http://dx.doi.org/10.1158/0008-5472.CAN-12-0569 206.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 208.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Lancet Oncol 2010; 11:108-9; PMID:20152761; http://dx.doi.org/10.1016/S1470-2045(09)70400-0 210.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Lancet Oncol 2010; 11:155-64; PMID:20004617; http://dx.doi.org/10.1016/S1470- 2045(09)70334-1 211.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Drug Discov 2011; 10:411-2; PMID:21629286; http://dx.doi.org/10.1038/nrd3463 212.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Vemurafenib enhances MHC induction in BRAF homozygous melanoma cells.Oncoimmunology 2013; 2:e22890; PMID:23483066; http://dx.doi.org/10.4161/onci.22890 216.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
N Engl J Med 2012; 366:707-14; PMID:22356324; http://dx.doi.org/10.1056/NEJMoa1112302 217.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Immunother 2009; 32:292-301; PMID:19242371;http://dx.doi.org/10.1097/CJI.0b013e31819b7c8e 221.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Clin Can- cer Res 2012; 18:6485-96; PMID:23032742; http://dx.doi.org/10.1158/1078-0432.CCR-12-1516 222.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Clin Cancer Res 2012; 18:6497-508; PMID:23032745; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012;1:1409-10; PMID:23243610; http://dx.doi.org/ 10.4161/onci.21059 225.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Vaccine 2012; 30:4216-24; PMID:22542815; http://dx.doi.org/10.1016/j.vaccine.2012.04.051 226.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
205:466-73; PMID:22147791; http://dx.doi.org/ 10.1093/infdis/jir769 227.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Sci Transl Med2010; 2:53ra74; PMID:20944089; http://dx.doi.org/ 10.1126/scitranslmed.3001094 229.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Transl Med 2012; 10:141; PMID:22776426; http://dx.doi.org/10.1186/1479-5876-10-141 230.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Br J Cancer 2011; 104:376-86; PMID:21063397; http://dx.doi.org/10.1038/sj.bjc.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Res 2007; 67:11601-11; PMID:18089789; http://dx.doi.org/10.1158/0008-5472.CAN-07-3243 232.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Immunol Cell Biol 2004; 82:488-96; PMID:15479434; http://dx.doi.org/ 10.1111/j.0818-9641.2004.01272.x 233.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Drug News Perspect 2008; 21:69-87; PMID:18389099; http://dx.doi.org/10.1358/dnp.2008.21.2.1188193 234.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Expert Opin Investig Drugs 2013; 22:149-59; PMID:23205468; http://dx.doi.org/10.1517/13543784.2013.749236 235.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Infect Dis 2007; 195:1324-31; PMID:17397003; http://dx.doi.org/10.1086/513276 236.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncogene 2008; 27:190-9; PMID: 18176600; http://dx.doi.org/10.1038/sj.onc.1210913 237.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Blood 2010; 115:3520-30;PMID:20197554; http://dx.doi.org/10.1182/blood- 2009-09-246124 239.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Mol Cancer Ther 2010; 9:489-98;PMID:20124451; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0628 240.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1191-3; PMID:23170276; http://dx.doi.org/ 10.4161/onci.20664 242.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1645-7; PMID:23264923; http://dx.doi.org/10.4161/onci.21746 245.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology2012; 1:326-33; PMID:22737608; http://dx.doi.org/ 10.4161/onci.18852 247.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Cancer Res 2005; 65:2009-17; PMID:15753401; http://dx.doi.org/10.1158/0008-5472.CAN-04-3216 248.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Med 2004; 10:294-8; PMID:14981514;http://dx.doi.org/10.1038/nm999 249.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy.Int Immunol 2003; 15:797-805; PMID:12807818; http://dx.doi.org/10.1093/intimm/dxg078 250.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
J Exp Med 1983; 157:1040-52; PMID: 6187879; http://dx.doi.org/10.1084/jem.157.3.1040 251.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Eur J Immunol 1998; 28:4010-9; PMID:9862337; http://dx.doi.org/10.1002/(SICI) 1521-4141(199812)28:12%3c4010::AID-IMMU4010%3e3.0.CO;2-5 253.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nature 2013; 504:S6-8; PMID:24352363; http://dx.doi.org/10.1038/504S6a 256.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Pharmacol Res 2012; 65:9- 22; PMID:21930211; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2007; 7:95-106; PMID:17251916; http://dx.doi.org/10.1038/nrc2051 259.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Nat Rev Cancer 2012;12:252-64; PMID:22437870; http://dx.doi.org/ 10.1038/nrc3239 260.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Semin Oncol 2014; 41:126-32; PMID:24565586; http://dx.doi.org/10.1053/j.seminoncol.2013.12.014 261.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Lancet Oncol 2013; 14:1035-7;PMID:24035406; http://dx.doi.org/10.1016/S1470- 2045(13)70401-7 262.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Lancet 2014; 384:1109-17; PMID:25034862; http://dx.doi.org/10.1016/ S0140-6736(14)60958-2 264.,OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1167-8; PMID:23170267; http://dx.doi.org/ 10.4161/onci.20591 269.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2012; 1:1323-43; PMID: 23243596; http://dx.doi.org/10.4161/onci.22009 270.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Clin Cancer Res 2013; 19:1009-20; PMID:23460532; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
Oncoimmunology 2013; 2:e22616; PMID: 23482345; http://dx.doi.org/10.4161/onci.22616 e974411-12 Volume 4 Issue 4 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/43/b2/koni-04-04-974411.PMC4485775.pdf
"6 STAT3 phosphorylation at tyrosine residue 705 (pY-STAT3) via Janus kinases (JAKs) is induced by pro- and anti- © Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, Eva-Maria Putz, Martin Holcmann, Michaela Schlederer, Beatrice Grabner, Ilija Crnc ec, Jasmin Svinka, Monica Musteanu, Thomas Hoffmann, Martin Filipits, Walter Berger, Valeria Poli, Lukas Kenner, Martin Bilban, Emilio Casanova, Mathias M €uller, Birgit Strobl, Editha Bayer, Thomas Mohr, Veronika Sexl, and Robert Eferl*Correspondence to: Robert Eferl; Email: robert.eferl@meduniwien.ac.atSubmitted: 10/23/2014; Revised: 12/10/2014; Accepted: 12/10/2014 http://dx.doi.org/10.1080/2162402X.2014.998529 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Gastroenterology 2010; 138:2101-14 e5; PMID:20420949; http://dx.doi.org/ 10.1053/j.gastro.2010.01.058 2.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Protein Cell 2013; 4:176-85; PMID:23483479; http://dx.doi.org/10.1007/s13238-013-2084-3 3.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Med 2013; 19:1423-37; PMID:24202395; http://dx.doi.org/ 10.1038/nm.3394 4.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Immunol 2010; 11:889-96; PMID: 20856220; http://dx.doi.org/10.1038/ni.1937 5.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Med 2013; 19:1264-72; PMID:24056773;http://dx.doi.org/10.1038/nm.33376.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Science 2014; 344:921-5; PMID:24812208; http://dx.doi.org/ 10.1126/science.1252510 7.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Immunol 2007; 178:2623-9;PMID:17312100; http://dx.do i.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Immunity 2004; 21:491-501; PMID:15485627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancer Cell 2009; 15:91-102; PMID:19185844;http://dx.doi.org/10.1016/j.ccr.2009.01.002 10.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancer Cell 2009; 15:103-13; PMID:19185845; http://dx.doi.org/10.1016/j.ccr.2009.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancers2014; 6:1394-407; PMID:24995503; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Biol Chem 2012; 287:18182-9; PMID:22496368; http://dx.doi.org/10.1074/jbc.M111.328831 13.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Gastroenterology 2010; 138:1003-11 e1-5; PMID:19962983; http://dx.doi.org/10.1053/j.gastro.2009.11.049 14.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Stat 2013; 2:e23010; PMID:24058791; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Clin Cancer Res 2007; 13:1362-6;PMID:17332277; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2313 17.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Front Biosci 2008; 13:2888-99; PMID:17981761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Med 2005; 11:1314-21; PMID:16288283; http://dx.doi.org/10.1038/nm1325 19.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175 21.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancer Res 2010; 70:7455-64; PMID:20841481; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Clin Invest 2003; 111:1297-308; PMID:12727921; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Immunity 1999; 10:39-49; PMID:10023769; http://dx.doi.org/10.1016/S1074-7613(00)80005-9 24.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Immunity 2003; 19:425-36; PMID:14499117; http://dx.doi.org/10.1016/S1074-7613(03)00232-2 26.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancers2014; 6:193-210; PMID:24473086; http://dx.doi.org/ 10.3390/cancers6010193 27.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Blood 2011; 117:1565-73; PMID:21127177; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
"Cancer Immunol, Immunother: CII 2001; 49:603-12; PMID:11225991; http://dx.doi.org/10.1007/s00262000015629.",Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Immu- nity 2013; 39:11-26; PMID:23890060; http://dx.doi.org/10.1016/j.immuni.2013.07.008 30.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nature 2001; 410:1107-11;PMID:11323675; http://dx.doi.org/10.1038/35074122 31.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Semin Cell Dev Biol 2008; 19:351-9; PMID:18620071; http://dx.doi.org/ 10.1016/j.semcdb.2008.06.004 32.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Med 2008; 14:282-9; PMID:18264109; http://dx.doi.org/10.1038/nm1720 33.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Exp Med 1999; 189:63-73; PMID:9874564; http://dx.doi.org/10.1084/jem.189.1.63 35.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cytokine2004; 26:45-56; PMID:15050604; http://dx.doi.org/ 10.1016/j.cyto.2003.12.002 36.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Immunol 2010; 184:2638- 45; PMID:20124100; http://dx.doi.org/10.4049/ jimmunol.0902960 37.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Clin Invest 2008; 118:3367-77; PMID:18776941; http://dx.doi.org/10.1172/JCI35213 38.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Front Immunol 2014; 5:276; PMID:24987392; http://dx.doi.org/10.3389/ﬁmmu.2014.00276 39.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Semin Immunol 2013; 25:263-72; PMID:24239567; http://dx.doi.org/10.1016/j.smim.2013.10.021 40.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Curr Opin Immunol 2013; 25:261-7; PMID:23579076; http://dx.doi.org/ 10.1016/j.coi.2013.03.004 41.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Curr Opin Immunol 2008;20:228-33; PMID:18479894; http://dx.doi.org/ 10.1016/j.coi.2008.03.010 42.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Curr Opin Immunol 2014; 27:16-25; PMID:24531241; http://dx.doi.org/10.1016/j.coi.2014.01.004 43.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Neuro-Oncol 2012;110:359-68; PMID:23096132; http://dx.doi.org/ 10.1007/s11060-012-0981-6 44.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Mol Cancer Ther 2010; 9:67-78; PMID:20053772; http://dx.doi.org/10.1158/1535-7163.MCT-09-0734 45.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancer Res 2010;70:6467-76; PMID:20682796; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-4058 46.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Clin Cancer Res 2014; 20:5579-88; PMID:25074610; http://dx.doi.org/10.1158/1078- 0432.CCR-13-2492 47.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Med 2010;16:1421-8; PMID:21102457; http://dx.doi.org/ 10.1038/nm.2250 48.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Cancer Cell 2013; 23:107-20; PMID:23273921;http://dx.doi.org/10.1016/j.ccr.2012.11.013 49.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Biol Chem 1998; 273:6132-8; PMID:9497331; http://dx.doi.org/10.1074/jbc.273.11.6132 50.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
J Med Chem 2012; 55:6645-68; PMID:22650325; http://dx.doi.org/10.1021/jm300207s 51.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
World J Gastroenterol 2014; 20:3738-50; PMID:24833840; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Transgenic Res 1999; 8:265-77; PMID:10621974; http://dx.doi.org/ 10.1023/A:1008942828960 54.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
PLoS One 2012; 7:e40852; PMID:22808277; http://dx.doi.org/10.1371/journal.pone.0040852 55.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Bioinformatics 2005; 21:2067-75; PMID:15657102; http://dx.doi.org/10.1093/bioinformatics/bti270 56.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Stat Med 1990;9:811-8; PMID:2218183; http://dx.doi.org/10.1002/ sim.4780090710 57.,OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
1–43; PMID:16646834; http://dx.doi.org/10.2202/1544-6115.1128 58.,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
Nat Genet 2000; 25:25-9; PMID:10802651; http://dx.doi.org/10.1038/75556 www.tandfonline.com e998529-9 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/02/da/koni-04-04-998529.PMC4485776.pdf
"Most immunocompetent animal models do not mimic human cancer in terms of how the cancer is initiated; most use © Jenette Creaney, Shaokang Ma, Sophie A Sneddon, Michelle R Tourigny, Ian M Dick, Justine S Leon, Andrea Khong, Scott A Fisher, Richard A Lake, W Joost L es- terhuis, Anna K Nowak, Shay Leary, Mark W Watson, and Bruce W Robinson*Correspondence to: Bruce W Robinson; Email: bruce.robinson@uwa.edu.auSubmitted: 12/23/2014; Revised: 01/16/2015; Accepted: 01/21/2015 http://dx.doi.org/10.1080/2162402X.2015.1011492 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Cancer Res 2012 72:1081-1091; PMID:22237626; http://dx.doi.org/10.1158/0008-5472.CAN-11-3722.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Nature 2014 515:577-581; PMID:25428507; http://dx.doi.org/ 10.1038/nature13988.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
N Engl J Med 2014 371:2189-2199; PMID:25409260; http://dx.doi.org/ 10.1056/NEJMoa1406498.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Science 2014 344:641-645;PMID:24812403; http://dx.doi.org/10.1126/ science.1251102.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Clin Cancer Res 2014 20:1125-1134; PMID:24323902; http://dx.doi.org/10.1158/1078-0432.CCR-13-2147.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Blood 2014 124:453-462; PMID:24891321; http://dx.doi.org/10.1182/blood- 2014-04-567933.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Int J Cancer 1992 52:881-886; PMID:1459729; http://dx.doi.org/10.1002/ ijc.2910520609.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Immunity 2000 12:83-93; PMID:10661408; http://dx.doi.org/ 10.1016/S1074-76130080161-2.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
PLoS One 2014 9:e107894; PMID:25243472; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
JImmunol 2004 173:5923-5928; PMID:15528325; http://dx.doi.org/10.4049/jimmunol.173.10.5923.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Adv Cancer Res 1996 70:145-177; PMID:8902056; http://dx.doi.org/10.1016/S0065-230X0860874-X.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Curr Opin Immu- nol 2013 25:284-290; PMID:23566921; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Cancer Immunol Res 2014 2:522-529;PMID:24894089; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0227.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Genomics 1993 18:455-456; PMID:8288258; http://dx.doi.org/10.1006/ geno.1993.1500.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
J Immunol 2000 165:6047-6055; PMID:11086036; http://dx.doi.org/ 10.4049/jimmunol.165.11.6047.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Oncoimmunology 2012 1:840-846; PMID:23162751; http://dx.doi.org/10.4161/onci.20493.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Cancer Immunol Immunother 2006 55:933- 947; PMID:16283304; http://dx.doi.org/10.1007/ s00262-005-0086-6.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
J Immunol 2001 166:5557-5566; PMID:11313395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Genome Biol 200910:R25; PMID:19261174; http://dx.doi.org/10.1186/ gb-2009-10-3-r25.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Bioinformatics 2012 28:2678-2679; PMID:22914218; http://dx.doi.org/10.1093/ bioinformatics/bts503.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Bioinformatics 2009 25:1754-1760; PMID:19451168; http://dx.doi.org/ 10.1093/bioinformatics/btp324.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Bio-informatics 2009 25:2078-2079; PMID:19505943; http://dx.doi.org/10.1093/bioinformatics/btp352.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Genome Res 2010 20:1297- 1303; PMID:20644199; http://dx.doi.org/10.1101/gr.107524.110.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Genome Res 2012 22:568-576; PMID:22300766; http://dx.doi.org/10.1101/gr.129684.111.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
Nucleic Acids Res 2010 38:e164; http://dx.doi.org/10.1093/nar/gkq603.,OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
"Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M. NetMHCpan, a method for MHC class I binding prediction beyond humans.Immunogenetics 2009 61:1-13; PMID:19002680; http://dx.doi.org/10.1007/s00251-008-0341-z.",OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
J Viral Hepat 2011 18:482-492; PMID:20529204; http://dx.doi.org/10.1111/j.1365-2893.2010.01331.x.,Non-OADS,/arxiv_data1/oa_pdf/37/7b/koni-04-07-1011492.PMC4485777.pdf
"1It has been established that Akt activation regulates the differentiation of CD8CTc e l l si n t o effector and memory T cells, whe re sustained Akt activation leads to terminal differentiation of effector CD8CT cells, whereas inhibition of Akt in vivo increases the number of memory CD8CTc e l l s .9 © Rasha Abu Eid, Kevin M Friedman, Mikayel Mkrtichyan, Andrea Walens, William King, John Janik, and Samir N Khleif *Correspondence to: Samir N Khleif; Email: SKhleif@gru.eduSubmitted: 11/17/2014; Revised: 12/29/2014; Accepted: 12/30/2014 http://dx.doi.org/10.1080/2162402X.2015.1005448 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Immunol Rev 2006; 211:214–24; PMID:16824130;http://dx.doi.org/10.1111/j.0105-2896.2006.00391.x 3.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Nature 1999; 401:708–12; PMID:10537110; http://dx.doi.org/ 10.1038/44385 4.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Proc Natl Acad Sci U S A 2005; 102:9571–6; PMID:15980149; http://dx.doi.org/10.1073/ pnas.0503726102 5.,OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Nat Immunol 2003; 4:225–34; PMID:12563257;http://dx.doi.org/10.1038/ni889 6.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Immunol 2005; 175:6169–76; PMID:16237114; http://dx.doi.org/10.4049/ jimmunol.175.9.6169 7.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Exp Med 2005; 202:123–33;PMID:15983064; http://dx.doi.org/10.1084/ jem.20050137 8.,OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
JImmunol 2012; 188:4305–14; PMID:22467649; http://dx.doi.org/10.4049/jimmunol.1103568 10.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Ann N Y Acad Sci 2010; 1183:149– 57; PMID:20146713; http://dx.doi.org/10.1111/j.1749-6632.2009.05134.x 11.,OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Immunol Rev 2003; 192:7–20; PMID:12670391; http://dx.doi.org/10.1034/j.1600-065X.2003.00008.x 12.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Immunol 2007; 178:5443–53; PMID:17442925; http://dx.doi.org/10.4049/ jimmunol.178.9.5443 13.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Immunol 2012; 188:3080–7; PMID:22379028; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Nature2009; 460:108–12; PMID:19543266; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Oncoimmunology 2014; 3:e29081; PMID:25083329; http://dx.doi.org/10.4161/ onci.29081 18.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Autoimmun 2008; 30:293–302; PMID:18313267; http://dx.doi.org/ 10.1016/j.jaut.2007.12.012 19.,OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Immunol 2007; 178:320–9; PMID:17182569; http://dx.doi.org/ 10.4049/jimmunol.178.1.320 20.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Blood 2005; 105:4743–8; PMID:15746082; http://dx.doi.org/10.1182/blood- 2004-10-3932 21.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
J Immunol 2008; 180:5794–8; PMID:18424697; http://dx.doi.org/10.4049/jimmunol.180.9.5794 22.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Cancer Res 2005; 65:7052–8; PMID:16103051; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0917 23.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Cancer Immunol Res 2014;2:1080–9; PMID:25080445; http://dx.doi.org/ 10.1158/2326-6066.CIR-14-0095 24.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Blood 2011; 117:808–14; PMID:20971955; http://dx.doi.org/ 10.1182/blood-2010-05-286286 26.,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
Available at: http://jaxmice.jax.org/strain/005023.html www.tandfonline.com e1005448-11 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/67/d9/koni-04-05-1005448.PMC4485779.pdf
"3 In secondary lymphoid organs, approx- imately 50% of mature conventional DCsexpressed IDO1, whereas neither plasma-cytoid DCs nor any other cell type did.This parallels the previously observedIDO1 induction during in vitro matura- tion of monocyte-derived DCs, which we observed during the terminal phase of theDC maturation program and might © Nathalie Vigneron, Nicolas van Baren, and Beno ^ıt J Van den Eynde *Correspondence to: Beno ^ıt J Van den Eynde; Email: benoit.vandeneynde@bru.licr.org Submitted: 12/16/2014; Revised: 12/23/2014; Accepted: 12/23/2014 http://dx.doi.org/10.1080/2162402X.2014.1003012 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Cancer Immunol Res 2015; 3(2):161–72; PMID: 25271151; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
IDO is a nodal patho- genic driver of lung cancer and metastasis development.Cancer Discov 2012; 2:722–35; PMID:22822050; http://dx.doi.org/10.1158/2159-8290.CD-12-0014 3.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Nat Med 2010; 16:279–85; PMID:20190767; http://dx.doi.org/ 10.1038/nm.2092 4.,OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Lab Invest2003; 83:1457–66; PMID:14563947; http://dx.doi.org/ 10.1097/01.LAB.0000090158.68852.D1 5.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
J Immunother Cancer 2014; 2:3;PMID:24829760; http://dx.doi.org/10.1186/2051- 1426-2-3.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Nature 2014; 515:568–71; PMID:25428505; http://dx.doi.org/10.1038/nature13954.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Sci Transl Med 2013; 5:200ra116; PMID:23986400; http://dx.doi.org/ 10.1126/scitranslmed.3006504.,OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Nat Med 2003; 9:1269–74; PMID:14502282; http://dx.doi.org/10.1038/nm934.,Non-OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
Clin Can Res 2007; 13:6993–7002; http://dx.doi.org/10.1158/1078-0432.CCR-07-0942.,OADS,/arxiv_data1/oa_pdf/b4/a3/koni-04-05-1003012.PMC4485782.pdf
"Granulin-epithelin precursor (GEP) is a pluripotent growth factor that regulates fetal development, tissue repair, and tumori- genesis in various cancers.13Our group has demonstrated overex- pression and a tumorigenic role of GEP in HCC.14-17GEP blockage by antibody inhibits the growth of establishedHCC 18,19and sensitizes HCC to chemotherapeutic agents.18,19 © Phyllis FY Cheung, Chi Wai Yip, Linda WC Ng, Chun Kwok Wong, Tan To Cheung, Chung Mau Lo, Sheung Tat Fan, and Siu Tim Cheung *Correspondence to: Siu Tim Cheung; Email: stcheung@hku.hkSubmitted: 01/09/2015; Revised: 02/03/2015; Accepted: 02/03/2015 http://dx.doi.org/10.1080/2162402X.2015.1016706 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Biomed Biotechnol 2011; 2011:676198; PMID:21541191; http://dx.doi.org/ 10.1155/2011/676198 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Blood 2008; 112:461-9; PMID:18650461; http://dx.doi.org/ 10.1182/blood-2007-09-077438 3.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Lancet 2000; 356:1795-9; PMID:11117911; http://dx.doi.org/10.1016/S0140-6736(00)03231-1 4.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Mol Med (Berl) 2011; 90:55-66;PMID:21870102; http://dx.doi.org/10.1007/s00109- 011-0806-75.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Clin Cancer Res 2011; 17:678-89; PMID:21325295; http://dx.doi.org/10.1158/1078- 0432.CCR-10-2173 6.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Gut 2012; 61:427- 38; PMID:21930732; http://dx.doi.org/10.1136/gutjnl-2011-300509 7.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Cancer 1998; 83:58-63;PMID:9655293; http://dx.doi.org/10.1002/(SICI) 1097-0142(19980701)83:1 <58::AID-CNCR8 >3.0.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Hepatol 2010; 52:370-9; PMID:19720422; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Gastroenterology 2010; 138:1931-42; PMID:20060829; http://dx.doi.org/10.1053/j.gastro.2009.12.051 10.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Hepatol 2005; 43:1013-20; PMID:16168521; http://dx.doi.org/ 10.1016/j.jhep.2005.05.026 www.tandfonline.com e1016706-11 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Clin Immunol 2008; 129:428-37; PMID:18824414; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Hepatology2009; 50:799-807; PMID:19551844; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Bioessays 2009; 31:1245-54; PMID:19795409; http://dx.doi.org/10.1002/bies.200900086 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Gastroenterology 2011; 140:344-55; PMID:20682318; http://dx.doi.org/10.1053/j.gastro.2010.07.049 15.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Clin Cancer Res 2004; 10:7629-36;PMID:15569995; http://dx.doi.org/10.1158/1078- 0432.CCR-04-0960 17.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Car-cinogenesis 2014; 35:2485-94; PMID:25115442; http://dx.doi.org/10.1093/carcin/bgu164 18.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Hepatology 2008; 47:1524-32; PMID:18393387; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Mol Cancer Ther 2014;13:3001-12; PMID:25253787; http://dx.doi.org/ 10.1158/1535-7163.MCT-14-001220.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
PLoS One 2011; 6:e28246;PMID:22194816; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
"Cancer Immunol Res 2014; 2:1209-19; PMID:25315249; http://dx.doi.org/10.1158/2326-6066.CIR-14-0096 22. Cooper MA, Fehniger TA, Caligiuri MA.",Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
"Trends Immunol 2001; 22:633-40; PMID:11698225; http://dx.doi.org/ 10.1016/S1471-4906(01)02060-9 23. Cooper MA, Fehniger TA, Turner SC, Chen KS, Gha- heri BA, Ghayur T, Carson WE, Caligiuri MA.",OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Blood 2001; 97:3146-51; PMID:11342442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Immunol 2002; 169:5377-81; PMID:12421908; http://dx.doi.org/10.4049/jimmunol.169.10.5377 25.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Hepatol 2012; 56:381-8; PMID:21756848; http://dx.doi.org/10.1016/j.jhep.2011.06.017 26.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236 27.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Semin Immunol 2006; 18:151-8; PMID:16730454; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
J Exp Med 2005; 202:583-8; PMID:16129707; http://dx.doi.org/10.1084/jem.2005099429.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Int J Dev Biol2004; 48:411-24; PMID:15349816; http://dx.doi.org/ 10.1387/ijdb.041811af 31.,OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Nat Rev Drug Disc 2012; 11:311-U87; PMID:22460124; http://dx.doi.org/10.1038/nrd2909 32.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Asian Pac J Cancer Prev: APJCP 2012; 13:5909-13; PMID:23317279; http://dx.doi.org/10.7314/APJCP.2012.13.11.5909 33.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Cancer Immunol Res 2014; 2:1125-31; PMID:25480554;http://dx.doi.org/10.1158/2326-6066.CIR-14-0160 35.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Cancer Sci 2007; 98:1652-8; PMID:17894551; http://dx.doi.org/10.1111/j.1349-7006.2007.00606.x 36.,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
Hepatology 2013; 57:2358-68; PMID:23424039; http://dx.doi.org/10.1002/ hep.26328 e1016706-12 Volume 4 Issue 7 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/d0/8c/koni-04-07-1016706.PMC4485783.pdf
"© Kirsten Ridder, Alexandra Sevko, Janina Heide, Maria Dams, Anne-Kathleen Rupp, Jadranka Macas, Julia Starmann, Marc Tjwa, Karl Plate, Holger S €ultmann, Peter Altevogt, Viktor Umansky, and Stefan Momma*Correspondence to: Stefan Momma; Email: momma_s2@hotmail.com; stefan.momma@kgu.deSubmitted: 10/02/2014; Revised: 01/09/2015; Accepted: 01/10/2015 http://dx.doi.org/10.1080/2162402X.2015.1008371 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Genotypingwas performed using particular PCR- protocols provided by Jack-son Laboratory (http://www.jax.org).,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Cell 2012; 151:1542-56; PMID:23260141; http://dx.doi.org/10.1016/j.cell.2012.11.024 4.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Semin Cancer Biol 2012; 22:342-9; PMID:22369922; http://dx.doi.org/10.1016/j.semcancer.2012.02.005 5.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Cancer Res 2007; 67:2912-5; PMID:17409393; http://dx.doi.org/10.1158/0008-5472.CAN-07-0520 6.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb15967.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Cell Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.org/10.1038/ncb1800 8.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Vesiclepedia: a compendium for extracellu- lar vesicles with continuous community annotation.PLoS Biol 2012; 10:e1001450; PMID:23271954; http://dx.doi.org/10.1371/journal.pbio.1001450 9.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Bioessays 2012; 34:489-97; PMID:22442051; http://dx.doi.org/10.1002/ bies.201100169 www.tandfonline.com e1008371-7 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
PLoS Biol 2014; 12:e1001874; PMID:24893313; http://dx.doi.org/ 10.1371/journal.pbio.1001874 11.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Oncogene 1997; 14:2005-13; PMID:9160879; http://dx.doi.org/10.1038/sj.onc.1201168 12.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Int J Oncol1999; 15:829-34; PMID:10493969; http://dx.doi.org/ 10.3892/ijo.15.4.829 13.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Transl Med 2011; 9:86; PMID:21651777; http://dx.doi.org/10.1186/1479-5876-9-86 14.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Curr Protoc Cell Biol 2006; Chapter 3:Unit 3.22; PMID:18228490;http://dx.doi.org/10.1002/0471143030.cb0322s30 15.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Cancer Lett 2009; 278:73-81; PMID:19188015; http://dx.doi.org/ 10.1016/j.canlet.2008.12.028 16.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Immunol Methods 1997; 207:203-12; PMID:9368647; http://dx.doi.org/ 10.1016/S0022-1759(97)00116-6 18.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Immunol 2002; 3:1156-62; PMID:12426563; http://dx.doi.org/ 10.1038/ni854 20.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175 21.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
2012; 24:207-12; PMID:22236695; http://dx.doi.org/10.1016/j.coi.2011.12.009 22.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Immunol2009; 10:1185-92; PMID:19783989; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Immu- nol 2009; 182:4499-506; PMID:19342621; http://dx.doi.org/10.4049/jimmunol.0802740 25.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Int J Biochem Cell Biol 2010; 42:1256-61; PMID:20144731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Nat Cell Biol 2012; 14:159-67; PMID:22179046; http://dx.doi.org/10.1038/ncb2396 27.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Cancer Res 2013; 73:2884-96; PMID:23338610; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2162 28.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Br J Cancer 2010; 103:532-41; PMID:20664596; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Neurochem 2011; 118:449-57; PMID:21561454; http://dx.doi.org/10.1111/j.1471-4159.2011.07307.x 30.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Extracell vesicles 2013; 2:1-6; PMID: 24009896;http://dx.doi.org/10.3402/jev.v2i0.19861 31.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
J Extracell vesicles 2014; 3:25011; PMID:25396408; http://dx.doi.org/10.3402/jev.,OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Gynecol Oncol 2011; 122:437-46; PMID:21601258;http://dx.doi.org/10.1016/j.ygyno.2011.04.035 33.,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
Biochem J 2009; 420:391-402; PMID:19260824; http://dx.doi.org/10.1042/BJ20081625 e1008371-8 Volume 4 Issue 6 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/c8/62/koni-04-06-1008371.PMC4485784.pdf
"© Karin Schilbach, Mohammed Alkhaled, Christian Welker, Franziska Eckert, Gregor Blank, Hendrik Ziegler, Marco Sterk, Friederike M €uller, Katja Sonntag, Thomas Wieder, Heidi Braum €uller, Julia Schmitt5, Matthias Eyrich, Sabine Schleicher, Christian Seitz, Annika Erbacher, Bernd J Pichler, Hartmut M €uller, Robert Tighe, Annick Lim, Stephen D Gillies, Wolfgang Strittmatter, Martin R €ocken, and Rupert Handgretinger *Correspondence to: Karin Schilbach; Email: karin.schilbach@med.uni-tuebingen.deSubmitted: 12/16/2014; Revised: 01/27/2015; Accepted: 01/29/2015 http://dx.doi.org/10.1080/2162402X.2015.1014760 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
"J Clin Oncol 2008; 26:2384-9; PMID:18467730; http://dx.doi.org/10.1200/ JCO.2007.14.7207 2. van den Broeke LT, Pendleton CD, Mackall C, Hel- man LJ, Berzofsky JA.",OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Cancer Immunol Immunother 2011; 60:693-703; PMID:21327638; http://dx.doi.org/10.1007/ s00262-011-0981-y 5.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Blood 2007; 109:5346-54; PMID:17327412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
J Clin Invest 2011; 121:4746-57; PMID:22056381; http://dx.doi.org/10.1172/JCI58814 7.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Immunity 2009; 30:92-107; PMID:19119024; http://dx.doi.org/10.1016/j.immuni.2008.11.005 10.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Eur J Immunol 2010; 40:3017-27; PMID:21061434; http://dx.doi.org/ 10.1002/eji.201040539 11.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nat Rev Immunol 2009; 9:259-70;PMID:19282852; http://dx.doi.org/10.1038/nri2528 13.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
N Engl J Med 2010; 362:875- 85; PMID:20220182; http://dx.doi.org/10.1056/ NEJMoa090568014.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Blood 2005; 106:2252-8; PMID:15933055; http://dx.doi.org/10.1182/blood-2005-03-1154 15.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Hybrid Hybridomics 2001; 20:305-12; PMID:11839248; http://dx.doi.org/10.1089/15368590152740707 17.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Br J Pharmacol 2009; 157:220-33; PMID:19459844; http://dx.doi.org/10.1111/j.1476- 5381.2009.00190.x 18.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Science 2006; 311:1924-7; PMID:16484453; http://dx.doi.org/ 10.1126/science.1122927 19.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nat Rev Immunol 2004; 4:665-74; PMID:15343366; http://dx.doi.org/10.1038/nri1435 2 1 .,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
J Immunol 2005; 174:6477-89;PMID:15879151; http://dx.doi.org/10.4049/ jimmunol.174.10.6477 22.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nat Immunol 2008; 9:495-502; PMID:18425106; http://dx.doi.org/10.1038/ni1581 23.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nature 2013; 494:361-5; PMID:23376950; http://dx.doi.org/10.1038/nature11824 24.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Curr Pharm Des 2010; 16:79- 100; PMID:20214620; http://dx.doi.org/10.2174/138161210789941874 25.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
CellCycle 2007; 6:784-9; PMID:17377503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Science 1995; 267:1018-21; PMID:7863327; http://dx.doi.org/10.1126/science.7863327 28.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Curr Opin Genet Dev 1997; 7:597- 602; PMID:9388774; http://dx.doi.org/10.1016/ S0959-437X(97)80005-6 29.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Exp Cell Res 2004; 301:1-7;PMID:15501438; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Histopathology 1989; 15:585-95; PMID:2558065; http://dx.doi.org/10.1111/j.1365- 2559.1989.tb01624.x 31.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Curr Opin Oncol 2013; 25:52-8; PMID:23159848; http://dx.doi.org/10.1097/ CCO.0b013e32835b639e 32.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Science 1994; 264:1467-71; PMID:8197461; http://dx.doi.org/ 10.1126/science.8197461 33.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nat Cell Biol 2006; 8:1291-7; PMID:17028578; http://dx.doi.org/10.1038/ncb1491 34.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Proc Natl Acad Sci U S A 2010; 107:3006-11; PMID:20133607; http://dx.doi.org/10.1073/ pnas.0914839107 35.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
J Immunol 2006; 176:211-6; PMID:16365412; http://dx.doi.org/10.4049/jimmunol.176.1.211 36.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Immunity 2007; 26:371-81; PMID:17363300; http://dx.doi.org/ 10.1016/j.immuni.2007.02.009 37.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nature 2007; 450:903-7; PMID:18026089; http://dx.doi.org/ 10.1038/nature06309 40.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
J Clin Invest 2008; 118:1398-404; PMID:18317595; http://dx.doi.org/10.1172/JCI33522 41.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nature 2001; 410:1107-11; PMID:11323675; http://dx.doi.org/10.1038/35074122 42.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nature 2004; 432:307-15; PMID:15549092; http://dx.doi.org/10.1038/nature03098 43.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Regulation of growth arrest in senescence: telomere damage is not the end of the story.Mech Ageing Dev 2006; 127:16-24; PMID:16229875;http://dx.doi.org/10.1016/j.mad.2005.09.002 44.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Cancer Res 2005; 65:6568-75; PMID:16061636; http://dx.doi.org/10.1158/0008-5472.CAN-05-0862 45.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
NatRev Mol Cell Biol 2006; 7:667-77; PMID:16921403; http://dx.doi.org/10.1038/nrm1987 46.,OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
J Interferon Cytokine Res 1999; 19:1351-61; PMID:10638704; http://dx.doi.org/ 10.1089/107999099312812 47.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
Nat Rev Cancer 2009; 9:400-14; PMID:19440234; http://dx.doi.org/10.1038/nrc2657 50.,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/koni-04-07-1014760.PMC4485786.pdf
"Genetic studies have found copy number alterations at all stages, and lack of substantial genetic differences between MGUS and MM.6,7Also, primary chromosomal translocations affecting the Ig locus are present at the MGUS phase of the disease, © Arianna Calcinotto, Maurilio Ponzoni, Roberto Ria, Matteo Grioni, Elena Cattaneo, Isabella Villa, Maria Teresa Sabrina Bertilaccio, Marta Chesi , Alessandro Rubi- nacci, Giovanni Tonon, P Leif Bergsagel, Angelo Vacca, and Matteo Bellone*Correspondence to: Matteo Bellone; Email: bellone.matteo@hsr.itSubmitted: 12/23/2014; Accepted: 01/14/2015 http://dx.doi.org/10.1080/2162402X.2015.1008850 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Annu Rev Pathol 2011; 6:249-74; PMID:21261519;http://dx.doi.org/10.1146/annurev-pathol-011110- 130249 2.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Am J Med 1978; 64:814-26; PMID:645746; http://dx.doi.org/10.1016/0002-9343(78)90522-3 3.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Clin Cancer Res2013; 19:985-94; PMID:23224402; http://dx.doi.org/ 10.1158/1078-0432.CCR-12-2922 4.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
N Engl J Med 2011;365:474-5; PMID:21812699; http://dx.doi.org/ 10.1056/NEJMc1106428 5.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leukemia 2013; 27:2067-8;PMID:23644420; http://dx.doi.org/10.1038/leu.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
AnnuRev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210- 101324 9.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
NEngl J Med 2013; 369:438-47; PMID:23902483; http://dx.doi.org/10.1056/NEJMoa1300439 11.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leukemia 2014; 28:1725-35; PMID:24518206; http://dx.doi.org/10.1038/leu.2014.70 13.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Cancer Cell 2008; 13:167-80; PMID:18242516; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Cancer Cell 2008; 13:85-7; PMID:18242508; http://dx.doi.org/10.1016/j.ccr.2008.01.022 15.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Int J Hema- tol 2013; 97:313-23; PMID:23456262; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leuk Res 2004; 28:259-66; PMID:14687621; http://dx.doi.org/10.1016/S0145-2126(03)00261-3 20.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Science 1989; 246:1306- 9; PMID:2479986; http://dx.doi.org/10.1126/ science.2479986 21.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Immunity 2010; 32:593-604; PMID:20510870; http://dx.doi.org/ 10.1016/j.immuni.2010.05.007 22.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Trends Immunol 2007; 28:519-24; PMID:17981504; http://dx.doi.org/10.1016/j.it.2007.09.004 23.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Nat Med 1995; 1:27-31; PMID:7584949; http://dx.doi.org/10.1038/nm0195- 27 27.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leukemia2014; 28:413-6; PMID:24045500; http://dx.doi.org/ 10.1038/leu.2013.268 28.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2008; 111:2725-32; PMID:18156498; http://dx.doi.org/10.1182/blood- 2006-11-056242 29.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leuk Lymphoma 2010; 51:920-7; PMID:20367137; http://dx.doi.org/10.3109/10428191003699563 30.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2009; 114:901-14; PMID:19383967; http://dx.doi.org/10.1182/blood-2009-01-200931 31.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2012; 120:3152-62;PMID:22919031; http://dx.doi.org/10.1182/blood- 2012-04-422758 32.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Cancer Cell 2011; 19:512-26; PMID:21481792; http://dx.doi.org/10.1016/j.ccr.2011.02.005 33.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2009; 114:3625-8;PMID:19710503; http://dx.doi.org/10.1182/blood- 2009-05-220285 34.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Oncogene 2006;25:4257-66; PMID:16518413; http://dx.doi.org/ 10.1038/sj.onc.1209456 35.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2014; 123:3305-15; PMID:24723682; http://dx.doi.org/10.1182/blood- 2014-02-554071 36.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Immunol Lett 2013; 152:83-8; PMID:23685256; http://dx.doi.org/10.1016/j.imlet.2013.05.003 38.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
J Oncol 2013; 2013:183602; PMID:23431298; http://dx.doi.org/10.1155/2013/183602 39.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Cancer Treat Rev 2000; 26:351-62; PMID:11006136; http://dx.doi.org/10.1053/ctrv.2000.0188 41.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Nat Med 2001; 7:575-83; PMID:11329059; http://dx.doi.org/10.1038/87904 42.,OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Blood 2011; 117:5573-81; PMID:21441462; http://dx.doi.org/10.1182/blood- 2011-01-270140 43.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Leukemia 2001;15:1274-6; PMID:11480571; http://dx.doi.org/ 10.1038/sj.leu.2402183 44.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Br J Haematol 2002; 118:239-42; PMID:12100153; http://dx.doi.org/10.1046/j.1365-2141.2002.03549.x 45.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
J Clin Oncol 2003; 21:16-9; PMID:12506164; http://dx.doi.org/10.1200/ JCO.2003.03.139 46.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
Am J Hematol 2010; 85:737-40; PMID:20730790; http://dx.doi.org/10.1002/ajh.21821 48.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
2003 Jun; 121(5):749-57; PMID:12780789; http://dx.doi.org/10.1046/j.1365-2141.2003.04355.x e1008850-10 Volume 4 Issue 6 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/74/2e/koni-04-06-1008850.PMC4485787.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 967–977Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  967Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8421 0New oral anticoagulants: their advantages and   disadvantages compared with vitamin K  antagonists in the prevention and treatment of  patients with thromboembolic events Ymer H Mekaj1,2 Agon Y Mekaj3 Shkelzen B Duci4 ermira i Miftari5 1institute of Pathophysiology, Faculty  of Medicine, University of Prishtina,   2Department of Hemostasis and  Thrombosis, National Blood  Transfusion Center of Kosovo, 3Clinic  of Neurosurgery, Faculty of Medicine,   University of Prishtina, 4Clinic of  Plastic and Reconstructive Surgery,   Faculty of Medicine, University  of Prishtina, 5The Hospital and  University Clinical Service of Kosovo,   Prishtina, KosovoAbstract:  Despite the discovery and application of many parenteral (unfractionated and  low-molecular-weight heparins) and oral anticoagulant vitamin K antagonist (VKA) drugs, the  prevention and treatment of venous and arterial thrombotic phenomena remain major medical  challenges.",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"The route of administration of anticoagulant drugs can be either  parenteral or oral.Correspondence: Agon Y Mekaj Clinic of Neurosurgery, Faculty of  Medicine, University of Prishtina, Rrethi i  spitalit p.n., Prishtina 10000, Kosovo Tel +377 4437 3545 Fax +386 4937 3545 email agon.mekaj@uni-pr.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Mekaj et al Running head recto: New oral anticoagulants: their advantages and disadvantages versus VKAs DOI: http://dx.doi.org/10.2147/TCRM.S84210",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
Available from: http://www.xarelto.,Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"Available at: http://www.daiichisankyo.com/ media_investors/media_relations/press_releases/detail/005784.htm l.  Accessed December 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
Available from: Available from http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"Available from: http://dsi.com/ prescribing-information-portlet/getPIContent?productName=Savaysa &inline=tru e. Accessed February 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
"Available from: http://us.boehringer-ingelheim.com/news_events/ press_releases/press_release_archive/2014/06-26-14-boehringer- ingelheim-investigational-antidote-pradaxa-dabigatran-etexilate-me - sylate-fda-breakthrough-therapy-designation.htm l. Accessed July 26,   2014.",Non-OADS,/arxiv_data1/oa_pdf/e3/db/tcrm-11-967.PMC4485791.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 1035–1042Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1035OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7669 5Fracture prevention service to bridge the  osteoporosis care gap Correspondence: Carmelinda ruggiero Department of Medicine, Institute  of gerontology and geriatrics, University  of Perugia Medical school, s Maria della  Misericordia hospital, sant’Andrea delle  Fratte, 06100 Perugia, Italy Tel +39 075 578 3839 email carmelinda.ruggiero@unipg.i t Carmelinda ruggiero1 elena Zampi1 giuseppe rinonapoli2 Marta Baroni1 rocco serra1 elisa Zengarini1 gregorio Baglioni3 giuliana Duranti3 sara ercolani1 Francesco Conti4 Auro Caraffa2 Patrizia Mecocci1 Maria luisa Brandi5 1geriatric Unit, University of Perugia,   hospital s Maria della Misericordia,   2Orthopedic and Traumatologic  Unit, University of Perugia, hospital  s Maria della Misericordia, 3Primary  Care Physicians, sIMg Umbria,   Perugia, 4Department of Clinical  and Molecular Medicine, sapienza  University of rome, AO sant’Andrea  hospital, rome, 5Department of  Internal Medicine, University of  Florence, Florence, ItalyBackground:  A care gap exists between the health care needs of older persons with fragility  fractures and the therapeutic answers they receive.",Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
"Hip  fracture rates have stabilized over the last 2 decades, with age-adjusted decreases  being observed in some centers.3  A fragility fracture at the hip is devastating and is associated with increased  morbidity, disability, and mortality.4 Epidemiological studies show an annual mortality Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ruggiero et al Running head recto: Fracture prevention to bridge osteoporosis care gap DOI: http://dx.doi.org/10.2147/CIA.S76695",Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
"Available from: http://www.health.nsw.gov.au/resources/gmct/ musculoskeletal/refracture_data_analysis_2009_pdf.as p. Accessed  January 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
Available from: http://www.nof.,Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/18/50/cia-10-1035.PMC4485792.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/b5/copd-10-1213.PMC4485793.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1213–1218International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1213OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8516 6Peak expiratory flow rate as a surrogate for  forced expiratory volume in 1 second in COPD  severity classification in Thailand Chaicharn Pothirat Warawut Chaiwong Nittaya Phetsuk Chalerm Liwsrisakun Chaiwat Bumroongkit Athavudh Deesomchok Theerakorn Theerakittikul atikun limsukon Division of Pulmonary, Critical Care  and Allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, ThailandBackground:  There are limited studies directly comparing correlation and agreement between  peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second (FEV1) for severity  classification of COPD.",Non-OADS,/arxiv_data1/oa_pdf/1b/b5/copd-10-1213.PMC4485793.pdf
"Sriphum,  Maung Chiang Mai district, Chiang Mai  50200, Thailand Tel +66 53 946 228 Fax +66 53 895 117 email cpothira@med.cmu.ac.t hJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pothirat et al Running head recto: PEFR in COPD severity classification DOI: http://dx.doi.org/10.2147/COPD.S85166",Non-OADS,/arxiv_data1/oa_pdf/1b/b5/copd-10-1213.PMC4485793.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1b/b5/copd-10-1213.PMC4485793.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/b5/copd-10-1213.PMC4485793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1043–1051Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1043OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8440 2geriatrician interventions on medication  prescribing for frail older people in residential  aged care facilities Arjun Poudel1 nancye M Peel2 Charles A Mitchell1 leonard C gray2 lisa M nissen1,3 ruth e hubbard2 1school of Pharmacy, 2Centre for  research in geriatric Medicine, The  University of Queensland, 3school  of Clinical sciences, Queensland  University of T echnology, Brisbane,   QlD, AustraliaObjective:  In Australian residential aged care facilities (RACFs), the use of certain classes  of high-risk medication such as antipsychotics, potent analgesics, and sedatives is high.",Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
"In Aus - tralia, the proportion of older people living in care accommodation increases with age  from 2% of people aged 65–74 years to 6% of people aged 75–84 years and 26% of  people aged 85 years and over.1 Those living in care homes often take more medica - tions than noninstitutionalized elderly, and the risk of morbidity as a result of medi - cation is high.2 Also, the incidence of adverse drug events increases with the number  of medications prescribed.3 Residential aged care facilities (RACFs) in Australia are  institutions in which prescribing of high-risk medication such as antipsychotics, potent  analgesics, and sedatives is high, with between 25% and 30% of patients receiving  such medication.4–6 Ensuring high-quality care and appropriate medication use for Correspondence: Arjun Poudel school of Pharmacy, The University  of Queensland, 20 Cornwall street,  Woolloongabba, Brisbane, QlD 4102,  Australia Tel +61 4 1650 3006 email a.poudel@uq.edu.a u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Poudel et al Running head recto: Geriatrician intervention in aged care facilities DOI: http://dx.doi.org/10.2147/CIA.S84402",Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
Available from: http://www.abs.,Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/91/24/cia-10-1043.PMC4485794.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 287–294Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  287Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6928 2Fixed-dose combinations in type 2 diabetes – role  of the canagliflozin metformin combination Joshua w Fleming   Laurie w Fleming   Courtney S Davis Department of Pharmacy Practice,   The University of Mississippi School  of Pharmacy, Jackson, MS, USA Correspondence: Joshua w Fleming   Department of Pharmacy Practice,  The University of Mississippi School  of Pharmacy, 2500 North State Street,  Jackson, MS 39216, USA   Tel +1 601 815 0604   Fax +1 601 984 2751   email jfleming2@umc.ed uAbstract:  Canagliflozin–metformin is one of the newest combination therapies available for the  treatment of type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
"Available from: http://www.cdc.gov// diabetes / pubs/statsreport14/national-diabetes-report-web.pd f. Accessed  September 28, 2014.",OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
"Available  from: http://www.pharmacytimes.com/publications/issue/2011/ December2011 /Considerations-for-FixedDose-Combination-Products- in-Cardiometabolic-Diseas e. Accessed February 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/7d/dmso-8-287.PMC4485795.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/66/amep-6-469.PMC4485796.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 469–470Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  469LEttEropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8765 4How can undergraduate ophthalmology teaching  be improved?,Non-OADS,/arxiv_data1/oa_pdf/b2/66/amep-6-469.PMC4485796.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b2/66/amep-6-469.PMC4485796.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/66/amep-6-469.PMC4485796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3293–3300Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3293Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8541 8effect of renal impairment on the pharmacokinetics  of levomilnacipran following a single oral dose  of levomilnacipran extended-release capsule   in humans correspondence: laishun chen Forest research institute, harborside  Financial center, Plaza 5 24th Fl  (room 68), Jersey city, nJ 07311, Usa   Tel +1 20 1427 8246   Fax +1 20 1427 8498   email laishun.chen@actavis.co m laishun chen William M greenberg elimor Brand-schieber Julie Wangsa antonia Periclou Parviz ghahramani Forest research institute, a subsidiary  of actavis inc., Jersey city, n J, UsaPurpose:  Levomilnacipran extended-release (ER) is indicated for treatment of major depressive  disorder in adults.",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
"Levomilnacipran ER  capsules (FETZIMA®) received US Food and Drug Administration (FDA) approval  in July 2013 for the treatment of major depressive disorder in adults, with a recom - mended dose of 40–120 mg once daily.1Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: Effect of renal impairment on the pharmacokinetics of levomilnacipran DOI: http://dx.doi.org/10.2147/DDDT.S85418",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
"Available from:  http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory   Information/Guidances/UCM072127.pd f. Accessed August 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
"Available from: http://www.fda.gov/downloads/Drugs/Guidances/ UCM204959.pd f. Accessed August 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/dddt-9-3293.PMC4485797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1017–1033Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1017RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5461 3epidemiology and management of osteoporosis in  the People’s Republic of China: current perspectives Xiao Lin1 Dan Xiong1 Yi-Qun Peng1 Zhi-Feng Sheng1 Xi-Yu wu1 Xian-Ping wu1 Feng wu2 Ling-Qing Yuan1 er-Yuan Liao1 1Institute of Metabolism and  endocrinology, 2Department  of Pathology, The Second Xiangya  Hospital, Central South University,   Changsha, Hunan, People’s Republic  of ChinaAbstract:  With the progressive aging of the population, osteoporosis has gradually grown into a  global health problem for men and women aged 50 years and older because of its consequences  in terms of disabilities and fragility fractures.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
"Moreover, because of the family planning policy in the  People’s Republic of China, the ratio of older people is likely to increase signifi - cantly in the coming years.Correspondence: Ling-Qing Yuan;  er-Yuan Liao Institute of Metabolism and  endocrinology, The Second  Xiangya Hospital, Central South  University, No 139 Middle Renmin  Road, Changsha, Hunan 410011,  People’s Republic of China email allenylq@hotmail.co m;  eyliao@21cn.co mJournal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Lin et al Running head recto: Osteoporosis in People’s Republic of China  DOI: http://dx.doi.org/10.2147/CIA.S54613",Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
Available from http://www.mca.,Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/12/fa/cia-10-1017.PMC4485798.pdf
"11 Interestingly, AICD seems to be reduced for epithelial V d2neg gdT cells, and increasing evidence supports an important role of this subset for tumor and infection immunosurveillance.12 Human V d2neggdT cells expand in the periphery of individuals during CMV infection in various pathophysiological contexts, including solid-organ and stem cell transplantation,13–17where they develop cytotoxic function and produce proinﬂammatorycytokines such as tumor necrosis factor a(TNF a) and IFN g. 18 Importantly, CMV-induced expansion of V d2neggdT cells cor- relates with decreased susceptibility to post-transplant cancers, © Florent Guerville, Sophie Daburon, Romain Marlin, Lydia Lartigue, Severine Loizon, Vincent Pitard, Lionel Couzi, Jean-Fran ¸cois Moreau, Julie D /C19echanet-Merville, and Benjamin Faustin*Correspondence to: Julie D /C19echanet-Merville; Email: jdechanet@cirid.org; Benjamin Faustin; Email: bfaustin@cirid.org Submitted: 11/28/2014; Revised: 12/23/2014; Accepted: 12/23/2014 http://dx.doi.org/10.1080/2162402X.2014.1003011 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Annu Rev Immunol 2014; 32:121– 55; PMID:24387714; http://dx.doi.org/10.1146/annurev- immunol-032713-120216 2.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Adv Immunol 1999; 71:77–144;PMID:9917911; http://dx.doi.org/10.1016/S0065- 2776(08)60400-9 5.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Exp Med 2011; 208:491–503; PMID:21383056; http://dx.doi.org/ 10.1084/jem.20100269 6.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Infect Dis 2001; 184:533–41;PMID:11494158; http://dx.doi.org/10.1086/322843 8.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Science 2005; 309:264–8; PMID:15933162; http://dx.doi.org/10.1126/science.1110267 10.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Exp Med 2009; 206:743–50; PMID:19307328; http://dx.doi.org/10.1084/jem.20081787 11.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Oncoimmunology 2014; 3:e27572; PMID:24734216; http://dx.doi.org/10.4161/ onci.27572 12.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Mol Ther J Am Soc Gene Ther 2014;22:1416–22; http://dx.doi.org/10.1038/mt.2014.104 13.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Clin Invest 1999; 103:1437–49; http://dx.doi.org/10.1172/ JCI540914.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Blood 2008; 112:1317–24; PMID:18539896; http://dx.doi.org/10.1182/blood-2008-01-136713 15.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
JClin Invest 2005; 115:3140–8; PMID:16211094; http://dx.doi.org/10.1172/JCI25221 16.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Immu-nol 2012; 13:872–9; PMID:22885985; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Am Soc Nephrol 2010; 21:181–8; PMID:19713314; http://dx.doi.org/10.1681/ASN.2008101072 20.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Cell 2014; 157:1013–22; PMID:24855941; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
The inﬂammasome: a molecular platform triggering activation of inﬂamma- tory caspases and processing of proIL- b. Mol Cell 2002; 10:417–26; PMID:12191486; http://dx.doi.org/10.1016/S1097-2765(02)00599-3 22.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Trends Immunol 2011; 32:373–9; PMID:21733753; http://dx.doi.org/ 10.1016/j.it.2011.05.004 23.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Annu Rev Phys- iol 2014; 76:57–78; PMID:24274736; http://dx.doi.org/10.1146/annurev-physiol-021113-170324 24.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Int J Biochem Cell Biol 2013; 45:2052–6; PMID:23838171; http://dx.doi.org/10.1016/j.biocel.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nature2012; 491:364–73; PMID:23151579; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Biotechnol 2008; 26:1179–86; PMID:18820684; http://dx.doi.org/ 10.1038/nbt.1500 27.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Immunity 2010; 32:367–78; PMID:20226691; http://dx.doi.org/ 10.1016/j.immuni.2010.02.012 28.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Cell2011; 145:745–57; PMID:21565393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Med 2012; 18:791–8; PMID:22484808; http://dx.doi.org/10.1038/nm.2717 30.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Int J Cancer 2003; 106:827–35; PMID:12918059; http://dx.doi.org/10.1002/ijc.1128531.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Cancer Metastasis Rev 2006; 25:417–34; PMID:17001512; http://dx.doi.org/ 10.1007/s10555-006-9013-3 32.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Cancer Res 2012; 72:2757–67; PMID:22427351; http://dx.doi.org/10.1158/0008-5472.CAN-11-3379 33.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Histochem Cytochem 2007; 55:443–52; PMID:17164409; http://dx.doi.org/10.1369/jhc.6A7101.2006 34.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Cell 2014; 156:1045–59; PMID:24581500; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Immunol 2001; 2:157–64;PMID:11175814; http://dx.doi.org/10.1038/84264 37.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Science 2010; 329:1205–10; PMID:20813954; http://dx.doi.org/10.1126/science.1192698 40.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Immunol 2010; 11:395–402; PMID:20351692; http://dx.doi.org/10.1038/ni.1864 42.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nature 2012; 481:278– 86; PMID:22258606; http://dx.doi.org/10.1038/nature10759 43.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nat Med 2009; 15:1170–8; PMID:19767732; http://dx.doi.org/ 10.1038/nm.2028 44.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Eur J Immunol 2000; 30:1113–9; PMID:10760800; http://dx.doi.org/10.1002/(SICI)1521-4141(200004) 30:4%3c1113::AID-IMMU1113%3e3.0.CO;2-P 48.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
J Immunol 2001; 167:1306–12; PMID:11466347; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
Nature 2003; 423:456–461; PMID:12732850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/ae/koni-04-05-1003011.PMC4485801.pdf
"As we © Transgene S.A. *Correspondence to: Xavier Pr /C19eville; Email: preville@transgene.fr Submitted: 12/23/2014; Accepted: 12/23/2014 http://dx.doi.org/10.1080/2162402X.2014.1003013 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
CA Cancer J Clin 2011; 61:69–90; PMID:21296855; http://dx.doi.org/ 10.3322/caac.201072.,Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Nat Med 2004; 10:909–15; PMID:15340416; http://dx.doi.org/10.1038/nm11003.,OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Immunity 2013; 39:1–10; PMID:23890059; http://dx.doi.org/10.1016/j.immuni.2013.07.012 Figure 1.,OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Nature Med 2002; 8:157–65; PMID:11821900; http://dx.doi.org/ 10.1038/nm0202-157 6.,Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Cancer Immunol Res 2014; 2(12):1163–74; PMID:25168392; http://dx.doi.org/10.1158/2326-6066.CIR-14-0050 7.,Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Nat Rev Cancer 2012; 12:298–306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245 8.,Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Cancer Immunol Immunother CII 2014;63(10):991–7; http://dx.doi.org/10.1007/s00262-014- 1590-3 9.,Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
"Clinical Can Res 2011; 17:1765–75; http://dx.doi.org/ 10.1158/1078-0432.CCR-10-2672 10. van den Boorn JG, Hartmann G. Turning tumors into vaccines: co-opting the innate immune system.",Non-OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
Immu- nity 2013; 39:27–37; PMID:23890061; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/b1/koni-04-05-1003013.PMC4485804.pdf
"8JAK phosphorylation has also been shown to activate other important pathways such as PI3K, RAS, © Roberto Bellucci, Allison Martin, Davide Bommarito, Kathy Wang, Steen H Hansen, Gordon J Freeman, and Jerome Ritz *Correspondence to: Roberto Bellucci; Email: Roberto_Bellucci@dfci.harvard.edu; Jerome Ritz; Email: Jerome_Ritz@dfci.harvard.eduSubmitted: 11/10/2014; Revised: 01/13/2015; Accepted: 01/14/2015 http://dx.doi.org/10.1080/2162402X.2015.1008824 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Blood 2008; 112:461-9; PMID:18650461; http://dx.doi.org/ 10.1182/blood-2007-09-077438 2.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Cell 2010; 142:847-56; PMID:20850008; http://dx.doi.org/10.1016/j.cell.2010.08.031 3.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Nat Immunol 2008; 9:495-502; PMID:18425106; http://dx.doi.org/10.1038/ni15815.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
AdvImmunol 2006; 90:1-50; PMID:16730260; http://dx.doi.org/10.1016/S0065- 2776(06)90001-7 7.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Clin Invest 2012; 122:2369-83; PMID:22684105; http://dx.doi.org/10.1172/JCI584578.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Immunity 2012; 36:529-41; PMID:22520846; http://dx.doi.org/ 10.1016/j.immuni.2012.03.017 9.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
1997; 278:1309-12; PMID:9360930; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Science 1994; 264:1415-21; PMID:8197455; http://dx.doi.org/ 10.1126/science.8197455 12.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Immunol 2012; 189:813-8; PMID:22675202; http://dx.doi.org/10.4049/jimmunol.1102041 13.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J LeukocBiol 2003; 73:540-5; PMID:12660229; http://dx.doi.org/10.1189/jlb.1002508 14.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Blood Rev 2006; 20:123-37; PMID:16364519; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Nat Immunol 2008;9:503-10; PMID:18425107; http://dx.doi.org/ 10.1038/ni1582 17.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
JImmunolMethods 2004; 294:15-22; PMID:15604012; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
EurJBiochem 2000;267:2260-7; PMID:10759849; http://dx.doi.org/ 10.1046/j.1432-1327.2000.01231.x 19.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Annu Rev Immunol 2005; 23:225-74; PMID:15771571; http://dx.doi.org/ 10.1146/annurev.immunol.23.021704.115526 20.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Clin Invest 1991; 88:282-9; PMID:1905328; http://dx.doi.org/10.1172/JCI115289 21.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
"Beatty GL, Paterson Y. IFN-gamma can promote tumor evasion of the immune system in vivo by down- regulating cellular levels of an endogenous tumor anti- gen. J Immunol 2000; 165:5502-8; PMID:11067903;http://dx.doi.org/10.4049/jimmunol.165.10.5502 22.",Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
JNeurooncol 1998; 39:227-36;PMID:9821108; http://dx.doi.org/10.1023/ A:1005902120612 24.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Eur J Immunol 2013; 43:747-57; PMID:23175469; http://dx.doi.org/10.1002/ eji.201242814 25.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Nature 2009; 458:206-10; PMID:19078956; http://dx.doi.org/10.1038/ nature07662 26.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
NatRev Drug Discov 2013; 12:130-46; PMID:23370250; http://dx.doi.org/10.1038/nrd3877 27.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Oncoimmunology 2012; 1:1223-5; PMID:23243584; http://dx.doi.org/ 10.4161/onci.21335 28.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Blood 2010; 116:2286-94; PMID:20460501; http://dx.doi.org/10.1182/blood- 2010-02-271874 29.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Eur J Immunol 2012; 42:541-50; PMID:22105417; http://dx.doi.org/10.1002/eji.201141832 30.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Immunity 1998; 9:25-34; PMID:9697833;http://dx.doi.org/10.1016/S1074-7613(00)80585-3 31.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Immunity 1994; 1:447-56; PMID:7895156;http://dx.doi.org/10.1016/1074-7613(94)90087-6 32.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Methods Enzymol1986; 119:611-8; PMID:3762411; http://dx.doi.org/ 10.1016/0076-6879(86)19082-3 34.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
JInvestDermatol 2004; 122:414-22; PMID:15009724; http://dx.doi.org/10.1046/j.0022- 202X.2004.22237.x 35.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Natl Cancer Inst 1990; 82:1071; PMID:2112201;http://dx.doi.org/10.1093/jnci/82.12.1071-a 37.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Int J Cancer 1993; 55:320-9; PMID:8370628; http://dx.doi.org/10.1002/ ijc.2910550224 38.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
"Taniguchi K, Petersson M, Hoglund P, Kiessling R, Klein G, Karre K. Interferon gamma induces lung colo- nization by intravenously inoculated B16 melanomacells in parallel with enhanced expression of class I major histocompatibility complex antigens.ProcNatlAcadSci US A 1987; 84:3405-9; PMID:3106968; http://dx.doi.org/10.1073/ pnas.84.10.3405 39.",Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Clin Cancer Res 2011; 17:6118-24; PMID:21705455; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0482 41.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Nat Med 1999; 5:1365-9; PMID:10581077; http://dx.doi.org/ 10.1038/70932 42.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Exp Med 2000; 192:1027-34; PMID:11015443; http://dx.doi.org/10.1084/jem.192.7.1027 43.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
ProcNatlAcadSci U SA 1998; 95:7556-61; PMID:9636188; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Eur J Immunol 1990; 20:2445-8; PMID:1701392; http://dx.doi.org/ 10.1002/eji.1830201113 45.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
J Immunol 2003; 170:1257-66; PMID:12538684; http://dx.doi.org/10.4049/jimmunol.170.3.1257 46.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
Immunobiology 2012; 217:385-93; PMID:22204817; http://dx.doi.org/10.1016/j.imbio.2011.10.016 47.,Non-OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
N Engl J Med 2012; 366:2455-65; PMID:22658128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
NEngl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690 49.,OADS,/arxiv_data1/oa_pdf/25/f8/koni-04-06-1008824.PMC4485824.pdf
"13Tumor cells treated *Correspondence to: David J Waxman; Email: djw@bu.edu Submitted: 11/18/2014; Revised: 01/02/2015; Accepted: 01/06/2015 http://dx.doi.org/10.1080/2162402X.2015.1005521 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nature 2012; 488:522-6; PMID:22854781; http://dx.doi.org/ 10.1038/nature11287 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nature 2013; 501:338-45; PMID:24048066; http://dx.doi.org/10.1038/ nature12625 4.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Immunotherapy 2009; 1:483-93; PMID:20635964; http://dx.doi.org/10.2217/imt.09.13 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2011; 71:4338-43; PMID:21712409; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0717 6.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
"Gajewski TF, Fuertes M, Spaapen R, Zheng Y, Kline J. Molecular proﬁling to identify relevant immune resis- tance mechanisms in the tumor microenvironment.Curr Opin Immunol 2011; 23:286-92; PMID: 21185705; http://dx.doi.org/10.1016/j.coi.2010.",OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Gynecol Oncol 2010; 116:222-33; PMID:19959212; http://dx.doi.org/10.1016/j.ygyno.2009.11.001 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Clin Cancer Res 2007; 13:4016-25; PMID:17606736; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0016 9.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Clin Oncol 2010; 28:4390-9; PMID:20697078; http://dx.doi.org/10.1200/ JCO.2009.27.6360 10.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Semin Oncol 2010; 37:499-507; PMID:21074065; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Mol Ther 2013; 21:348- 57; PMID:23011032; http://dx.doi.org/10.1038/ mt.2012.204 12.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Clin Cancer Res 2011; 17:6958-62; PMID:21900389; http://dx.doi.org/10.1158/1078-0432.CCR-11-1595 13.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Oncogene 2010; 29:482-91; PMID:19881547; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Oncogene 2011; 30:1147-58; PMID:21151176; http://dx.doi.org/ 10.1038/onc.2010.500 16.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Exp Med 2005; 202:1691-701;PMID:16365148; http://dx.doi.org/10.1084/ jem.20050915 17.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.org/ 10.1038/nm1523 18.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Immunol Immun- other 2013; 62:203-16; PMID:23389507; http://dx.doi.org/10.1007/s00262-012-1388-0 19.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Clin Invest 2008; 118:1991-2001; PMID:18523649; http://dx.doi.org/10.1172/JCI35180 20.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nat Rev Clin Oncol2009; 6:638-47; PMID:19786984; http://dx.doi.org/ 10.1038/nrclinonc.2009.146 21.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2011; 71:768-78; PMID:21156650; http://dx.doi.org/10.1158/0008-5472.CAN-10-2788 22.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Clin Cancer Res 2007; 13:644-53;PMID:17255288; http://dx.doi.org/10.1158/1078- 0432.CCR-06-1209 23.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
SeminImmunopathol 2011; 33:369-83; PMID:21611872; http://dx.doi.org/10.1007/s00281-011-0245-0 25.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2009; 69:4309-18; PMID:19435909; http://dx.doi.org/10.1158/0008-5472.CAN-08-4102 26.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2012; 72:1103-15;PMID:22237627; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3380 27.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2013; 73:119-27; PMID:23108141;http://dx.doi.org/10.1158/0008-5472.CAN-12-222528.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nat Rev Clin Oncol 2014; 11:413-31; PMID:24913374; http://dx.doi.org/ 10.1038/nrclinonc.2014.89 29.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Lett 2014; 353:272-80;PMID:25069038; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Eur J Immunol 2002; 32:2881-7;PMID:12355441; http://dx.doi.org/10.1002/ 1521-4141(2002010)32:10%3c2881::AID- IMMU2881%3e3.0.CO;2-K 33.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cell 1994; 76:977-87; PMID:8137431; http://dx.doi.org/10.1016/0092-8674(94)90376-X 34.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Toxi- col Pathol 2012; 40:186-204; PMID:22222887; http://dx.doi.org/10.1177/0192623311430693 35.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Eur J Immunol 2014; 44:2703-11; PMID:24838857; http://dx.doi.org/ 10.1002/eji.201344392 36.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Invest Dermatol 2006; 126:32-41; PMID:16417215; http://dx.doi.org/10.1038/sj.jid.5700001 37.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Immunity 2009; 30:636-45;PMID:19464986; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Immunity 2012; 37:549-62; PMID:22940097; http://dx.doi.org/ 10.1016/j.immuni.2012.05.029 39.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Crit Rev Clin Lab Sci 2012; 49:49-61; PMID:22468857; http://dx.doi.org/10.3109/ 10408363.2012.666845 40.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Indian J Cancer 2013; 50:142-8;PMID:23979206; http://dx.doi.org/10.4103/0019- 509X.117027 41.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer J 2010; 16:295-303; PMID:20693839; http://dx.doi.org/ 10.1097/PPO.0b013e3181eb5066 42.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Immunol 2014; 193:757-63; PMID:24913978; http://dx.doi.org/ 10.4049/jimmunol.1400188 44.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Oncoimmunology 2012; 1:298-305; PMID:22737605; http://dx.doi.org/10.4161/onci.19068 45.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Mol Cancer 2014; 13:158; PMID:24965046; http://dx.doi.org/10.1186/1476- 4598-13-158 46.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Immunol Immunother 2013; 62:383-91; PMID:22926062; http://dx.doi.org/10.1007/s00262-012-1343-0 47.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Immunol Immunother 2013; 62:171- 82; PMID:23011589; http://dx.doi.org/10.1007/ s00262-012-1322-5 48.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Immunity2003; 19:561-9; PMID:14563320; http://dx.doi.org/ 10.1016/S1074-7613(03)00264-4 49.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Int J Immunopharmacol 2000; 22:707-18; PMID:10884591; http://dx.doi.org/10.1016/S0192- 0561(00)00033-3 50.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Immunol 2014; 193:1709-16; PMID:25000978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cyto- kine Growth Factor Rev 2002; 13:169-83; PMID:11900992; http://dx.doi.org/10.1016/S1359- 6101(01)00021-1 52.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Immunity 2014; 41:49- 61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010 53.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Clin Dev Immunol 2012;2012:890178; PMID:22400040; http://dx.doi.org/ 10.1155/2012/890178 55.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Invest Dermatol 2013; 133:1610-9; PMID:23223128; http://dx.doi.org/10.1038/jid.2012.444 56.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2011; 71:3528-39; PMID:21444678; http://dx.doi.org/10.1158/0008-5472.CAN-10-4523 58.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Res 2012; 72:6325-32; PMID:23222302; http://dx.doi.org/ 10.1158/0008-5472.CAN-12-2027 59.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Immunol 2003; 170:5018-26; PMID:12734346; http://dx.doi.org/10.4049/jimmunol.170.10.5018 60.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cell Death Differ2014; 21:15-25; PMID:23787994; http://dx.doi.org/ 10.1038/cdd.2013.67 61.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Oncol Res 2010; 18:601-5; PMID:20939436; http://dx.doi.org/10.3727/ 096504010X12777678141662 62.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Control Release 2014; 187:175- 82; PMID:24887014; http://dx.doi.org/10.1016/j.jconrel.2014.05.045 63.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Adv Exp Med Biol 2014; 812:105- 11; PMID:24729221; http://dx.doi.org/10.1007/978- 1-4939-0620-8_14 65.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Clin Invest 2000; 105:R15-24; PMID:10772661; http://dx.doi.org/10.1172/JCI8829 66.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Nat Rev Cancer 2005; 5:397-405; PMID:15864281; http://dx.doi.org/ 10.1038/nrc1613 68.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Lett 2013; 330:241-9; PMID:23228633; http://dx.doi.org/10.1016/j.canlet.2012.11.055 70.,OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Clin Invest 2014; 124:4082-92; PMID:25105369; http://dx.doi.org/10.1172/ JCI76739 71.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Lancet Oncol 2009; 10:459-66; PMID:19269895; http://dx.doi.org/10.1016/S1470-2045(09)70025-7 72.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Onkologie 2004; 27:239-45;PMID:15249712; http://dx.doi.org/10.1159/ 000077973 73.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Pediatr Hematol Oncol 1995; 17:134-9; PMID:7749762; http://dx.doi.org/10.1097/00043426-199505000-00006 74.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
Cancer Immunol Immunother 2009; 58:1627-34; PMID:19221744; http://dx.doi.org/10.1007/s00262-009-0671-1 76.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
J Immunother 2013; 36:477-89;PMID:24145359; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/7b/51/koni-04-04-1005521.PMC4485826.pdf
"The primary localization of MM is the BM, where interac- tions between neoplastic and surrounding cells (i.e., MSCs, immune cells, endothelial cells, osteoblasts, and osteoclasts) are believed to mediate disease development and progression.6,7 The distinctive effector functions of tumor-inﬁltrating CD4C T cells shift disease prognosis toward regression or promotion, © Giulia Di Lullo, Magda Marcatti, Silvia Heltai, Emanuela Brunetto, Cristina Tresoldi, Attilio Bondanza, Chiara Bonini, Maurilio Ponzoni, Giovan ni Tonon, Fabio Ciceri, Claudio Bordignon, and Maria Pia Protti*Correspondence to: Maria Pia Protti; Email: m.protti@hsr.itSubmitted: 12/01/2014; Revised: 12/30/2014; Accepted: 12/30/2014 http://dx.doi.org/10.1080/2162402X.2015.1005460 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Rev Cancer 2007; 7:585-98;PMID:17646864; http://dx.doi.org/10.1038/nrc2189 3.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Eur J Haematol 2011; 86:1-15; PMID:20942854; http://dx.doi.org/10.1111/ j.1600-0609.2010.01542.x 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Leuk Res 2012; 36(Suppl 1):S3-12;PMID:23176722; http://dx.doi.org/10.1016/S0145- 2126(12)70003-6 5.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Rev Clin Oncol 2011; 8:479-91; PMID:21522124; http://dx.doi.org/10.1038/nrclinonc.2011.63 6.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Leukemia 2009; 23:10-24;PMID:18843284; http://dx.doi.org/10.1038/leu.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cancer Microenviron 2011; 4:313-23; PMID:21866321; http://dx.doi.org/10.1007/s12307- 011-0086-3 8.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245 9.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Tissue Antigens 2014; 83:237-46; PMID:24641502; http://dx.doi.org/10.1111/ tan.12329 10.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139 11.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Exp Med 2011; 208:469-78; PMID:21339327; http://dx.doi.org/10.1084/jem.20101876 12.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Proc Natl Acad Sci U S A 2002; 99:13009-13; PMID:12235374; http://dx.doi.org/10.1073/ pnas.202491499 13.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cancer Res 2005; 65:2026-34;PMID:15753403; http://dx.doi.org/10.1158/0008- 5472.CAN-04-3337 14.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood 2008; 112:2878-85; PMID:18669891; http://dx.doi.org/10.1182/blood-2008-03-143222 15.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood 2010; 116:3554-63; PMID:20664052; http://dx.doi.org/10.1182/blood-2010-05-283895 16.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood 2010; 115:5385- 92; PMID:20395418; http://dx.doi.org/10.1182/ blood-2009-10-246660 17.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood Cancer J 2013; 3:e148; PMID:24036947; http://dx.doi.org/10.1038/ bcj.2013.34 18.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Immunol 2009; 10:857-63; PMID:19578369; http://dx.doi.org/10.1038/ni.1767 19.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Allergy Clin Immunol 2009; 123:1244-52.e2; PMID:19439349; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cancer Lett 2012; 326:23-32; PMID:22809567;http://dx.doi.org/10.1016/j.canlet.2012.07.013 24.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Pancreas2014; 43:470-7; PMID:24622082; http://dx.doi.org/ 10.1097/MPA.0000000000000055 25.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Immunity 2014; 40:772-84; PMID:24816405; http://dx.doi.org/10.1016/j.immuni.2014.03.010 26.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Immunother 2012; 61:1965-75; PMID:22527243; http://dx.doi.org/10.1007/s00262-012-1241-5 27.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cancer Cell 2009; 16:309-23; PMID:19800576; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Med 2003; 9:1151-7; PMID:12910264; http://dx.doi.org/ 10.1038/nm914 29.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Clin Oncol 2005; 23:3412-20; PMID:15809451; http://dx.doi.org/10.1200/JCO.2005.04.242 30.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Deﬁning the human T helper 17 cell phenotype.Trends Immunol 2012; 33:505-12; PMID:22682163; http://dx.doi.org/10.1016/j.it.2012.05.004 31.",OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Biol Chem 2002; 277:33676-82; PMID:12087100; http://dx.doi.org/10.1074/jbc.M204204200 32.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Leukemia 2008; 22:1595-603; PMID:18509351; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Transl Oncol 2011; 4:9-19; PMID:21286373; http://dx.doi.org/10.1593/ tlo.10172 34.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood 2006; 108:2020-8; PMID:16728703; http://dx.doi.org/10.1182/blood-2005-11-013458 35.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Int Immunol 1998; 10:1421-33; PMID:9796908; http://dx.doi.org/10.1093/intimm/10.10.1421 38.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Immunol 2013; 190:5799-808; PMID:23630362; http://dx.doi.org/ 10.4049/jimmunol.1202677 39.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Semin Immunopathol 2010; 32:17-31; PMID:20127093; http://dx.doi.org/ 10.1007/s00281-009-0188-x 40.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Nat Immunol2011; 12:383-90; PMID:21502992; http://dx.doi.org/ 10.1038/ni.2025 41.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cytokine Growth Factor Rev 2014; 25:257-71; PMID:24856143; http://dx.doi.org/10.1016/j.cytogfr.2014.04.005 42.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
J Biol Chem 2007; 282:16006-15; PMID:17438334; http://dx.doi.org/ 10.1074/jbc.M611040200 43.,OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
ClinCancer Res 2008; 14:6432-9; PMID:18927282; http://dx.doi.org/10.1158/1078-0432.CCR-07-4401 44.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Hepatology2011; 54:900-9; PMID:21674558; http://dx.doi.org/ 10.1002/hep.24486 45.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Clin Exp Immunol 2012; 168:192-9; PMID:22471280; http://dx.doi.org/10.1111/j.1365-2249.2012.04570.x 46.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Hematology 2015; 20:143-7; PMID:25055724; http://dx.doi.org/ 10.1179/1607845414Y.0000000182 47.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Blood Rev 2010; 24 (Suppl 1):S5-11; PMID:21126636; http://dx.doi.org/ 10.1016/S0268-960X(10)70003-5 48.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Clin Lymphoma Myeloma 2005; 6:200-7; PMID: 16354325; http://dx.doi.org/10.3816/CLM.2005.n.047 52.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Semin Hematol 2009; 46:110-7; PMID:19389494; http://dx.doi.org/10.1053/j.seminhematol.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Leukemia 2013; 27:711-7;PMID:23032723; http://dx.doi.org/10.1038/ leu.2012.282 54.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Cancer Res2007; 67:9142-9; PMID:17909019; http://dx.doi.org/ 10.1158/0008-5472.CAN-06-4690 55.,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
Histopathology2006; 48:529-35; PMID:16623778; http://dx.doi.org/ 10.1111/j.1365-2559.2006.02375.x www.tandfonline.com e1005460-13 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/1f/81/koni-04-05-1005460.PMC4485827.pdf
"9 Given that excess cytokine release is a known side effect of BsAbs, we also considered the ideal BsAb to have functional monova- lency of CD3 engagement in the absence of FcR(n) binding to © Mahiuddin Ahmed, Ming Cheng, Irene Y Cheung, and Nai-Kong V Cheung *Correspondence to: Nai-Kong V Cheung; Email: cheungn@mskcc.orgSubmitted: 11/14/2014; Accepted: 11/15/2014 http://dx.doi.org/10.4161/2162402X.2014.989776 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Expert Opin Biol Ther 2011; 11:843-53; PMID:21449821; http://dx.doi.org/ 10.1517/14712598.2011.572874 2.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Immunol 2003; 170:4397- 402; PMID:12682277; http://dx.doi.org/10.4049/ jimmunol.170.8.4397 3.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Science 2008; 321:974-7; PMID:18703743; http://dx.doi.org/ 10.1126/science.1158545 4.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Clin Oncol 2011; 29:2493-8; PMID:21576633; http://dx.doi.org/10.1200/JCO.2010.32.7270 5.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Immunother 2011; 34:597-605;PMID:21904216; http://dx.doi.org/10.1097/ CJI.0b013e3182307fd8 6.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Clin Cancer Res 2012; 18:465-74; PMID:22096026; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1270 7.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Br J Cancer 2010; 102:124-33; PMID:19953093;http://dx.doi.org/10.1038/sj.bjc.6605364 8.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Trends Biotechnol 2010; 28:355-62; PMID:20447706; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Mol Biol 2001; 310:635-58; PMID:11439029; http://dx.doi.org/10.1006/ jmbi.2001.4780 11.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Cancer 1992; 70:633-8; PMID:1623478; http://dx.doi.org/10.1002/1097-0142(19920801)70:3%3c633::AID- CNCR2820700315%3e3.0.CO;2-F 13.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Eur J Nuclear Med 1996; 23:145-9; PMID:8925848; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Clin Invest 2012; 122:2066-78; PMID:22585577; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
ASN Neuro 2011; 3:pii: e00054; PMID:21395555; http://dx.doi.org/10.1042/AN20110006 17.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Blood 2007; 109:4245-8; PMID:17264296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
"Jin HJ, Nam HY, Bae YK, Kim SY, Im IR, Oh W, Yang YS, Choi SJ, Kim SW. GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells.Cell Mol Life Sci 2010; 67:1845-58; PMID:20165901; http://dx.doi.org/10.1007/s00018- 010-0292-z 19.",OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Immunol 2009; 183:5748-55; PMID:19812201; http://dx.doi.org/ 10.4049/jimmunol.0901409 20.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Int JCancer 2014; 136(2):476-86; PMID:24895182; http://dx.doi.org/10.1002/ijc.29007 22.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Immunotechnology 1997; 3:83-105;PMID:9237094; http://dx.doi.org/10.1016/S1380- 2933(97)00067-5 24.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Mol Biol 1999; 293:41-56; PMID:10512714; http://dx.doi.org/10.1006/jmbi.1999.3156 26.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Protein Eng 1996; 9:617-21;PMID:8844834; http://dx.doi.org/10.1093/protein/ 9.7.617 28.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
MAbs 2014; 6:381-91; PMID:24492297; http://dx.doi.org/ 10.4161/mabs.27385 29.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Mol Immunol2007; 44:1935-43; PMID:17083975; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Biol Chem 2011; 286:1812-8; PMID:21097496; http://dx.doi.org/10.1074/jbc.M110.172957 31.,OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Cancer Res 2005; 65:2882-9; PMID:15805290;http://dx.doi.org/10.1158/0008-5472.CAN-04-2637 32.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Toxicol Appl Pharmacol 1996; 138:84-9; PMID:8658517; http://dx.doi.org/10.1006/taap.1996.0101 34.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Curr Drug Metab2013; 14:764-90; PMID:23952252; http://dx.doi.org/ 10.2174/13892002113149990099 35.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Clin Pharmacol Ther 2008; 84:548-58; PMID:18784655;http://dx.doi.org/10.1038/clpt.2008.170 36.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
Pain 2010; 149:135-42; PMID:20171010; http://dx.doi.org/10.1016/j.pain.2010.01.024 38.,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
J Am Chem Soc 1998; 120:1138-45; http://dx.doi.org/10.1021/ja9733649 www.tandfonline.com e989776-11 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/ca/4b/koni-04-04-989776.PMC4485828.pdf
"Mice lacking MHC-II on pDCs developed larger tumors andexhibited impaired Th17 cell responses ascompared to control animals, suggesting a functional role for pDC-driven Th17 cells in promoting antitumor immunity.Accordingly, transfer of tumor-speciﬁc © Leslie Gu /C19ery and St /C19ephanie Hugues *Correspondence to: Stephanie Hugues; Email: stephanie.hugues@unige.chSubmitted: 11/10/2014; Accepted: 11/12/2014 http://dx.doi.org/10.4161/2162402X.2014.988476 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2013;4:59; PMID:23508732; http://dx.doi.org/ 10.3389/ﬁmmu.2013.00059 2.,OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
Cancer Res.2013;73:1063-75; PMID:23345163; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2013;93:343-52; PMID:23136258; http://dx.doi.org/ 10.1189/jlb.0812397 4.,Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2014;192:824-32;PMID:24337377; http://dx.doi.org/10.4049/jimmunol.,OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2013;73:4629-40; PMID:23722543; http://dx.doi.org/10.1158/0008-5472.CAN-12-3058 6.,Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2010;5:e10458; PMID:20454561; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2014;5:276; PMID:24987392;http://dx.doi.org/10.3389/ﬁmmu.2014.00276 9.,OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
Blood.2008;112:362-73; PMID:18354038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
2009;31:787-98; PMID:19879162; http://dx.doi.org/10.1016/j.immuni.2009.09.014 www.tandfonline.com e988476-3 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/16/86/koni-04-05-988476.PMC4485838.pdf
"9,10Maternal immunization against tumor-associated antigens, instead, is not a © Giuseppina Barutello, Claudia Curcio, Michela Spadaro, Maddalena Arigoni, Rosalinda Trovato, Elisabetta Bolli, Yujuan Zheng, Francesco Ria, El ena Quaglino, Manuela Iezzi, Federica Riccardo, Lars Holmgren, Guido Forni, and Federica Cavallo*Correspondence to: Federica Cavallo; Email: federica.cavallo@unito.itSubmitted: 12/09/2014; Revised: 12/29/2014; Accepted: 12/30/2014 http://dx.doi.org/10.1080/2162402X.2015.1005500 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Carcinogenesis 2011; 32:787-95;PMID:21436188; http://dx.doi.org/10.1093/carcin/ bgr054 2.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Cancer Prev Res (Phila) 2014; 7:1072-80; PMID:25245763; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0178 3.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Nature 1970; 228:573; PMID:5528694; http://dx.doi.org/10.1038/228573a0 4.,OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Nat Rev Immunol 2007; 7:715- 25; PMID:17703228; http://dx.doi.org/10.1038/nri2155 5.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Ann New York Acad Sci 2003; 987:199-206; PMID: 12727640; http://dx.doi.org/10.1111/j.1749- 6632.2003.tb06049.x 6.,OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Lancet 2007; 370:1947-59; PMID:17854885; http://dx.doi.org/10.1016/S0140- 6736(07)61261-6 7.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
N Engl J Med 2008; 359:1555-64; PMID:18799552; http://dx.doi.org/ 10.1056/NEJMoa0708630 8.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Am J Reprod Immunol 1998; 39:279-83; PMID:9553653; http://dx.doi.org/ 10.1111/j.1600-0897.1998.tb00365.x 12.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Nat Rev Cancer 2006; 6:204-16;PMID:16498443; http://dx.doi.org/10.1038/nrc1815 14.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Cancer Res 2004; 64:2858-64; PMID:15087404; http://dx.doi.org/10.1158/0008-5472.CAN-03-2962 17.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
J Clin Invest 2004; 113:709-17; PMID:14991069; http://dx.doi.org/10.1172/ JCI19850 18.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Vaccine 2005; 23:3280-7; PMID:15837233; http://dx.doi.org/10.1016/j.vaccine.2005.01.086 19.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
J Exp Med 1998; 188:589-96; PMID:9687535; http://dx.doi.org/ 10.1084/jem.188.3.589 20.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
JImmunol 2006; 177:7626-33; PMID:17114432; http://dx.doi.org/10.4049/jimmunol.177.11.7626 22.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
J Immunol 2010; 184:6124-32;PMID:20435927; http://dx.doi.org/10.4049/ jimmunol.0901215 23.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Adv Immunol 2006; 90:175- 213; PMID:16730264; http://dx.doi.org/10.1016/ S0065-2776(06)90005-4 24.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
J Immunol 2000; 165:5133-42; PMID:11046045; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Oncoimmunology 2012; 1:316-25; PMID:22737607; http://dx.doi.org/10.4161/onci.19127 26.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
A DNA vaccine targeting angiomo- tin inhibits angiogenesis and suppresses tumor growth.Proc Natl Acad Sci U S A 2006; 103:9208-13; PMID:16754857; http://dx.doi.org/10.1073/ pnas.0603110103 27.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Nat Med 1998; 4:627-30; PMID:9585241; http://dx.doi.org/10.1038/nm0598-627 29.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Blood 2012; 119:5640-9; PMID:22535666; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Proc Natl Acad Sci U S A1998; 95:652-6; PMID:9435247; http://dx.doi.org/ 10.1073/pnas.95.2.652 31.,OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Mucosal Immunol 2010; 3:461-74; PMID:20485331; http://dx.doi.org/10.1038/mi.2010.23 32.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Cancer Treat Rev 2012; 38:133-42; PMID:21549508; http://dx.doi.org/10.1016/j.ctrv.2011.03.008 33.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
Cancer Res 2010; 70:2604-12; PMID:20332241; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-2548 www.tandfonline.com e1005500-9 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/14/c2/koni-04-05-1005500.PMC4485839.pdf
"1,2Although GVL is © Tomomi Toubai, Hou Guoqing, Corrine Rossi, Nathan Mathewson, Katherine Oravecz-Wilson, Emily Cummings, Julia Wu, Yaping Sun, Sung Choi, and Pavan Reddy*Correspondence to: Tomomi Toubai; Email: tomomit@med.umich.edu, Pavan Reddy; Email: reddypr@med.umich.eduSubmitted: 12/12/2014; Revised: 02/02/2015; Accepted: 02/03/2015 http://dx.doi.org/10.1080/2162402X.2015.1016699 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
N Engl J Med 2010; 363:2091-101; PMID:21105791; http://dx.doi.org/10.1056/NEJMoa1004383 2.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Clin Oncol 2013; 31:1530-8; PMID:23478054; http://dx.doi.org/ 10.1200/JCO.2012.45.0247 3.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Curr Opin Oncol 2012; 24:182-90; PMID:22234252; http://dx.doi.org/10.1097/CCO.0b013e32834f5c41 5.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Nat Med 2005; 11:1244-9; PMID:16227991; http://dx.doi.org/10.1038/nm1309 6.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Blood 2011; 118:192-204; PMID:21471527; http://dx.doi.org/ 10.1182/blood-2010-12-324616 8.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Science 1992; 258:808-12; PMID:1439790; http://dx.doi.org/ 10.1126/science.1439790 9.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Cell1994; 79:143-56; PMID:7923373; http://dx.doi.org/ 10.1016/0092-8674(94)90407-3 10.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Cell 1995; 83:289-99; PMID:7585946; http://dx.doi.org/10.1016/0092- 8674(95)90170-111.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
N Engl J Med 2009; 360:470-80;PMID:19129520; http://dx.doi.org/10.1056/ NEJMoa0808253 12.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Clin Oncol 2009; 27:5202-7; PMID:19770381; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Int Immunopharma- col 2003; 3:345-57; PMID:12639812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Cell2005; 123:321-34; PMID:16239148; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Immunity 2002; 16:99-109; PMID:11825569; http://dx.doi.org/10.1016/S1074-7613(01)00260-6 16.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Science 1999; 285:412-5; PMID:10411505; http://dx.doi.org/10.1126/science.285.5426.412 17.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
"Raghavan M, Wijeyesakere SJ, Peters LR, Del Cid N. Calreticulin in the immune system: ins and outs.Trends Immunol 2013; 34:13-21; PMID:22959412; http://dx.doi.org/10.1016/j.it.2012.08.002 18.",Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Nat Med 2002; 8:575-81; PMID:12042807; http://dx.doi.org/10.1038/nm0602-575 19.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Nat Med 2004; 10:987-92; PMID:15286785; http://dx.doi.org/10.1038/nm1089 20.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Curr Opin Immunol2014; 27:26-32; PMID:24513968; http://dx.doi.org/ 10.1016/j.coi.2014.01.005 21.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Nat Rev Cancer 2012; 12:265-77;PMID:22437871; http://dx.doi.org/10.1038/nrc3258 22.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Blood 2006; 108:2106-13; PMID:16757687; http://dx.doi.org/ 10.1182/blood-2006-03-007427 23.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Proc Natl Acad Sci U S A 2007; 104:1289-94; PMID:17229838; http://dx.doi.org/10.1073/ pnas.0610383104 24.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Exp Med 2002; 195:1233-45; PMID:12021304; http://dx.doi.org/ 10.1084/jem.20011930 25.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Immunol 2008; 181:6923-33; PMID:18981112; http://dx.doi.org/10.4049/jimmunol.181.10.6923 26.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Sci Transl Med 2014; 6:232ra51; PMID:24739759; http://dx.doi.org/ 10.1126/scitranslmed.3008068 27.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Immunol 2006; 177:3582-9; PMID:16951317; http://dx.doi.org/10.4049/jimmunol.177.6.3582 28.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Exp Med 1999; 189:797-802; PMID:10049943; http://dx.doi.org/10.1084/jem.189.5.797 29.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Mol Immunol 2008; 45:1414-23; PMID:17936359; http://dx.doi.org/10.1016/j.molimm.2007.08.020 31.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Biol Chem 2010;285:4520-35; PMID:19959473; http://dx.doi.org/ 10.1074/jbc.M110.166330 32.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
"EMBO J 2009; 28:3730-44; PMID:19851281; http://dx.doi.org/10.1038/emboj.2009.296 33. van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, Cav /C19e H, Trka J, Saha V, Schrappe M, et al.",OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Blood 2014; 123:1691-8; PMID:24366361; http://dx.doi.org/10.1182/blood-2013-06-509794 34.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Nat Genet 2011; 43:673-8; PMID:21642990; http://dx.doi.org/10.1038/ng.858 35.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Leukemia 2010; 24:1258- 64; PMID:20445578; http://dx.doi.org/10.1038/ leu.2010.87 37.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Leukemia 2011; 25:254-8; PMID:21102428; http://dx.doi.org/10.1038/leu.2010.275 38.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
Immunity 1996; 5:537-49; PMID:8986714; http://dx.doi.org/10.1016/S1074-7613(00)80269-1 39.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
"J Immunol 2005; 174:5398- 406; PMID:15843538; http://dx.doi.org/10.4049/ jimmunol.174.9.5398 42. van Hall T, van Bergen J, van Veelen PA, Kraakman M, Heukamp LC, Koning F, Melief CJ, Ossendorp F,Offringa R. Identiﬁcation of a novel tumor-speciﬁc CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.",Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Immunol2000; 165:869-77; PMID:10878361; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Clin Invest 1999; 104:317-25; PMID:10430613; http://dx.doi.org/ 10.1172/JCI7111 44.,Non-OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
J Clin Invest 2001; 107:1581-9; PMID:11413166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/94/koni-04-07-1016699.PMC4485841.pdf
"2A potential risk of CD40 agonistic IgG1 antibodies isthe induction of ADCC against dendritic © P Ellmark, S M Mangsbo, C Furebring, T H T €otterman, and P Norl /C19en *Correspondence to: P Ellmark; Email: pek@alligatorbioscience.comSubmitted: 12/22/2014; Revised: 01/20/2015; Accepted: 01/21/2015 http://dx.doi.org/10.1080/2162402X.2015.1011484 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Br J Cancer 2014; 111:2214-9; PMID:25211661; http://dx.doi.org/10.1038/bjc.2014.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Immunity 2013; 39:1-10; PMID:23890059; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Clin Cancer Res 2013;19:1035-43; PMID:23460534; http://dx.doi.org/ 10.1158/1078-0432.CCR-12-2064.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Int Immunol2008;20:1467-79; PMID:18824504; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Clin Cancer Res 2011; 17:2270-80; PMID:21389097; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Cancer Immunol Res 2014; 2:80-90; PMID:24778163; http://dx.doi.org/ 10.1158/2326-6066.CIR-13-0067.8.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
Clin Cancer Res 2014; 20: 1747-56; PMID:24691639; http://dx.doi.org/10.1158/1078-0432.CCR-13-2116.,Non-OADS,/arxiv_data1/oa_pdf/f2/46/koni-04-07-1011484.PMC4485842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/36/dmso-8-275.PMC4485843.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 275–286Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  275Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S7945 0randomized, double-blind, placebo-controlled,  clinical study on the effect of Diabetinol® on   glycemic control of subjects with impaired   fasting glucose Malkanthi evans1 William V Judy2 Dale Wilson3 John a rumberger4 najla guthrie1 1KgK Synergize inc., london,  On, canada; 2SiBr research inc.,  Bradenton, Fl , USA;  3london  health Sciences center, University  of Western Ontario, london, O n,  canada; 4Princeton longevity center,  Princeton, nJ, USa correspondence: Malkanthi evans   KgK Synergize inc., 255 Queens   avenue, london, On, n6a 5r8, canada   Tel +1 519 438 9374 extn 239   Fax +1 519 438-8314   email mevans@kgksynergize.co mBackground:  This study investigated the efficacy of Diabetinol® in people with diabetes on  medication but not meeting the American Association of Clinical Endocrinologists and American  Diabetes Association glycemic, blood pressure, and lipid targets.",Non-OADS,/arxiv_data1/oa_pdf/fa/36/dmso-8-275.PMC4485843.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/fa/36/dmso-8-275.PMC4485843.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/36/dmso-8-275.PMC4485843.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 263–274Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  263Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5705 4Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
"Or use: http://youtu.be/rB5PzC5js_ Qinterventions to improve long-term weight loss   in patients following bariatric surgery: challenges   and solutions Melanie McGrice Kathlene Don Paul Nutrition Plus enterprises,  Melbourne, viC, Australia Correspondence: Melanie McGrice   Nutrition Plus enterprises, PO Box  9064, South Yarra, Melbourne, viC 3141,  Australia   Tel +61 1300 438 550   email dietitian@nutritionplus.com.a uAbstract:  Bariatric surgery aims to provide long-term weight loss and improvement in weight- related comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs311/en /.,Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
Available from: http://www.who.int/ dietphysicalactivity/pa/en /.,Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/6b/dmso-8-263.PMC4485844.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/d9/opth-9-1121.PMC4485847.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1121–1128Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1121Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8395 0Causes of uveitis in children without juvenile  idiopathic arthritis stephanie B engelhard asima Bajwa ashvini K reddy Department of Ophthalmology,   University of Virginia, Charlottesville,   Va, UsaBackground:  The purpose of this study was to report the demographics, disease characteristics,  treatments, and visual outcomes of pediatric uveitis patients without juvenile idiopathic arthritis  managed in a tertiary medical center.",Non-OADS,/arxiv_data1/oa_pdf/17/d9/opth-9-1121.PMC4485847.pdf
"Although children represent only  2.1%–13.8% of patients seen in uveitis clinics, they can present significant diagnostic  and therapeutic challenges.1–3 Children with uveitis are often preverbal or asymptom - atic, and may present to the ophthalmologist with already significant ocular damage.4,5 Correspondence: ashvini K reddy Department of Ophthalmology,  University of Virginia, 1300 Jefferson Park  avenue, Charlottesville, Va 22908, Usa Tel +1 434 243 5890 Fax +1 434 924 5180 email akr5u@hscmail.mcc.virginia.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Engelhard et al Running head recto: Pediatric uveitis at a Mid-Atlantic US tertiary referral center DOI: http://dx.doi.org/10.2147/OPTH.S83950",Non-OADS,/arxiv_data1/oa_pdf/17/d9/opth-9-1121.PMC4485847.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/17/d9/opth-9-1121.PMC4485847.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/d9/opth-9-1121.PMC4485847.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/70/opth-9-1135.PMC4485848.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology Clinical Ophthalmology 2015:9 1135Dove press submit your manuscript | www.dovepress.co m Dove press  Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/70/opth-9-1135.PMC4485848.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 1135RetRa CtiO nopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S9072 5Potential role of lampalizumab for treatment of geographic   atrophy [Retraction] Rhoades W, Dickson D, Do DV.",Non-OADS,/arxiv_data1/oa_pdf/f3/70/opth-9-1135.PMC4485848.pdf
"Sincerely, Diana V Do, MD William Rhoades, MD Drew Dickson, BAJournal name: Clinical Ophthalmology Article Designation: Retraction Y ear: 2015 Volume: 9 Running head verso: Rhoades et al Running head recto: Potential role of lampalizumab for treatment DOI: http://dx.doi.org/10.2147/OPTH.S90725",Non-OADS,/arxiv_data1/oa_pdf/f3/70/opth-9-1135.PMC4485848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/5e/ppa-9-837.PMC4485849.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 837–845Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  837OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8426 8Clinical significance of barriers to blood glucose  control in type 2 diabetes patients with insufficient  glycemic control Takeo suzuki1 ryoko Takei2 T oyoshi inoguchi2,3 noriyuki sonoda2,3 shuji sasaki2 T oshihiko Kaise1 ryoichi Takayanagi2 1Development and Medical Affairs  Division, glaxo smithKline K.K.,   T okyo, 2Department of Medicine  and Bioregulatory science, graduate  school of Medical sciences,   3innovation center for Medical  redox navigation, Kyushu University,   Fukuoka, JapanBackground:  The purpose of this study was to assess actual barriers to blood glucose control in  patients with type 2 diabetes mellitus and to investigate barrier-related factors in an exploratory  manner.",Non-OADS,/arxiv_data1/oa_pdf/c0/5e/ppa-9-837.PMC4485849.pdf
"In 2012, the American Diabetes Asso - ciation and European Association for Study of Diabetes announced a new consensus  statement in response to this issue, emphasizing a patient-centered approach.1 They  propose that physicians set target blood glucose values for individual patients and  discuss with the patient which therapy should be selected, taking into consideration  not only the risk of hypoglycemia, disease duration, age (life expectancy), severity of  complications, and the presence/absence of support, but also each patient’s attitude correspondence: Takeo suzuki healthoutcomes Department,  Development and Medical Affairs  Division, glaxosmithKline K.K.,  4-6-15, Sendagaya, Shibuya-ku,  Tokyo 151-8566, Japan Tel +81 3 5786 6021 Fax +81 3 5786 5225 email takeo.2.suzuki@gsk.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Suzuki et al Running head recto: Barriers to blood glucose control DOI: http://dx.doi.org/10.2147/PPA.S84268",Non-OADS,/arxiv_data1/oa_pdf/c0/5e/ppa-9-837.PMC4485849.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c0/5e/ppa-9-837.PMC4485849.pdf
"Available  from: http://www.nittokyo.or.jp/chousakenkyu_10004.htm l. Accessed  February 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/5e/ppa-9-837.PMC4485849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/0e/opth-9-1147.PMC4485850.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1147–1154Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1147Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8211 6The association between neovascular age-related  macular degeneration and regulatory T cells  in peripheral blood Christopher Fugl Madelung1,2 Mads Krüger Falk1,2 T orben lykke sørensen1,2 1Clinical eye research Unit,   Department of Ophthalmology,   Copenhagen University hospital,   roskilde, Denmark; 2University  of Copenhagen, Copenhagen,   DenmarkPurpose:  To investigate regulatory T cells (Tregs) and subsets of the Treg population in patients  with neovascular age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/25/0e/opth-9-1147.PMC4485850.pdf
"The  Y402H polymorphism of complement factor H has been found to account for 43% of  the disease heritability, and altered complement regulatory proteins have been described  in the blood.3,4 Some studies indicate that systemic alterations in the B and T cells Correspondence: Christopher Fugl  Madelung Clinical eye research Unit,  Department of Ophthalmology,  Copenhagen University hospital,  Køgevej 7-13, DK-4000 roskilde,  Denmark Tel +45 4732 3900 Fax +45 4636 2645 email christopherfugl@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Madelung et al Running head recto: Regulatory T cells in age-related macular degeneration DOI: http://dx.doi.org/10.2147/OPTH.S82116",Non-OADS,/arxiv_data1/oa_pdf/25/0e/opth-9-1147.PMC4485850.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/25/0e/opth-9-1147.PMC4485850.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/0e/opth-9-1147.PMC4485850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 157–169The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  157Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5768 2Recent advances in gene therapy for lysosomal  storage disorders David P w Rastall1 Andrea Amalfitano1,2 1Department of Microbiology and  Molecular Genetics,  2Department of  Pediatrics, College of Osteopathic  Medicine, Michigan State University,  east Lansing, M i, USA Correspondence: Andrea Amalfitano   Department of Microbiology and  Molecular Genetics, 4194 Biomedical  Physical Sciences, Michigan State  University, east Lansing, Mi 48824, USA   email amalfit1@msu.ed uAbstract:  Lysosomal storage disorders (LSDs) are a group of genetic diseases that result in  metabolic derangements of the lysosome.",Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK11578 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
Available from: http://www.google.com/patents/US2014011289 6.,Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/12/tacg-8-157.PMC4485851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/51/opth-9-1137.PMC4485852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1137–1145Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1137Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8135 5Modulation of hla-Dr in dry eye patients  following 30 days of treatment with a lubricant  eyedrop solution Karen B Fernandez seth P epstein geoffrey s raynor alan T sheyman Morgan l Massingale Peter g Dentone lukas D landegger Penny a asbell Department of Ophthalmology, Mount  sinai school of Medicine, new Y ork,   nY, UsaPurpose:  To determine the changes in dry eye disease (DED) severity and the percentage of  cells expressing HLA-DR on the ocular surface following treatment with lubricant eyedrops  containing polyethylene glycol and propylene glycol (PEG/PG) and the gelling agent hydroxy - propyl guar (HP-Guar).",Non-OADS,/arxiv_data1/oa_pdf/c1/51/opth-9-1137.PMC4485852.pdf
"Aside from it being an anatomical barrier to the external environment,  the conjunctival epithelium has the ability to build up an inflammatory response by Correspondence: Penny a asbell Department of Ophthalmology, Mount  sinai school of Medicine, 1 gustave  l. levy Place, Box 1183, new York,  nY 10029, Usa Tel +1 212 241 7911 Fax +1 212 241 4550 email penny.asbell@mssm.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Fernandez et al Running head recto: Effect of lubricant eyedrops on HLA-DR in dry eye DOI: http://dx.doi.org/10.2147/OPTH.S81355",Non-OADS,/arxiv_data1/oa_pdf/c1/51/opth-9-1137.PMC4485852.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c1/51/opth-9-1137.PMC4485852.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/51/opth-9-1137.PMC4485852.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/15/oajsm-6-219.PMC4485853.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 219–224Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  219OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8080 9evaluating the distance between the femoral  tunnel centers in anatomic double-bundle  anterior cruciate ligament reconstruction   using a computer simulation Yasutaka Tashiro Ken Okazaki Yukihide iwamoto Department of Orthopaedic Surgery,   graduate School of Medical Sciences,   Kyushu University, Fukuoka, Japan correspondence: Yasutaka Tashiro   Department of Orthopaedic Surgery,  graduate School of Medical Sciences,  Kyushu University, 3-1-1 Maidashi,  higashi-ku, Fukuoka 812-8582, Japan   Tel +81 92 642 5488   Fax +81 92 642 5507   email 11yasu@med.kyushu-u.ac.j pPurpose:  We aimed to clarify the distance between the anteromedial (AM) bundle and poste - rolateral (PL) bundle tunnel-aperture centers by simulating the anatomical femoral tunnel place - ment during double-bundle anterior cruciate ligament reconstruction using 3-D computer-aided  design models of the knee, in order to discuss the risk of tunnel overlap.",Non-OADS,/arxiv_data1/oa_pdf/d0/15/oajsm-6-219.PMC4485853.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/d0/15/oajsm-6-219.PMC4485853.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/15/oajsm-6-219.PMC4485853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/ott-8-1523.PMC4485854.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1523–1532OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1523Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8223 5anterior gradient protein 3 is associated with less  aggressive tumors and better outcome of breast  cancer patients Joanna Obacz1 Veronika Brychtova1 Jan Podhorec1 Pavel Fabian2 Petr Dobes1 Borivoj Vojtesek1 roman hrstka1 1regional centre for applied  Molecular Oncology (recaMO),   2Department of Pathology, Masaryk  Memorial cancer institute, Brno,   czech republicAbstract:  Anterior gradient protein (AGR) 3 is a highly related homologue of pro-oncogenic  AGR2 and belongs to the family of protein disulfide isomerases.",Non-OADS,/arxiv_data1/oa_pdf/fa/31/ott-8-1523.PMC4485854.pdf
"It was demonstrated that AGR2 is upregulated  in response to estradiol treatment both in vitro5 and in vivo,6 and its high expres - sion correlates with ER status7 and predicts poor prognosis in ER-positive breast correspondence: roman hrstka recaMO, Masaryk Memorial cancer  institute, Zluty kopec 7, 65653 Brno,  czech republic email hrstka@mou.c zJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Obacz et al Running head recto: Significance of AGR3 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S82235",Non-OADS,/arxiv_data1/oa_pdf/fa/31/ott-8-1523.PMC4485854.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fa/31/ott-8-1523.PMC4485854.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/ott-8-1523.PMC4485854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/f5/ott-8-1567.PMC4485855.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1567–1574OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1567Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7052 4Profile of blinatumomab and its potential  in the treatment of relapsed/refractory acute  lymphoblastic leukemia Josep-Maria Ribera Albert Ferrer Jordi Ribera eulàlia Genescà Clinical Hematology Department,   iCO-Hospital Germans Trias i Pujol,   Josep Carreras Research institute,   Universitat Autònoma de Barcelona,   Badalona, SpainAbstract:  The CD19 marker is expressed on the surface of normal and malignant immature  or mature B-cells.",Non-OADS,/arxiv_data1/oa_pdf/e2/f5/ott-8-1567.PMC4485855.pdf
"With regard to BCP ALL, the CD19 marker has been used as a target for  immunotherapy.2 Several generations and types of CD19 CAR T-cells have been  developed showing a high efficiency in the lysis of CD19-positive blast cells.3,4 In turn,  blinatumomab has demonstrated promising activity and a favorable safety profile in  relapsed/refractory (R/R) ALL and in ALL with minimal residual disease (MRD), and  is currently being evaluated in first-line therapy in adults with BCP ALL.5–8Correspondence: Josep-Maria Ribera Clinical Hematology Department,  iCO-Hospital Germans Trias i Pujol,  Josep Carreras Research institute,  c/Canyet S/N, 08916 Badalona, Spain Tel +34 934 97 8987   Fax +34 934 97 8995   email jribera@iconcologia.ne t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Ribera et al Running head recto: Potential of blinatumomab in the treatment of R/R ALL DOI: http://dx.doi.org/10.2147/OTT.S70524",Non-OADS,/arxiv_data1/oa_pdf/e2/f5/ott-8-1567.PMC4485855.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/f5/ott-8-1567.PMC4485855.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/f5/ott-8-1567.PMC4485855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/75/ott-8-1575.PMC4485856.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1575–1580OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1575STudy Pr OTO cOlopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8257 0Single-port versus conventional multiport access  prophylactic laparoscopic bilateral salpingo- oophorectomy in high-risk patients for ovarian  cancer: a comparison of surgical outcomes Stefano Angioni1 Alessandro Pontis1 Federica Sedda1 Theodoros Zampetoglou2 Vito cela3 liliana Mereu4 Pietro litta5 1department of Surgical Sciences,   university of cagliari, cagliari, Italy;   2Obstetrics and Gynecology, Iaso  Thessalia Hospital, larissa, Greece;   3department of Obstetrics and  Gynecology, university of Pisa,   Pisa, 4Ospedale S chiara, Trento,   5department of Obstetrics and  Gynecology, university of Padua,   Padua, ItalyAbstract:  Bilateral salpingo-oophorectomy (BSO) in carriers of BRCA1  and BRCA2  mutations  is widely recommended as part of a risk-reduction strategy for ovarian or breast cancer due to  an underlying genetic predisposition.",Non-OADS,/arxiv_data1/oa_pdf/40/75/ott-8-1575.PMC4485856.pdf
"To further reduce the morbidity associated with the placement of multiple correspondence: Stefano Angioni department of Surgical Sciences, Section  of Obstetrics and Gynecology, university  of cagliari, Azienda Ospedaliero  universitaria, Blocco Q, 09042  Monserrato, Italy Tel +39 070 5109 3399 Email sangioni@yahoo.i t Journal name: OncoTargets and Therapy Article Designation: Study Protocol Y ear: 2015 Volume: 8 Running head verso: Angioni et al Running head recto: SO in high-risk patients for ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S82570",Non-OADS,/arxiv_data1/oa_pdf/40/75/ott-8-1575.PMC4485856.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/40/75/ott-8-1575.PMC4485856.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/75/ott-8-1575.PMC4485856.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) wh ich permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.CHILDHOOD OBESITY June 2015 jVolume 11, Number 3 ªMary Ann Liebert, Inc. DOI: 10.1089/chi.2014.0111 269",Non-OADS,/arxiv_data1/oa_pdf/98/db/chi.2014.0111.PMC4485882.pdf
"Available at http://www.portal.state.pa.us/portal/server .pt/community/schools/14130/mandated_school_health_program_%28exams_screens%29/556692 Last accessed February 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/98/db/chi.2014.0111.PMC4485882.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/31/main.PMC4485901.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.006 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/31/main.PMC4485901.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/31/main.PMC4485901.pdf
EBioMedicineEBioMedicine 2 (2015) 181 http://dx.doi.org/10.1016/j.ebiom.2015.03.006 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/29/3b/main.PMC4485903.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/3b/main.PMC4485903.pdf
Lancet http://dx.doi.org/10.1016/S0140-6736(14)62038-9 (Nov 26. pii: S0140-6736(14)62038-9 [Epub ahead of print] PubMed PMID: 25467588).EBioMedicine 2 (2015) 278 –279 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.008 .,OADS,/arxiv_data1/oa_pdf/89/19/main.PMC4485904.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.011 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/19/main.PMC4485904.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/19/main.PMC4485904.pdf
"http://dx.doi.org/10.3109/ 10428190903419130 (Jan, PMID: 20055658).",OADS,/arxiv_data1/oa_pdf/89/19/main.PMC4485904.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/ef/main.PMC4485905.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.0152352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/ef/main.PMC4485905.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/ef/main.PMC4485905.pdf
EBioMedicineEBioMedicine 2 (2015) 273 http://dx.doi.org/10.1016/j.ebiom.2015.03.014 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/95/48/main.PMC4485907.pdf
"These results may suggest the role of COX-independent mechanism in EGFR downregulation detected in vitro by high concentration of the drugs, plausibly through a direct inhibitory effect on the activation of AP-1 activity ( Dong et al., 1997 ).EBioMedicine 2 (2015) 372 –373 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.019 .",Non-OADS,/arxiv_data1/oa_pdf/60/5f/main.PMC4485908.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.04.013 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/5f/main.PMC4485908.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/5f/main.PMC4485908.pdf
The outcomes from these studies suggest that in contrastEBioMedicine 2 (2015) 376 –377 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.020 .,Non-OADS,/arxiv_data1/oa_pdf/08/75/main.PMC4485910.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.04.015 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/08/75/main.PMC4485910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/75/main.PMC4485910.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/36/main.PMC4485911.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.0032352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/main.PMC4485911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/36/main.PMC4485911.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/e0/main.PMC4485912.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.020 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/e0/main.PMC4485912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/e0/main.PMC4485912.pdf
http://dx.doi.org/10.1161/CIRCRESAHA.116.303614 (in Press).,Non-OADS,/arxiv_data1/oa_pdf/07/e0/main.PMC4485912.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/13/main.PMC4485913.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.012 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/36/13/main.PMC4485913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/13/main.PMC4485913.pdf
http://www.idf.org/sites/ default/ ﬁles/EN_6E_Atlas_Full_0.pdf (Ref Type: Online Source).,Non-OADS,/arxiv_data1/oa_pdf/36/13/main.PMC4485913.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/57/nihms676264.PMC4486022.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four figures and can be found with this article online  at http://dx.doi.org/10.1016/j.celrep.2014.09.016 .,OADS,/arxiv_data1/oa_pdf/0d/57/nihms676264.PMC4486022.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/02/main.PMC4486090.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.006 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/02/main.PMC4486090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/ab/main.PMC4486091.pdf
The caecal mass was carefully milked back from http://dx.doi.org/10.1016/j.ijscr.2015.05.010 2210-2612/Crown Copyright © 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1a/ab/main.PMC4486091.pdf
This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/ab/main.PMC4486091.pdf
2003. http://www.fda.gov/downloads/Drugs/ …/ Guidances/ucm070124.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/b2/40262_2014_Article_232.PMC4486092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/39/main.PMC4486096.pdf
A http://dx.doi.org/10.1016/j.ijscr.2015.05.005 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c5/39/main.PMC4486096.pdf
This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/39/main.PMC4486096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/main.PMC4486097.pdf
All the patients were females in the http://dx.doi.org/10.1016/j.ijscr.2015.05.015 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/main.PMC4486097.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/main.PMC4486097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/87/main.PMC4486098.pdf
Three http://dx.doi.org/10.1016/j.ijscr.2015.05.013 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/61/87/main.PMC4486098.pdf
This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/87/main.PMC4486098.pdf
A drain was placed above prolene mesh and removed http://dx.doi.org/10.1016/j.ijscr.2015.05.014 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/d8/main.PMC4486099.pdf
"(2012), http://dx.doi.org/10.1155/2012/ 142351 http://www.hindawi.com/journals/crionm/2012/142351/ [10] M.A.",Non-OADS,/arxiv_data1/oa_pdf/0f/d8/main.PMC4486099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/ff/main.PMC4486100.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.012 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/ff/main.PMC4486100.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/ff/main.PMC4486100.pdf
"(2014) 1–2,http://dx.doi.org/10.1155/2014/756040 .",Non-OADS,/arxiv_data1/oa_pdf/9e/ff/main.PMC4486100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/49/main.PMC4486101.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.011 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/49/main.PMC4486101.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/49/main.PMC4486101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/6b/main.PMC4486102.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.020 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/6b/main.PMC4486102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/61/main.PMC4486103.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.019 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/61/main.PMC4486103.pdf
This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/61/main.PMC4486103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/17/main.PMC4486104.pdf
"Routine laboratory tests showed elevatedd-dimer levels (> 32 mg/l), signs of systemic inﬂammation (CRP http://dx.doi.org/10.1016/j.ijscr.2015.05.016 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/17/main.PMC4486104.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/17/main.PMC4486104.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/c3/main.PMC4486105.pdf
He had not neurological signs and symp- http://dx.doi.org/10.1016/j.ijscr.2015.05.017 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/c3/main.PMC4486105.pdf
"79 (January (1)) (2013) 124–130, http://dx.doi.org/10.1016/j.wneu.2011.05.057 , Epub 2011 November 4.",Non-OADS,/arxiv_data1/oa_pdf/48/c3/main.PMC4486105.pdf
"81(March–April (3–4)) (2014) 651,http://dx.doi.org/10.1016/j.wneu.2013.06.006 , e15-6.",OADS,/arxiv_data1/oa_pdf/48/c3/main.PMC4486105.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/77/main.PMC4486106.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.024 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/main.PMC4486106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/af/main.PMC4486107.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.026 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c7/af/main.PMC4486107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/af/main.PMC4486107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/35/main.PMC4486108.pdf
"Clinicalstage IIIB, T4a(SE)N2M0 gastric cancer was diagnosed (according http://dx.doi.org/10.1016/j.ijscr.2015.05.023 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8a/35/main.PMC4486108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/3b/main.PMC4486109.pdf
"In closer observation, a skin-colored region rep- http://dx.doi.org/10.1016/j.ijscr.2015.05.021 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/main.PMC4486109.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/3b/main.PMC4486109.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 24, Number 12, 2015 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2014.0532 1429",Non-OADS,/arxiv_data1/oa_pdf/42/7f/scd.2014.0532.PMC4486142.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015ORIGINAL  ARTICLE Human coagulation factor VIII domain-specific recombinant  polypeptide expression Su Jin Choi1, Ki Jung Jang1, Jeong-A Lim2, Hye Sun Kim1 1Department of Biological  Science, College of Natural Scienc es, Ajou University, Suwon, Korea, 2National Institute of Arthritis and  Musculoskeletal and Skin Diseases, National  Institutes of Health, Bethesda, MD, USA p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.103Blood Res 2015;50:103-8.",Non-OADS,/arxiv_data1/oa_pdf/5c/74/br-50-103.PMC4486152.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015ORIGINAL  ARTICLE Stability of eosin-5'-maleimide dye used in flow cytometric analysis  for red cell membrane disorders Simmi Mehra, Neetu Tyagi, Pranav Dorwal, Amit  Pande, Dharmendra Jain, Ritesh Sachdev,  Vimarsh Raina Department of Pathology, Medant a, The Medicity, Gurgaon, India p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.109Blood Res 2015;50:109-12.",Non-OADS,/arxiv_data1/oa_pdf/fb/3c/br-50-109.PMC4486153.pdf
"Pasquale Niscola 1, Andrea Tendas1, Laura Scaramucci1,  Marco Giovannini1, Stefano Fratoni2, Paolo de Fabritiis1 1Hematology Division and 2Pathology Department,  Sant'Eugenio Hospital, Rome, Italy Correspondence to:  Pasquale Niscola Hematology Division, S. Eugenio Hospital, Piazzale  dell’Umanesimo 10, 00144, Rome, Italy E-mail: pniscola@gmail.com   Received on Aug. 15, 2014; Revised on Sep. 25, 2014; Accepted on May 14, 2015 http://dx.doi.org/10.5045/br.2015.50.2.113 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/32/68/br-50-113.PMC4486154.pdf
"Pasquale Niscola 1, Andrea Tendas1, Laura Scaramucci1,  Marco Giovannini1, Stefano Fratoni2, Paolo de Fabritiis1 1Hematology Division and 2Pathology Department,  Sant'Eugenio Hospital, Rome, Italy Correspondence to:  Pasquale Niscola Hematology Division, S. Eugenio Hospital, Piazzale  dell’Umanesimo 10, 00144, Rome, Italy E-mail: pniscola@gmail.com   Received on Aug. 15, 2014; Revised on Sep. 25, 2014; Accepted on May 14, 2015 http://dx.doi.org/10.5045/br.2015.50.2.113 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/77/a9/br-50-114.PMC4486155.pdf
"Dong-Yeop Shin 1, Hyo-Rak Lee1, Hye Jin Kang1, Im Il Na1,  Yoon Hwan Chang2, Sung Hyun Yang1 1Division of Hematology and Medical Oncology,  Department of Internal Medicine, and 2Department of  Laboratory Medicine, Korea Cancer Center Hospital, Korea  Institute of Radiological Sciences, Seoul, Korea Correspondence to:  Dong-Yeop Shin Division of Hematology and Medical Oncology,  Department of Internal Medicine, Korea Cancer Center  Hospital, 75 Nowon-gil, Nowon-gu, Seoul 139-706, Korea E-mail: baramg@hanmail.net   Received on Nov. 10, 2014; Revised on Nov. 25, 2014; Accepted on May 18, 2015 http://dx.doi.org/10.5045/br.2015.50.2.114 *This research was supported by the Radiological Transla- tional Research Program of the Korea Institute of Radiologi-cal and Medical Sciences (50470-2014).",Non-OADS,/arxiv_data1/oa_pdf/77/a9/br-50-114.PMC4486155.pdf
"Jaeeun Yoo, Yonggoo Kim, Kyungja Han Department of Laboratory Me dicine, College of Medicine,  The Catholic University of Korea, Seoul, Korea Correspondence to:  Kyungja Han Department of Laboratory Medi cine, College of Medicine,  The Catholic University of Korea, Seoul St. Mary’s Hospital,  222, Banpo-daero, Seocho-g u, Seoul 137-701, Korea E-mail: hankja@catholic.ac.kr Received on Dec. 10, 2014; Revised on Jan. 17, 2015; Accepted on May 19, 2015 http://dx.doi.org/10.5045/br.2015.50.2.117AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/69/1c/br-50-117.PMC4486156.pdf
"Jaeeun Yoo, Yonggoo Kim, Kyungja Han Department of Laboratory Me dicine, College of Medicine,  The Catholic University of Korea, Seoul, Korea Correspondence to:  Kyungja Han Department of Laboratory Medi cine, College of Medicine,  The Catholic University of Korea, Seoul St. Mary’s Hospital,  222, Banpo-daero, Seocho-g u, Seoul 137-701, Korea E-mail: hankja@catholic.ac.kr Received on Dec. 10, 2014; Revised on Jan. 17, 2015; Accepted on May 19, 2015 http://dx.doi.org/10.5045/br.2015.50.2.117AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/b9/50/br-50-118.PMC4486157.pdf
"bloodresearch.or.kr Blood Res 2015;50:113-21.Letters to the Editor 121 Sciences, 2Department of Pathology, Institute of Liver and  Biliary Sciences, 3Department of Hepatology, Institute of  Liver and Biliary Sciences, New Delhi, India Correspondence to:  Pratibha Dhiman Department of Hematology, Institute of Liver and Biliary  Sciences, Sector D1, Vasant  kunj, New Delhi 110070, India E-mail: dhimandrpra tibha@yahoo.com   Received on Dec. 19, 2014; Revised on Feb. 16, 2015; Accepted on May 26, 2015 http://dx.doi.org/10.5045/br.2015.50.2.118 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/b9/50/br-50-118.PMC4486157.pdf
"67 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 50 ㆍNumber 2 ㆍJune 2015 http://dx.doi.org/10.5045/br.2015.50.2.67 Editorial Mesenchymal niche: the sensor and effector of leukemogenesis Il-Hoan Oh, M.D., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/d0/d3/br-50-67.PMC4486158.pdf
"69 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 50 ㆍNumber 2 ㆍJune 2015 http://dx.doi.org/10.5045/br.2015.50.2.69 Perspective Reduced-intensity conditioning  hematopoietic stem cell transplantation: looking forward to an international consensus Monazza Chaudhry, M.D.1, Natasha Ali, M.D.2 1Medical College, The Aga Khan University, Karachi, Pakistan 2Department of Pathology and La boratory Medicine/Oncology,  The Aga Khan University Hospital, Karachi, Pakistan The treatment for hematological malignancies has  excelled over the past decade.",Non-OADS,/arxiv_data1/oa_pdf/b7/94/br-50-69.PMC4486159.pdf
"71 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 50 ㆍNumber 2 ㆍJune 2015 http://dx.doi.org/10.5045/br.2015.50.2.71 Gelatinous transformation of the bone marrow in hepatocellular  carcinoma Jeonghyun Chang, Chan-Jeoung Park Department of Laboratory Medicine, Univ ersity of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Correspondence to Chan-Jeoung Park, M.D., Ph.D., Department of Laboratory Medici ne, Asan Medical Center and University of Ulsan College of  Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea, E-mail: cjpark@amc.seoul.kr A 52-year-old woman with a history of hepatocellular carcinoma with bone me tastasis (T6, L5-S1) was referred  for pancytopenia after undergoing radi ation therapy and transarterial chemoemb olization.",Non-OADS,/arxiv_data1/oa_pdf/17/76/br-50-71.PMC4486160.pdf
"72 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 50 ㆍNumber 2 ㆍJune 2015 http://dx.doi.org/10.5045/br.2015.50.2.72 Intraleukocytic hemozoin pigments in complicated Plasmodium   falciparum  cerebral malaria Sadia Sultan, Syed Mohammed Irfan Department of Haematol ogy, Liaquat National Hospital and Medical College, Karachi, Pakistan Correspondence to Sadia Sultan, MBBS, FCPS, Department of Haematology, Liaquat National Hospital and Medical College, National Stadium Rd,  Karachi 74800, Pakistan, E-mail: sadia.sultan@lnh.edu.pk A 33-year-old man presented with left hypochondrium pa in and high-grade fever fo r 1 week and generalized  convulsions followed by persistent unconsciousness.",Non-OADS,/arxiv_data1/oa_pdf/a8/a6/br-50-72.PMC4486161.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015REVIEW  ARTICLE Apoptosis: role in myeloid cell development Shilpa Sarvothaman1, Ram Babu Undi1, Satya Ratan Pasupuleti1, Usha Gutti2, Ravi Kumar Gutti1 1Stem Cells and Haematological Disorders Labo ratory, Department of Bioche mistry, School of Life Scie nces, University of Hyderaba d,  Hyderabad, 2Department of Biotec hnology, GITAM Institute of  Science, GITAM University, Visakhapatnam, India p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.73Blood Res 2015;50:73-9.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/br-50-73.PMC4486162.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015ORIGINAL ARTICLE Down-regulation of the autophagy gene, ATG7 , protects bone  marrow-derived mesenchymal stem cells from stressful conditions Sedigheh Molaei1, Mehryar Habibi Roudkenar1, Fatemeh Amiri1, Mozhgan Dehghan Harati1, Marzie  Bahadori1, Fatemeh Jaleh1, Mohammad Ali Jalili1, Amaneh Mohammadi Roushandeh2 1Blood Transfusion Research Center, High Institute for Re search and Education in Transfusion Medicine, Tehran, 2Department of  Anatomical Sciences, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.80Blood Res 2015;50:80-6.",Non-OADS,/arxiv_data1/oa_pdf/89/65/br-50-80.PMC4486163.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015ORIGINAL  ARTICLE Bortezomib inhibits the survival and proliferation of bone marrow  stromal cells Ha-Yon Kim1, Ji-Young Moon2, Haewon Ryu2, Yoon-Seok Choi2, Ik-Chan Song2, Hyo-Jin Lee2,  Hwan-Jung Yun2, Samyong Kim2, Deog-Yeon Jo2 1Department of Drug Activity, New Drug Developmen t Center, Medical Innovati on Foundation, Osong, 2Department of Internal  Medicine, School of Medici ne, Chungnam National University, Daejeon, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.87Blood Res 2015;50:87-96.",Non-OADS,/arxiv_data1/oa_pdf/3b/08/br-50-87.PMC4486164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/4.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 50 ㆍNUMBER 2 June 2015ORIGINAL  ARTICLE Maximum standardized uptake value on positron emission  tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma Hee Ryeong Jang1, Moo Kon Song2, Joo Seop Chung2, Deok Hwan Yang3, Jeong Ok Lee4, Junshik Hong5,  Su Hee Cho6, Seong Jang Kim7, Dong Hoon Shin8, Young Joo Park1, Jin-Suk Kang1, Jeong Eun Lee1, Moon  Won Lee1, Ho-Jin Shin2 1Department of Internal Medicine, Pusan National Univ ersity Hospital, Department of Hematology-Oncology, 2Pusan National  University Hospital, Busan, 3Chonnam National University Hwasun Hosp ital, Hwasun, Department of Hematology, 4Seoul National  University Bundang Hospital, Seongnam, 5Gachon University Gi l Hospital, Incheon, 6Department of Hemato logy-Oncology, Pusan  National University Yang san Hospital, Yangsan, 7Department of Nuclear Medi cine, Pusan National University Hospital, Busan,  8Department of Pathology, Pu san National University Yang san Hospital, Yangsan, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2015.50.2.97Blood Res 2015;50:97-102.",Non-OADS,/arxiv_data1/oa_pdf/e8/dd/br-50-97.PMC4486165.pdf
"Therefore, sequential changes in each patient are rarely  reported.3) We report a case of HES with cardiac involvement  progressing from thrombotic to fibrotic stages in more than 4  years’ follow-up.pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.100 •	Received: September 15, 2014  •	Revised: December 11, 2014  •	Accepted: May 19, 2015 •		Address for Correspondence: S hung Chull Chae, Division of Cardiology, Department of Internal Medicine, Kyungpook National University School of Medicine, 130  Dongdeok-ro, Jung-gu, Daegu 700-721, Korea   Tel: +82-53-420-5527, Fax: +82-53-426-2046, E-mail: scchae@knu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 48-year-old man presented with New York Heart Associ - ation class III dyspnea and pitting edema in both legs for 2  months.",Non-OADS,/arxiv_data1/oa_pdf/49/25/jcu-23-100.PMC4486173.pdf
"She did not  have any history of heart disease, hypertension or diabetes  mellitus, but had undergone subtotal gastrectomy due to pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.103 stomach cancer.",Non-OADS,/arxiv_data1/oa_pdf/fa/e6/jcu-23-103.PMC4486174.pdf
"As the features were consistent with SCMP CASE REPORT J Cardiovasc Ultrasound  2015;23(2):103-106 •	Received: September 23, 2014  •	Revised: October 27, 2014  •	Accepted: May 19, 2015 •		Address for Correspondence: Jin Oh Na, Department of Cardiology, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea     Tel: +82-2-2626-3025, Fax: +82-2-863-1109, E-mail: jinona@medimail.co.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Surgical Removal of a Left Ventricular   Thrombus Which Showed Morphologic   Changes Over Time in a Patient with   Stress-Induced Cardiomyopathy Jah Yeon Choi, MD1, Eun Jin Park, MD1, Sung Hun Park, MD1, Hee Dong Kim, MD1,   Ji Young Song, MD1, Ji Bak Kim, MD1, Sun Ki Lee, MD1,   Yang Gi Ryu, MD2, Man Jong Baek, MD2, and Jin Oh Na, MD1 Departments of 1Cardiology, 2Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Seoul, Korea Although stress-induced cardiomyopathy (SCMP) is a reversible disease and the prognosis is usually excellent, several  complications can occur and can result in fatal adverse events.",Non-OADS,/arxiv_data1/oa_pdf/fa/e6/jcu-23-103.PMC4486174.pdf
Case Case 1 A 75-year-old female with hypertension was presented to our pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.107 department because of dyspnea on exertion.,Non-OADS,/arxiv_data1/oa_pdf/13/7d/jcu-23-107.PMC4486175.pdf
"She underwent a two-dimensional transthoracic echo - cardiography for the preoperative evaluation.CASE REPORT J Cardiovasc Ultrasound  2015;23(2):107-112 •	Received: November 4, 2014  •	Revised: March 9, 2015  •	Accepted: May 19, 2015 •		Address for Correspondence: Wook-Jin Chung, Department of Cardiovascular Medicine, Gachon University Gil Medical Center, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea   Tel: +82-32-460-3054, Fax: +82-32-469-1906, E-mail: heart@gachon.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Unusual Diaphragmatic Hernias Mimicking  Cardiac Masses Si Hun Kim, MD1,2, Myoung Gun Kim, MD1,2, Su Ji Kim, MD1,2,   Jeonggeun Moon, MD1,2, Woong Chol Kang, MD, PhD1,2,   Mi-Seung Shin, MD, PhD1,2, and Wook-Jin Chung, MD, PhD1,2 1Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, Korea   2Gachon Cardiovascular Research Institute, Gachon University School of Medicine, Incheon, Korea Hiatal hernia and Morgagni hernia are sorts of diaphragmatic hernias that are rarely detected on transthoracic echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/13/7d/jcu-23-107.PMC4486175.pdf
"Here, we report a case of sinus of Val - salva aneurysm mimicking membranous septal aneurysm associ -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.113 ated with perimembranous VSD, that was ruptured later, caus - ing severe right-sided heart failure.",Non-OADS,/arxiv_data1/oa_pdf/4b/00/jcu-23-113.PMC4486176.pdf
"However, the follow-up was CASE REPORT J Cardiovasc Ultrasound  2015;23(2):113-117 •	Received: November 27, 2014  •	Revised: April 15, 2015  •	Accepted: May 19, 2015 •		Address for Correspondence: Shin-Jae Kim, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877  Bangeojinsunhwando-ro, Dong-gu, Ulsan 682-714, Korea   Tel: +82-52-250-8873, Fax: +82-52-251-8235, E-mail: kimsc226@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Case of Perimembranous Ventricular  Septal Defect Associated with Sinus of  Valsalva Aneurysm Mimicking Membranous  Septal Aneurysm Hyung Rae Kim, MD1, Shin-Jae Kim, MD, PhD1, Kyoung Hoon Lim, MD1, Jong Min Kim, MD1,   Jun Ho Lee, MD1, Yong-Giun Kim, MD1, Jong-Pil Jung, MD2, and Sang-Gon Lee, MD, PhD1 Departments of 1Internal Medicine, 2Cardiac Surgery, Ulsan University Hospital, University of Ulsan College of  Medicine, Ulsan, Korea Sinus of Valsalva aneurysms are rare.",Non-OADS,/arxiv_data1/oa_pdf/4b/00/jcu-23-113.PMC4486176.pdf
She unfortunately sus -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.118 tained a left hemispheric stroke post-operatively.,Non-OADS,/arxiv_data1/oa_pdf/74/42/jcu-23-118.PMC4486177.pdf
"Radiographics 2005;25 Suppl 1:S173-89 .IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2015;23(2):118-118 •	Received: September 16, 2014  •	Revised: December 20, 2014  •	Accepted: May 19, 2015 •		Address for Correspondence: Leonard Leong Litt Yeo, Division of Neurology, Department of Medicine, National University Health System, 1 E Kent Ridge Road,  Singapore 119228   Tel: +65-6772-6532, Fax: +65-6872-4101, E-mail: leonard_ll_yeo@nuhs.edu.sg •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fig.",Non-OADS,/arxiv_data1/oa_pdf/74/42/jcu-23-118.PMC4486177.pdf
"The patient was discharged home 38 days pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.119 after surgery, in stable clinical condition.",Non-OADS,/arxiv_data1/oa_pdf/e7/89/jcu-23-119.PMC4486178.pdf
"•	Received: November 29, 2014  •	Revised: December 28, 2014  •	Accepted: May 19, 2015 •		Address for Correspondence: Dominique de Zuttere, Department of Clinical Physiology, Franco-Britannique Hospital, 4 rue Kléber, Levallois-Perret Cedex 92309,  France   Tel: +33-1-47-59-55-01, Fax: +33-1-47-59-59-75, E-mail: dominique.de.zuttere@ihfb.org •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Simultaneous Bilateral Infective  Endocarditis with Right Ventricular   Mural Involvement Dominique de Zuttere, MD1, Hervé Lardoux, MD1, Paulo Rocha, MD1,   Sylvie Plassart, MD2, Julie Sana-Sillard, MD2, and Jean-Michel Grinda, MD3 1Department of Clinical Physiology, Franco-Britannique Hospital, Levallois-Perret, France   2Intensive Care Unit, Franco-Britannique Hospital, Levallois-Perret, France   3CERIC, Ambroise-Paré Clinic, Neuilly-sur-Seine, France KEY WORDS:  Echocardiography  · Endocarditis  · Infective endocarditis  · Cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/e7/89/jcu-23-119.PMC4486178.pdf
Therefore it is likely that the pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.59 REVIEW J Cardiovasc Ultrasound  2015;23(2):59-69 prevalence of aortic valve stenosis will increase even further with  the demographic change toward an elderly population in de - veloped countries.,Non-OADS,/arxiv_data1/oa_pdf/aa/74/jcu-23-59.PMC4486179.pdf
"Pacific St., Box 356422, Seattle,  WA 98195, USA   Tel: +1-206-685-1397, Fax: +1-206-616-4847, E-mail: cmotto@uw.edu •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Aortic Stenosis: Changing Disease  Concepts Nina Rashedi, MD and Catherine M. Otto, MD Division of Cardiology, University of Washington School of Medicine, Seattle, WA, USA Aortic stenosis (AS) occurs in almost 10% of adults over age 80 years with a mortality about 50% at 2 years unless outflow  obstruction is relieved by aortic valve replacement (AVR).",Non-OADS,/arxiv_data1/oa_pdf/aa/74/jcu-23-59.PMC4486179.pdf
http://dx.doi.org/10.1016/S0140-6736(15)60290-2.,OADS,/arxiv_data1/oa_pdf/aa/74/jcu-23-59.PMC4486179.pdf
http://dx.doi.org/10.1016/S0140-6736(15)60308-7.,OADS,/arxiv_data1/oa_pdf/aa/74/jcu-23-59.PMC4486179.pdf
http://dx.doi.org/10.1016/j.jacc.2015.03.014.,OADS,/arxiv_data1/oa_pdf/aa/74/jcu-23-59.PMC4486179.pdf
"First, the most prevalent congenital anomaly in DS in this study pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.70 was patent ductus arteriosus, probably related with the mod - erate altitude of Mexico City as interpreted by the authors.",Non-OADS,/arxiv_data1/oa_pdf/af/1b/jcu-23-70.PMC4486180.pdf
"•	Received: May 26, 2015  •	Revised: May 30, 2015  •	Accepted: June 1, 2015 •		Address for Correspondence: Chi Young Shim, Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea   Tel: +82-2-2228-8453, Fax: +82-2-2227-7732, E-mail: cysprs@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Down Syndrome in Moderate Altitude  Residents: Are There Unique Features?",Non-OADS,/arxiv_data1/oa_pdf/af/1b/jcu-23-70.PMC4486180.pdf
"It is the most common chromosomal  abnormality.1) The incidence of DS in world literature var - ies from 1/600 to 800;2) in Mexico it is reported to be 1/420 to  480.3) Because of a defect in the distribution of chromosomes  in DS affected individuals have three copies of chromosome 21,  clinical manifestations are variable and cannot establish the type pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.72 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(2):72-77 •	Received: January 29, 2015  •	Revised: April 25, 2015  •	Accepted: May 19, 2015 •		Address for Correspondence: María Elena Soto, ABC Medical Center I.A.P, Cardiovascular Division, Investigation Department, Sur 136 No.",Non-OADS,/arxiv_data1/oa_pdf/4e/89/jcu-23-72.PMC4486181.pdf
"116, Colonia Las  Américas, Delegación Alvaro Obregón, México City 01120, Mexico   Tel: +52-55-732911, Fax: +52-55-730994, E-mail: mesoto50@hotmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.of chromosomal abnormality, therefore the diagnosis requires a  karyotype determination.4) The prevalence of congenital heart disease (CHD) in DS is  approximately 43%.5) The most common cardiac malforma - tions associated with DS include atrioventricular canal, patent  ductus arteriosus and atrial septal defect (ASD) and ventricular  septal defect (VSD).6) Some of the congenital heart conditions  have intra and extra-cardiac shunts that can lead to pulmo -Prevalence of Congenital Heart Disease  and Pulmonary Hypertension in Down’s  Syndrome: An Echocardiographic Study Nilda Espinola-Zavaleta, MD, PhD1,2, María Elena Soto, MD, PhD1,2,   Angel Romero-Gonzalez, MD2, Lidia del Carmen Gómez-Puente, MD3,   Luis Muñoz-Castellanos, MD2, Aasha S. Gopal, MD4,   Candace Keirns, MD5, and Eulo Lupi-Herrera, MD1 1ABC Medical Center I.A.P, Cardiovascular Division, Mexico City, Mexico   2National Institute of Cardiology “Ignacio Chavez”, Echocardiography in Out-Patient Clinic,   Immunology Department, Embryology Department, Mexico City, Mexico   3The John Langdon Down Foundation, A.C, Pediatric Department, Mexico City, Mexico   4St.",Non-OADS,/arxiv_data1/oa_pdf/4e/89/jcu-23-72.PMC4486181.pdf
"Recent clinical studies have dem - onstrated changes in myocardial function through regional  myocardial deformation imaging, including speckle-tracking pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.78 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(2):78-85 •	Received: March 4, 2015  •	Revised: May 16, 2015  •	Accepted: May 19, 2015 •		Address for Correspondence: Dong Heon Yang, Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, 130 Dongdeok-ro,  Jung-gu, Daegu 700-212, Korea   Tel: +82-53-200-5524, Fax: +82-53-424-6721, E-mail: ddhyang@knu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.echocardiography.1) We evaluated about prognostic value of  myocardial longitudinal strain in patients with chronic AR.",Non-OADS,/arxiv_data1/oa_pdf/01/74/jcu-23-78.PMC4486182.pdf
"86 Introduction The prevalence of excessive weight and obesity (EwO) has  increased worldwide, and the problem includes Mexico.1)2)  EwO are known independent factors in the development of  heart failure3-5) since they lead to a cardiomyopathy state  through inflammatory and hormonal mechanisms as a result  of cardiac steatosis; this refers to the pathological accumula - tion of triglycerides in myocytes which in turn, leads to reactive  oxygen species release that foster fibrosis formation, hypertro - phy and myocardial apoptosis.6) Moreover, excessive accumula -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.86 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(2):86-90 tion of epicardial fat fosters a pro-inflammatory state.7) Also, individuals with EwO develop a hyperdynamic state  that in the long-run, leads to ventricular remodeling and dys - function.8) Ventricular remodeling and dilation may condition  mechanical asynchrony, a marker reflecting heart failure pro - gression in several populations.9) Previous studies have docu - mented the presence of interventricular asynchrony in female  obese, diabetic patients.10) Schuster et al.11) demonstrated the  existence of intraventricular asynchrony in 10 morbidly obese  individuals but that reverted after 8 weeks of physical training.",Non-OADS,/arxiv_data1/oa_pdf/ee/78/jcu-23-86.PMC4486183.pdf
"•	Received: December 2, 2014  •	Revised: May 26, 2015  •	Accepted: May 26, 2015 •		Address for Correspondence: Nydia Ávila-Vanzzini, Department of Echocardiography, “Ignacio Chávez” National Cardiology Institute, Juan Badiano No.1, Colonia  Sección XVI, Delegación Tlalpan, Mexico City 14080, Mexico   Tel: +52-55-73-29-11 ext 12-12, Fax: +52-55-730994, E-mail: vazzny74@yahoo.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Excessive Weight and Obesity Are  Associated to Intra-Ventricular  Asynchrony: Pilot Study Nydia Ávila-Vanzzini, MD1, Cyntia Zulema Machain Leyva, MD1,   Luis Eduardo Rodríguez Castellanos, MD1, José Antonio Arias Godínez, MD1,   María Eugenia Ruiz Esparza, MD1, and Hector Herrera Bello, MD2 1Department of Echocardiography, “Ignacio Chávez” National Cardiology Institute, Mexico City, Mexico   2Intermediate Care, Clinical Foundation Médica Sur, Mexico City, Mexico  Background: Excessive weight and obesity (EwO) are independent factors in the development of heart failure; they lead to  a state of myocardiopathy via inflammatory and hormonal mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/ee/78/jcu-23-86.PMC4486183.pdf
"91 Introduction Patients with pulmonary arterial hypertension (PAH) have  a high mortality rate despite earlier disease recognition and  availability of new drug treatments which have improved sur -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.2.91 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(2):91-99 vival in recent years.1-3) Irrespective of the etiology of PAH, right  ventricular (RV) function is the main determinant of symp - toms and survival.4)5) Because transthoracic 2-dimensional  echocardiography (2DE) gives us important information about  •	Received: April 13, 2015  •	Revised: May 25, 2015  •	Accepted: May 26, 2015 •		Address for Correspondence: James D. Thomas, Center for Heart Valve Disease, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, 676 North St.  Clair St., Suite 600, Chicago, IL 60611, USA   Tel: +1-312-926-4220, Fax: +82-42-257-5753, E-mail: jthomas8@nmh.org •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Impaired Global Right Ventricular  Longitudinal Strain Predicts Long-Term  Adverse Outcomes in Patients with  Pulmonary Arterial Hypertension Jae-Hyeong Park, MD1,2, Margaret M. Park, BS1, Samar Farha, MD3,   Jacqueline Sharp, CNP1, Erika Lundgrin, BA3, Suzy Comhair, PhD3,   Wai Hong Tang, MD1, Serpil C. Erzurum, MD2, and James D. Thomas, MD1,4  1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA   2Cardiology Division of Internal Medicine, Chungnam National University, Chungnam National University Hospital,  Daejeon, Korea   3Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA   4Center for Heart Valve Disease, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago,   IL, USA Background:  New 2-dimensional strain echocardiography enables quantification of right ventricular (RV) mechanics by  assessing global longitudinal strain of RV (GLSRV) in patients with pulmonary arterial hypertension (PAH).",Non-OADS,/arxiv_data1/oa_pdf/5c/44/jcu-23-91.PMC4486184.pdf
"Despite these caveats, IL-6 blockade certainly warrants further study as a potential treatment modality for patients with DMD.EBioMedicine 2 (2015) 274 –275 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.014 .",Non-OADS,/arxiv_data1/oa_pdf/a7/fd/main.PMC4486189.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.018 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/a7/fd/main.PMC4486189.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/fd/main.PMC4486189.pdf
"To date, numerous attempts to treat AD by removing A β, interfering with A βaggregation steps, or directly altering APP have failed in humanEBioMedicine 2 (2015) 276 –277 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.009 .",Non-OADS,/arxiv_data1/oa_pdf/4d/48/main.PMC4486190.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.017 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/4d/48/main.PMC4486190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/48/main.PMC4486190.pdf
"Nonetheless, the RASKET multiplex assay detects exons 2, 3 and 4 KRAS and NRAS mutations from a small amount of DNA (50 –100 ng) that is extracted from formalin ﬁxed paraf- ﬁn embedded tissues in a short turnaround time of 4.5 h.EBioMedicine 2 (2015) 280 –281 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.007 .",Non-OADS,/arxiv_data1/oa_pdf/e3/35/main.PMC4486191.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.008 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/e3/35/main.PMC4486191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/35/main.PMC4486191.pdf
Nature http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/35/main.PMC4486191.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/28/main.PMC4486192.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.0212352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/28/main.PMC4486192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/28/main.PMC4486192.pdf
"In chronic HCV infected patients,EBioMedicine 2 (2015) 370 –371 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.010 .",Non-OADS,/arxiv_data1/oa_pdf/25/46/main.PMC4486194.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.04.001 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/25/46/main.PMC4486194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/46/main.PMC4486194.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/fb/main.PMC4486195.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.04.009 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/fb/main.PMC4486195.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/fb/main.PMC4486195.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/15/main.PMC4486196.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.010 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/15/main.PMC4486196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/15/main.PMC4486196.pdf
"), S1 –S4.http://dx.doi.org/10.1016/j.jacl.2014.03.003 (May–Jun).",OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
http://dx.doi.org/10.1161/ATVBAHA.114.,Non-OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
"(Shanghai) 45 (1), 2 –10.http://dx.doi.org/10.1093/abbs/gms112 (Jan, Review).",Non-OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
"EBioMedicine 2 (4), 356 –364.EBioMedicine 2 (2015) 284 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.006 .",OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.004 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/93/main.PMC4486198.pdf
"134,2988 –2990.EBioMedicine 2 (2015) 282 –283 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.015 .",Non-OADS,/arxiv_data1/oa_pdf/52/53/main.PMC4486199.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.022 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/53/main.PMC4486199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/53/main.PMC4486199.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/23/main.PMC4486202.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.007 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/23/main.PMC4486202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/23/main.PMC4486202.pdf
"Based on these results, assessment of all RASmutational status in metastatic CRC patients prior to anti-EGFR an- tibody therapy would be bene ﬁcial for both patients' quality of life and optimal use of healthcare resources; regulatory authorities and public health institutions, such as the National Comprehensive Cancer Net- work have recommended compulsory RAStesting ( http://www.nccn.",Non-OADS,/arxiv_data1/oa_pdf/1e/23/main.PMC4486202.pdf
http://dx.doi.org/10.1158/1078-0432.CCR- 14-0983 .,Non-OADS,/arxiv_data1/oa_pdf/1e/23/main.PMC4486202.pdf
These ﬁndings are important inEBioMedicine 2 (2015) 374 –375 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.003 .,Non-OADS,/arxiv_data1/oa_pdf/a9/66/main.PMC4486203.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.03.013 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/66/main.PMC4486203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/66/main.PMC4486203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan Journal of Medicine 2015, 10: 28634 - http://dx.doi.org/10.3402/ljm.v10.28634 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/5e/LJM-10-28634.PMC4486353.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2015, 10: 28634 - http://dx.doi.org/10.3402/ljm.v10.28634",Non-OADS,/arxiv_data1/oa_pdf/64/5e/LJM-10-28634.PMC4486353.pdf
"1993; 7: 582 /C15.Letter to the editor Citation: Libyan Journal of Medicine 2015, 10: 28634 - http://dx.doi.org/10.3402/ljm.v10.28634 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/5e/LJM-10-28634.PMC4486353.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 28166 - http://dx.doi.org/10.3402/jom.v7.28166 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b6/d8/JOM-7-28166.PMC4486354.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 28166 - http://dx.doi.org/10.3402/jom.v7.28166",Non-OADS,/arxiv_data1/oa_pdf/b6/d8/JOM-7-28166.PMC4486354.pdf
"Data shown are individual values fortriplicates of the test.Bacterial hydrogen sulfide production Citation: Journal of Oral Microbiology 2015, 7: 28166 - http://dx.doi.org/10.3402/jom.v7.28166 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b6/d8/JOM-7-28166.PMC4486354.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 28166 - http://dx.doi.org/10.3402/jom.v7.28166",Non-OADS,/arxiv_data1/oa_pdf/b6/d8/JOM-7-28166.PMC4486354.pdf
@ERSpublications This largest published registry of IPF patients shows surprising disease severity and treatment variation http://ow.ly/JbWRn Copyright ©ERS 2015.,Non-OADS,/arxiv_data1/oa_pdf/bf/63/ERJ-02176-2014.PMC4486374.pdf
@ERSpublications The ESR/ERS provide new recommendations for lung cancer screening in this white paperhttp://ow.ly/KbUck Copyright ©ERS/ESR 2015.,Non-OADS,/arxiv_data1/oa_pdf/1c/28/ERJ-00330-2015.PMC4486375.pdf
"2014; http://ec.europa.eu/eurostat/documents/ 2995521/6131615/3-25112014-BP-EN/aab2c2d3-aed9-430a-a561-e188b8ef49d8 Date last updated: November 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1c/28/ERJ-00330-2015.PMC4486375.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.028 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
"Case Rep.5 (12) (2014) 899–901, http://dx.doi.org/10.1016/j.ijscr.2014.09.036 [3] M. Akin, O. Kurukahvecioglu, T. Tezcaner, A.Z.",Non-OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
"26 (8) (2008) 973.e3–973.e4, http://dx.doi.org/10.1016/j.ajem.2008.02.",OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
"Case Rep. 10 (2015) 17–19,http://dx.doi.org/10.1016/j.ijscr.2015.03.005 [5] K.A.",OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
"46 (5) (2011) 893–896, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
"Imaging 38 (5) (2014) 557–564, http://dx.doi.org/ 10.1016/j.clinimag.2014.04.020 [7] R. Kassir, T. Debs, C. Boutet, S. Baccot, K. Abboud, J. Dubois, A. Boueil Bourlier, V. Yvorel, O. Tiffet, Intussusception of the Meckel’s diverticulum within its ownlumen: unknown complication, Int.",Non-OADS,/arxiv_data1/oa_pdf/b5/a7/main.PMC4486395.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/35/main.PMC4486396.pdf
"Peroral cholangioscopy (POCS) revealed papillary tumors without mucinproduction at the oriﬁce of the left hepatic duct, while no tumor http://dx.doi.org/10.1016/j.ijscr.2015.05.033 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f6/35/main.PMC4486396.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/35/main.PMC4486396.pdf
Alexandria (VA); 2014. http://www.diabetes.org/diabetes- basics/statistics/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
Geneva.http://apps.who.int/bmi/index.jsp?intro .,Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
http://micromedex.com/redbook .,Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
http://www.cms.gov/Medicare/ Medicare-Fee-for-Service-Payment/FeeScheduleGenInfo/index.html/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
Baltimore (MD); 2012. http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
"Washington, DC; 2014. http://www.bls.",Non-OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
http://support.sas.com/ documentation/cdl/en/statug/63033/ HTML/default/viewer.htm#statu g_genmod_sect004.htm .,OADS,/arxiv_data1/oa_pdf/bf/ef/40273_2014_Article_248.PMC4486397.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/f4/main.PMC4486401.pdf
Ultrasonography of abdomen http://dx.doi.org/10.1016/j.ijscr.2015.05.039 2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/80/f4/main.PMC4486401.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/f4/main.PMC4486401.pdf
Intestinal Anastomosis Available at: http://emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/80/f4/main.PMC4486401.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/51/main.PMC4486402.pdf
On the basis of a presumptive clinical diagnosis of exacerbated cholecystitis with gallstones the patient underwent surgical treat- http://dx.doi.org/10.1016/j.ijscr.2015.06.001 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/51/main.PMC4486402.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/23/main.PMC4486403.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.034 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/23/main.PMC4486403.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/b6/main.PMC4486404.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.030 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/b6/main.PMC4486404.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/b6/main.PMC4486404.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC4486405.pdf
Routine laboratory test results were: aspar-tate aminotransferase (AST) 5 IU/L (normal 10–33 IU/L); alanineaminotransferase (ALT) 121 IU/L (normal 6–35 IU/L); alkaline phos-phatase 884 IU/L (normal 120–340 IU/L); /H9253-glutamyltransferase 684 IU/L (normal 8–60 IU/L); total bilirubin (T-bil) 0.5 mg/dL (nor-mal 0.4–1.4 mg/dL); amylase 87 IU/L (normal 31–106 IU/L); lipase49 IU/L (normal 8–46 IU/L); and normal inﬂammatory markers.Laboratory test results for tumor markers were: carcinoembryonicantigen (CEA) 2.9 ng/mL (normal 0–5.0 ng/mL); carbohydrate anti-gen (CA) 19–9 2 U/mL (normal 0–37 U/mL); DUPAN-2 940 U/mL http://dx.doi.org/10.1016/j.ijscr.2015.05.031 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC4486405.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC4486405.pdf
"2012 (2012) 1–2, http://dx.doi.org/10.1155/2012/402798 [18] M.N.",Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC4486405.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/d0/main.PMC4486406.pdf
"Because the protrusion of the activating rod did not arrive at the lower vestibule, we ligatured a nylon thread at the point of the con- http://dx.doi.org/10.1016/j.ijscr.2015.05.037 2210-2612/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5e/d0/main.PMC4486406.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/b0/main.PMC4486407.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.05.036 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/b0/main.PMC4486407.pdf
This is an open access article under the CC BY-NC-NDlicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/b0/main.PMC4486407.pdf
June 2014. http://www.oecd.org/els/ health-systems/Obesity-Update-2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
Rockville: ofﬁce of the Surgeon General (US); 2001. http://www.ncbi.nlm.nih.gov/pubmed/20669513 .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2013. http://www.cdc.gov/stltpublichealth/psr/npao/index.html .,OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
Sep 1998. http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
23 March 2010. http://www.gpo.gov/fdsys/pkg/BILLS-111hr3590 enr/pdf/BILLS-111hr3590enr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2011 Feb 16.http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce ments/ucm245617.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2003 Nov 13. http://www.pbs.org/wgbh/pages/ frontline/shows/prescription/hazard/fenphen.html .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
Oct–Dec 2010. http://ip-science.thomsonreuters.com.au/ m/pdf/SpotlightOn_cwp_Q4_10.pdf .,OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2012. http://www.fda.gov/newsevents/ newsroom/pressannouncements/ucm312468.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
"Winifred S. Hayes, Inc. 2013. http://www.hayesinc.com/ hayes/blog/blog-bridging-the-evidence-gap-to-treat-obesity/ .",Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
Department of Health and Human Services; 2013 Dec. http://effectivehealthcare.ahr q.gov/ehc/assets/File/Obesity- Horizon-Scan-High-Impact-1312.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2010. http://www.fda.gov/safety/ medwatch/safetyinformation/safetyalertsforhumanmedical products/ucm228830.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.cms.gov/ Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ index.html?redirect=/ehrincentiveprograms/ .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
May 2013. http://media.npr.org/documents/2013/jun/ ama-resolution-obesity.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014;5. http://www.obesityaction.org/educational- resources/resource-articles-2/weight-loss-surgery/self-monitoring-the-way-to-successful-weight-management .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.opm.gov/ healthcare-insurance/healthcare/carriers/2014/2014-04.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.advisory.com/daily-brieﬁng/2014/ 04/03/feds-offer-guidance-on-how-to-cover-obesity-treatment .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2003. http://www.gpo.,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
1990. http://www.ssa.gov/OP_Home/ssact/title19/ 1927.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
July 2008.http://www.cms.gov/Regulati ons-and-Guidance/Guidance/ Transmittals/downloads/R2PDB.pdf .,OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2013. http://www.govtrack.us/congress/bills/113/s1184 .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.aging.ny.gov/ news/2013/Strategic_plan%20NYSDOH%20Obesity%202005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
December 2012. http://www.cms.gov/Medicare/ Medicare-Fee-for-Service-Payment/sharedsavingsprogram/ Downloads/ACO-NarrativeMeasures-Specs.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014.http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData.html .,OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2014. http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2014/ List_of_HEDIS_2014_Measures.pdf .,OADS,/arxiv_data1/oa_pdf/8e/cd/40273_2015_Article_264.PMC4486408.pdf
2013. http://www.who.int/ mediacentre/factsheets/fs311/en/ .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2014. http://www.cdc.gov/obesity/data/adult.html .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2010. http://www.fda.gov/safety/ medwatch/safetyinformation/safetyalertsforhumanmedicalprodu cts/ucm228830.htm .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2012. http://www.fda.gov/ downloads/Drugs/DrugSafety/UCM312590.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2010. http://www.unitedhealth group.com/Newsroom/Articles/News/UnitedHealth%20Group/ 2010/0414DiabetesObesity.aspx .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2013. http://www.medispan.com/ drug-pricing-analysis-pricerx.aspx .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2013. http://www.medicare paymentandreimbursement.com/2013/01/ofﬁce-visit-cpt-e-code- fee-schedule.html .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
2014. http://www.xe.com .,Non-OADS,/arxiv_data1/oa_pdf/ad/d4/40273_2014_Article_182.PMC4486409.pdf
Available from: http://www.nber.org/ papers/w12291.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/b0/40273_2014_Article_230.PMC4486410.pdf
Availablefrom: http://meps.ahrq.gov/data_stats/download_data_ﬁles.jsp .,OADS,/arxiv_data1/oa_pdf/85/b0/40273_2014_Article_230.PMC4486410.pdf
Available from http://www.meps.ahrq.gov/mepsweb/dataﬁles/ publications/mr27/mr27.pdf .,OADS,/arxiv_data1/oa_pdf/85/b0/40273_2014_Article_230.PMC4486410.pdf
Available from http://www.census.gov/popest/ .,OADS,/arxiv_data1/oa_pdf/85/b0/40273_2014_Article_230.PMC4486410.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.05.013 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/8d/77/main.PMC4486458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/77/main.PMC4486458.pdf
EBioMedicineEBioMedicine 2 (2015) 365 http://dx.doi.org/10.1016/j.ebiom.2015.05.015 2352-3964/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/ea/e9/main.PMC4486461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/e9/main.PMC4486461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/99/main.PMC4486463.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.03.006 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/99/main.PMC4486463.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/16/main.PMC4486464.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.05.006 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/16/main.PMC4486464.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4486465.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 398 –403 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.012 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4486465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4486465.pdf
Pres.. http://dx.doi.org/10.1111/ jfpp.12240 .,Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4486465.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 424 –429 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.004 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/6d/b4/main.PMC4486466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/b4/main.PMC4486466.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/b4/main.PMC4486466.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 404 –408 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.12.005 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/45/66/main.PMC4486467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/66/main.PMC4486467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/66/main.PMC4486467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 491 –502 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.024 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
"As for the Peregrine Falcon, the species were put on the endangered species list in 1970 because of a problem with egg shell thinning that was caused mainly by use of the pesti- cide DDT during the 1950s and 60s, habitat loss, hunting, Figure 1 Locations of falcon captures in Saudi Arabia (< http://www.mekshat.com/vb/showthread.php?t=322535 ).492 M.Y.",Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
Down- loaded from < http://www.birdlife.org > on 27/05/2013.,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
Downloaded from<http://www.birdlife.org > downloaded 9/04/2014.,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
Available at: <http://www.cites.org/eng/com/ac/25/E25-09-07.pdf >.Implications of trapping of Falcons in Saudi Arabia 501,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
http://dx.doi.org/10.1016/S1537- 51102)00239-8 .,OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
"XX, Bonn, Germany < http://www.cms.int/en/document/2nd- draft-saker-falcon-global-action-plan-sakergap >.Levin, A., 2003.",Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
Reports presented on the International Conference ‘‘Conservation of steppe and semidesert ecosystems in Eurasia’’ < http://issuu.com/rc_news/docs/poster/9?e=6470848/ 2093118 >.,Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
"Modeling and Control of the Peregrine Falcon Population, National Conference of Undergraduate Research,UNC-Asheville Wittenberg University < http://www4.witten- berg.edu/academics/mathcomp/mathematics/students/student_pro- jects/Peterson%20Falcon%20Paper.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/11/34/main.PMC4486468.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.03.010,Non-OADS,/arxiv_data1/oa_pdf/37/5b/main.PMC4486469.pdf
Webcast http://globenewswire.com/news-release/2014/01/17/603196/10064629/en/Onconova-Therapeutics-Inc-to-Host- Webcast-Regarding-Insights-Into- Rigosertib-Mechanism-of-Action-With-Scientific-Founder-Dr-E-Premkumar-Reddy.html ; 2014.,Non-OADS,/arxiv_data1/oa_pdf/37/5b/main.PMC4486469.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/27/main.PMC4486470.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 430 –437 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.012 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2e/27/main.PMC4486470.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/27/main.PMC4486470.pdf
"Currently available NHP genome assemblies in public  databases include baboon, bonobo, bushbaby, chimpanzee, cynomolgus monkey, gibbons,  guerilla, lemurs, marmoset, orangutan, rhesus monkey, squirrel monkey, tarser, vervet  (http://www.ncbi.nlm.nih.gov/genome/browse/ ) and more are being added all the time.",Non-OADS,/arxiv_data1/oa_pdf/e7/28/nihms661887.PMC4486519.pdf
Homology of primate nAChRs to human nAChRs We assessed the homology of primate nAChRs to human using CDS Fasta alignment  sequences retrieved from the UCSC table browser ( https://genome.ucsc.edu/ ).,OADS,/arxiv_data1/oa_pdf/e7/28/nihms661887.PMC4486519.pdf
[J Adv Prosthodont  2015;7:183-90] KEY WORDS: Dental implant; Zirconia abutment; Titanium insert; Fracture load; Preparation depth; Artificial aginghttp://dx.doi.org/10.4047/jap.2015.7.3.183 http://jap.or.kr J Adv Prosthodont 2015;7:183-90 INTRODUCTION Implant-supported fixed dental prosthesis is a standardized  restoration method that is often used when an aesthetically critical anterior single tooth is missing.,Non-OADS,/arxiv_data1/oa_pdf/c5/f2/jap-7-183.PMC4486613.pdf
"82 62 530 5577: e-mail, mcnihil@jnu.ac.krReceived September 18, 2014 / Last Revision February 23, 2015 /  Accepted March 18, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/f2/jap-7-183.PMC4486613.pdf
ORCID Han-Sung Joo  http://orcid.org/0000-0001-6932-1089Kwi-Dug Yun  http://orcid.org/0000-0002-2965-3967Min-Kyung Ji  http://orcid.org/0000-0002-3525-644XHyun-Pil Lim  http://orcid.org/0000-0001-5586-1404 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/c5/f2/jap-7-183.PMC4486613.pdf
"[J Adv Prosthodont 2015;7:191-8] KEY WORDS: Implant; Overdenture; Bone loss; Patients satisfactionhttp://dx.doi.org/10.4047/jap.2015.7.3.191 http://jap.or.kr J Adv Prosthodont 2015;7:191-8 INTRODUCTION Half  of  all conventional mandibular dentures demonstrate  problems with prosthesis stability and retention, with reten-tion being the single most important deficiency reported.",Non-OADS,/arxiv_data1/oa_pdf/8b/af/jap-7-191.PMC4486614.pdf
ORCID Sara Tavakolizadeh  http://orcid.org/0000-0002-8685-5565Fariborz Vafaee  http://orcid.org/0000-0001-5988-2819Masume Khoshhal  http://orcid.org/0000-0003-3959-6430Zahra Ebrahimzadeh  http://orcid.org/0000-0002-0362-4914 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/8b/af/jap-7-191.PMC4486614.pdf
[J Adv Prosthodont 2015;7:199-206] KEY WORDS: Adaptation; Scannable stone; Surface roughness; Type IV stone; Zirconia corehttp://dx.doi.org/10.4047/jap.2015.7.3.199 http://jap.or.kr J Adv Prosthodont 2015;7:199-206 INTRODUCTION Forming an accurate impression of  the patient’s oral envi- ronment and fabricating a working model from gypsum that accurately reproduces the relationship with the abutment teeth are two of  the most important processes in prosthesis fabrication.,Non-OADS,/arxiv_data1/oa_pdf/ac/1c/jap-7-199.PMC4486615.pdf
"82 2 32905620: e-mail, noreason07@korea.ac.krReceived October 12, 2014 / Last Revision January 30, 2015 / Accepted  February 9, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/1c/jap-7-199.PMC4486615.pdf
ORCID Ki-Baek Kim  http://orcid.org/0000-0003-3821-9764Jae-Hong Kim  http://orcid.org/0000-0002-2679-8802Sa-Hak Kim  http://orcid.org/0000-0002-5893-6413 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/ac/1c/jap-7-199.PMC4486615.pdf
"Retrieved April 12, 2014, Available from http://en.zhermack.",Non-OADS,/arxiv_data1/oa_pdf/ac/1c/jap-7-199.PMC4486615.pdf
[J Adv Prosthodont 2015;7:207-13] KEY WORDS: Implant-supported dental prosthesis; Torque; Dental cementhttp://dx.doi.org/10.4047/jap.2015.7.3.207 http://jap.or.kr J Adv Prosthodont 2015;7:207-13 INTRODUCTION The topic of  screw–retained versus cemented implant resto- rations has been debated by many authors.1-10 Screw-retained  implant prostheses have the advantage of  predictable retriev-ability compared to cemented ones.,Non-OADS,/arxiv_data1/oa_pdf/22/27/jap-7-207.PMC4486616.pdf
"82 62 220 3820: e-mail, jhajung@chosun.ac.krReceived October 22, 2014 / Last Revision February 9, 2015 / Accepted   March 5, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/27/jap-7-207.PMC4486616.pdf
ORCID Seok-Gyu Kim  http://orcid.org/0000-0002-4024-0215 Chae-Heon Chung  http://orcid.org/0000-0003-1089-2885Mee-Kyoung Son  http://orcid.org/0000-0001-9225-1744 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/22/27/jap-7-207.PMC4486616.pdf
[J Adv Prosthodont 2015;7:214-23] KEY WORDS: All-ceramic; Bond strength; Indirect composite; Sandblasting; Zirconiahttp://dx.doi.org/10.4047/jap.2015.7.3.214 http://jap.or.kr J Adv Prosthodont 2015;7:214-23 INTRODUCTION The majority of all-ceramic restorations have a two-layer  structure that is comprised of  a weak ceramic veneer laid over a strong supporting core.,Non-OADS,/arxiv_data1/oa_pdf/6b/d7/jap-7-214.PMC4486617.pdf
[J Adv Prosthodont 2015;7:224-32] KEY WORDS: Immediate dentin sealing; SEM analysis; Dentin bonding; Thermocycling; Ceramic restorationhttp://dx.doi.org/10.4047/jap.2015.7.3.224 http://jap.or.kr J Adv Prosthodont 2015;7:224-32 INTRODUCTION Patient expect for improved esthetics has driven the advan- cement of ceramic for use with fixed partial prostheses.1 Many clinical studies demonstrate excellent long-term suc - cess of  ceramic restorations.,Non-OADS,/arxiv_data1/oa_pdf/e3/2e/jap-7-224.PMC4486618.pdf
"82 2 440 7519: e-mail, hswhsh@khu.ac.kr Received November 25, 2014 / Last Revision March 19, 2015 / Accepted  April 2, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/2e/jap-7-224.PMC4486618.pdf
oRCiD Richard Leesungbok  http://orcid.org/0000-0002-8381-723XSang-Min Lee  http://orcid.org/0000-0002-3887-4323Su-Jung Park  http://orcid.org/0000-0002-4111-2231Suk-Won Lee  http://orcid.org/0000-0003-2726-3567Do Yun Lee  http://orcid.org/0000-0002-8638-7423Byung-Jin Im  http://orcid.org/0000-0001-5661-2258Su-Jin Ahn  http://orcid.org/0000-0003-2128-1561 RefeRenCes  1.,Non-OADS,/arxiv_data1/oa_pdf/e3/2e/jap-7-224.PMC4486618.pdf
"[J Adv Prosthodont 2015;7:233-9] KEY WORDS: Marginal fit; CAD/CAM; Zirconia; Layering; Press-over; CAD-onhttp://dx.doi.org/10.4047/jap.2015.7.3.233 http://jap.or.kr J Adv Prosthodont 2015;7:233-9 INTRODUCTION Due to the increasing demands for esthetic restorations and  biocompatibility concerns, all ceramic restorations have been widely used in the last few decades.",Non-OADS,/arxiv_data1/oa_pdf/35/83/jap-7-233.PMC4486619.pdf
"989171883704: e-mail, taghvam@yahoo.comReceived November 26, 2014 / Last Revision March 16, 2015 / Accepted  April 13, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/83/jap-7-233.PMC4486619.pdf
ORCID Kianoosh Torabi  http://orcid.org/0000-0002-5916-6158 Mahroo Vojdani  http://orcid.org/0000-0001-6073-0847Rashin Giti  http://orcid.org/0000-0003-1091-9574Masumeh Taghva  http://orcid.org/0000-0001-6662-2257Soheil Pardis  http://orcid.org/0000-0002-5142-1177 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/35/83/jap-7-233.PMC4486619.pdf
"[J Adv  Prosthodont 2015;7:240-8] KEY WORDS: All-on-Four; Edentulous mandibles; Fixed prosthesis; Implant; Finite element analysis; Stress http://dx.doi.org/10.4047/jap.2015.7.3.240 http://jap.or.kr J Adv Prosthodont 2015;7:240-8 INTRODUCTION Fixed implant-supported prostheses for edentulous mandi-bles are proved the best way to overcome the problems of   traditional dentures, which enable patients to get similar bite force and comfort as natural teeth.",Non-OADS,/arxiv_data1/oa_pdf/df/e3/jap-7-240.PMC4486620.pdf
"86 21 31162490: e-mail, wang_dento@163.comReceived December 4, 2014 / Last Revision February 23, 2015 /  Accepted March 18, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/e3/jap-7-240.PMC4486620.pdf
ORCID Xiaomei Li  http://orcid.org/0000-0002-3945-0709Zhizhong Cao  http://orcid.org/0000-0002-0892-1379Xiaoqian Qiu  http://orcid.org/0000-0003-4066-0858Zhen Tang  http://orcid.org/0000-0002-3325-3237 Lulu Gong  http://orcid.org/0000-0003-1689-3424 Dalin Wang  http://orcid.org/0000-0002-8618-807XREFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/df/e3/jap-7-240.PMC4486620.pdf
"[J Adv Prosthodont  2015;7:249-56] KEY WORDS: Titanium; Surface treatment; Non-thermal atmospheric pressure plasma; Micromechanical  retention; Self-adhesive resin cement; Shear bond strengthhttp://dx.doi.org/10.4047/jap.2015.7.3.249 http://jap.or.kr J Adv Prosthodont 2015;7:249-56 INTRODUCTION Titanium (Ti) and its alloys are widely used as dental mate - rials in prosthodontics and implantology because of  their  low density, high corrosion resistance, superior biocompati-bility and good mechanical properties.",Non-OADS,/arxiv_data1/oa_pdf/22/33/jap-7-249.PMC4486621.pdf
"90 532 5070236: e-mail, emreseker@hotmail.comReceived December 10, 2014 / Last Revision March 20, 2015 / Accepted  April 8, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/33/jap-7-249.PMC4486621.pdf
ORCID Emre seker  http://orcid.org/0000-0003-3917-8271 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/22/33/jap-7-249.PMC4486621.pdf
"[J Adv Prosthodont 2015;7:257-63] KEY WORDS: Galvano crowns; Marginal adaptation; Laser sintered Co-Cr; Electroformed coping; Biocompatibilityhttp://dx.doi.org/10.4047/jap.2015.7.3.257 http://jap.or.kr J Adv Prosthodont 2015;7:257-63 INTRODUCTION Rehabilitation of  tooth loss that may have occurred for var - ious reasons with prosthetic restorations positively affects the quality of  the patient’s life.1 In addition to the mechani- cal properties, marginal compatibility of  the prosthetic res- torations is expected to be good, to satisfy the patient es-thetically and functionally, to be biocompatible with the oral tissues, and to show long term clinical success.",Non-OADS,/arxiv_data1/oa_pdf/bc/0d/jap-7-257.PMC4486622.pdf
"905356243867: e-mail, dentistsedat49@hotmail.comReceived February 2, 2015 / Last Revision March 16, 2015 / Accepted  April 7, 2015 © 2015  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/0d/jap-7-257.PMC4486622.pdf
"ORCID Tahir Karaman  http://orcid.org/0000-0001-5643-5116 Sabiha Zelal Ulku  http://orcid.org/0000-0001-8023-9422Ali Ihsan Zengingul  http://orcid.org/0000-0003-3510-6027 Sedat Guven  http://orcid.org/0000-0002-2739-2281 Veysel Eratilla  http://orcid.org/0000-0003-1709-8406 Ebru Sumer  http://orcid.org/0000-0002-4857-5845  AKNOWLEDgEMENTS We thank to Dr. Ismail Yildiz (Dicle University, Faculty of   Biostatistics) for his helpful advices for statistical analysis.Evaluation and comparison of the marginal adaptation of two different substructure materials",Non-OADS,/arxiv_data1/oa_pdf/bc/0d/jap-7-257.PMC4486622.pdf
[J Adv Prosthodont 2015;7:264-70] KEY WORDS: Horizontal insertion prosthesis; Horizontal Denture®; Alveolar bone atrophy; Dental prosthesis  design; Dental implants; Edentulous jawhttp://dx.doi.org/10.4047/jap.2015.7.3.264 http://jap.or.kr J Adv Prosthodont 2015;7:264-70 INTRODUCTION Overdentures can be defined as full removable dentures  that are combined with dental implants to improve stability in the mouth.,Non-OADS,/arxiv_data1/oa_pdf/90/8c/jap-7-264.PMC4486623.pdf
Identi ﬁcation of drug targets The primary source of con ﬁrmed druggable targets was the curated list of 1030 genes recently published by Rask-Anderson et al.19This list was developed with publicly available resources including: the DrugBank20 database (http://www.drugbank.ca); the Drugs@FDA database (http://www.accessdata.fda.gov/scripts/cder/drugsatfda/); and the Drugs inClinical Trials Database (http://www.centerwatch.com).,OADS,/arxiv_data1/oa_pdf/58/e8/mp201528a.PMC4486648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Targeting the schizophrenia genome T Lencz and AK Malhotra 826 Molecular Psychiatry (2015), 820 –826 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/58/e8/mp201528a.PMC4486648.pdf
"[ http://www.census.gov/hhes/fertility/data/cps/2008.html ] Unger JB, Molina GB.",OADS,/arxiv_data1/oa_pdf/24/a3/nihms681617.PMC4486655.pdf
"Address correspondence to Sascha Brunke, sascha.brunke@leibniz-hki.de.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /EC.00078-15 .",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
"The protein sequences of C. dubliniensis Cd36_ 44490 (CdCsr1), C. albicans orf19.3794 (CaCsr1), C. glabrata CAGL 0J05060g (CgCsr1), S. cerevisiae YJL056C (ScZap1), Aspergillus fumigatus Afu1g10080 (ZafA), and Cryptococcus neoformants (CnZap1) were com- pared using NCBI PBLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ); they were aligned with the ClustalW2 multiple-sequence-alignment tool ( http: //simgene.com/ClustalW ), and the phylogenetic tree was constructed at http://www.phylogeny.fr (34).",OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1021 /pr0603699 .Böttcher et al.,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1007/s10534 -013-9646-y .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1111/j.1365-2958.2008.06528.x .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Mol Biol Cell 15:456 – 467. http://dx.doi.org/10.1091/mbc.E03-03-0179 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Mol Mi- crobiol 56:397– 415. http://dx.doi.org/10.1111/j.1365-2958.2005.04557.x .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi .org/10.1016/j.cbpa.2009.11.008 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1371/journal.ppat .1003034 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
FrontCell Infect Microbiol 3:90. http://dx.doi.org/10.3389/fcimb.2013.00090 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1128/IAI.00559-07 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1086/421946 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.4103 /0255-0857.99484 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1111/j.1439-0507.2010.01899.x .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Int J Microbiol 2012: 205921. http://dx.doi.org/10.1155/2012/205921 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1016/j.fgb.2006.11.014 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1371 /journal.pbio.1000133 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org /10.1128/EC.05196-11 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1074/jbc.271.38.23203 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Eu-karyot Cell 4:837– 848. http://dx.doi.org/10.1128/EC.4.5.837-848.2005 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
FEMS Yeast Res 8:883– 896. http://dx.doi.org/10.1111/j.1567-1364.2008 .00414.x .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi .org/10.1371/journal.ppat.1002777 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1371 /journal.pbio.1002076 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Eukaryot Cell 12:604 – 613. http://dx.doi.org /10.1128/EC.00336-12 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1128/AAC.01072-07 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
J Immunol 189:2502– 2511. http://dx.doi.org/10.4049/jimmunol.1200185 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Gene 341:119 – 127. http://dx.doi.org/10.1016/j.gene.2004.06.021 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1093 /nar/gkr1292 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1371/journal.pone.0019741 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1093/nar/gkr931 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1093/emboj/19.14.3704 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1038 /sj.emboj.7600122 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1073 /pnas.97.14.7957 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Biometals 22:411– 420. http://dx.doi.org/10.1007 /s10534-008-9177-0 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1016/S1567-1356(03) 00240-X .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1016/j .femsle.2005.09.015 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org /10.1038/nrmicro2836 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1074/jbc.273.44.28713 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Mol Microbiol 57:834 – 846. http://dx.doi.org/10.1111/j.1365-2958.2005.04734.x .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10 .1371/journal.pone.0043773 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Metallomics http://dx.doi.org/10 .1039/c4mt00331d .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
"http://dx.doi.org/10.1093/emboj/19.12.2845 .52.O’Connor L, Caplice N, Coleman DC, Sullivan DJ, Moran GP.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1128/EC.00042-10 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1101/gr.097501.109 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1111/j.1472-765X.2006.02044.x .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2007.05726.x .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
Eukaryot Cell 10:803– 819. http://dx.doi.org/10.1128 /EC.00310-10 .,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi .org/10.1371/journal.pgen.1004658 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1007/BF00328721 .,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
http://dx.doi.org/10.1046/j.1439-0507.1999.00259.x .Böttcher et al.,OADS,/arxiv_data1/oa_pdf/cf/b1/zek661.PMC4486669.pdf
"To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2015-000097) Received 27 February 2015 Revised 6 May 2015 Accepted 8 May 2015 1Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Miyagi, Japan 2Division of Research in Student Support, Institute for Excellence in Higher Education, Section of Clinical Medicine, Tohoku University, Sendai, Miyagi, Japan Correspondence to Dr Susumu Ogawa; ogawa-s@hosp.tohoku.ac.jpABSTRACT Background and objectives: A lower urinary pH (UpH) is closely linked to diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/bmjdrc-2015-000097.PMC4486685.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/bmjdrc-2015-000097.PMC4486685.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 503 –511 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.12.003 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fd/20/main.PMC4486727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/20/main.PMC4486727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/20/main.PMC4486727.pdf
Res.. http://dx.doi.org/ 10.1007/s11356-014-3434-2 .Conocarpus biochar as a soil amendment for reducing heavy metal availability 511,Non-OADS,/arxiv_data1/oa_pdf/fd/20/main.PMC4486727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/69/main.PMC4486731.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 359 –373 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.002 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/main.PMC4486731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/69/main.PMC4486731.pdf
"4.BRAF gene and malignant melanoma According to recent statistics released by the National Cancer Institute of the NIH ( http://www.cancer.gov/cancertopics/ types/melanoma ), 76,100 new cases of melanoma have been reported in 2014.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/main.PMC4486731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/e4/main.PMC4486732.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 466 –475 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.018 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/99/e4/main.PMC4486732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/e4/main.PMC4486732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486733.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 382 –389 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.004 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 374 –381 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.005 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
"To avoid the redundant or over-lapping miRNAs, the repeated sequences of miRNAs within the above animal species were removed and the remaining sequences were used as query sequences for BLAST search.The ESTs and GSSs sequences from the 11 studied species were downloaded from the GenBank nucleotide databases of National Center for Biotechnology Information (NCBI)(http://www.ncbi.nlm.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
Target prediction for identiﬁed miRNAs The mRNA database of the 11 ﬁsh species downloaded from NCBI database ( http://www.ncbi.nlm.nih.gov/sites/ entrez?db=unigene ) and their 30-UTR sequences which P20 nt in length were extracted and used for target prediction.,OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2014.",OADS,/arxiv_data1/oa_pdf/f1/13/main.PMC4486735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 476 –483 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.021 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
"12, 1959– 1966. http://dx.doi.org/10.1039/C0GC00135J .",Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
http://dx.doi.org/10.1016/ j.biortech.2013.12.101 .,OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
http://dx.doi.org/10.1007/s10529-008-9638-0 .,Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
http://dx.doi.org/10.1016/j.indcrop.2010.04.005 .,OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
"36, 671–678.http://dx.doi.org/10.1007/s10295-009-0536-9 .",Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
http://dx.doi.org/ 10.1039/C2CS15311D .,Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
http://dx.doi.org/10.1016/j.copbio.,OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC4486736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486737.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.03.002,OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486737.pdf
"Perfusion Analysis Before perfusion analysis, potential motion artifacts (motion between time points) in the DSC data were detected and corrected using FSL ( http://www.fmrib.ox.ac.uk/fsl/ ).Figure 1 shows theanalysis methods that were used in the experiments.",OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486737.pdf
"Finally, all labels were mapped to the perfusion maps by rigid coregistration in SPM ( http://www.fil.ion.ucl.ac.uk/spm/ ).",OADS,/arxiv_data1/oa_pdf/98/69/main.PMC4486737.pdf
1936-5233/15http://dx.doi.org/10.1016/j.tranon.2015.03.011,Non-OADS,/arxiv_data1/oa_pdf/02/a9/main.PMC4486738.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 438 –442 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.019 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/47/main.PMC4486739.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/47/main.PMC4486739.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/47/main.PMC4486739.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/12/main.PMC4486740.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 409 –416 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.12.007 1319-562X ª2014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/c4/12/main.PMC4486740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/12/main.PMC4486740.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/72/ac/40264_2015_Article_304.PMC4486763.pdf
Ofﬁce for National Statistics; Available from: http://www.ons.,OADS,/arxiv_data1/oa_pdf/72/ac/40264_2015_Article_304.PMC4486763.pdf
Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/72/ac/40264_2015_Article_304.PMC4486763.pdf
Available from: http://CRAN.R-project.org/ package=lme4 .,Non-OADS,/arxiv_data1/oa_pdf/72/ac/40264_2015_Article_304.PMC4486763.pdf
"3: 111-120, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.111 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 111Received on March 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/09/df/in-15-111.PMC4486773.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/df/in-15-111.PMC4486773.pdf
"3: 121-124, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.121 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 121Received on February 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/11/e1/in-15-121.PMC4486774.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/e1/in-15-121.PMC4486774.pdf
"3: 125-134, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.125 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 125Received on February 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/5a/in-15-125.PMC4486775.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/5a/in-15-125.PMC4486775.pdf
"3: 135-141, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.135 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 135Received on March 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/in-15-135.PMC4486776.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/in-15-135.PMC4486776.pdf
"3: 142-149, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.142 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 142Received on March 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bc/95/in-15-142.PMC4486777.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/95/in-15-142.PMC4486777.pdf
"3: 150-160, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.150 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 150Received on May 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e1/e5/in-15-150.PMC4486778.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/e5/in-15-150.PMC4486778.pdf
"3: 161-166, June, 2015http://dx.doi.org/10.4110/in.2015.15.3.161 pISSN 1598-2629    eISSN 2092-6685 161Received on April 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f6/10/in-15-161.PMC4486779.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/10/in-15-161.PMC4486779.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/93/87/40264_2015_Article_299.PMC4486783.pdf
2005.Available at: http://www.eurocat-network.eu/content/EUROCAT -Guide-1.3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/87/40264_2015_Article_299.PMC4486783.pdf
Updated 2015. http://www.goldcopd.org/ uploads/users/ﬁles/GO LD_Report_2015_Feb18.pdf .,OADS,/arxiv_data1/oa_pdf/29/06/12325_2015_Article_218.PMC4486785.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/49/rjv071.PMC4486866.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/58/rjv070.PMC4486869.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007621).,Non-OADS,/arxiv_data1/oa_pdf/79/59/bmjopen-2015-007621.PMC4486941.pdf
The haplotype frequencies were esti-mated by PHASE software 20 21(http://www.stat.,OADS,/arxiv_data1/oa_pdf/79/59/bmjopen-2015-007621.PMC4486941.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/59/bmjopen-2015-007621.PMC4486941.pdf
and babies in Europe in 2010: May 2013. http://www.europeristat.,Non-OADS,/arxiv_data1/oa_pdf/f5/8c/bmjopen-2014-006973.PMC4486942.pdf
http://unicef.org.uk/Documents/Baby_Friendly/Guidance/neonatal_standards.pdf?epslanguage=en (accessed Sep2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/8c/bmjopen-2014-006973.PMC4486942.pdf
"UTIN online: Rapporto dimissioni 2010: Network dei centri di Terapia Intensiva Neonataledel Lazio, 2011. http://www.asplazio.it/servizi/files/utin/Rapporto_UTIN_2010.pdf (accessed Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/f5/8c/bmjopen-2014-006973.PMC4486942.pdf
"Field DJ, Manktelow BM, Boyle EM, et al.The Neonatal Survey and Yorkshire Neonatal Network Report 2010 , 2011. https://www2.le.ac.",Non-OADS,/arxiv_data1/oa_pdf/f5/8c/bmjopen-2014-006973.PMC4486942.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007260).,Non-OADS,/arxiv_data1/oa_pdf/ec/b5/bmjopen-2014-007260.PMC4486943.pdf
2010. http://www.statmodel.com 15.,OADS,/arxiv_data1/oa_pdf/ec/b5/bmjopen-2014-007260.PMC4486943.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008470).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
http://www.isdscotland.org/Health-Topics/Cancer/Cancer-Statistics/Male-Genital-Organs/#prostate(accessed 8 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"London: Office for National Statistics (ONS), 2011. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77 –239726 (accessed 8 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"Cardiff: National Collaborating Centre for Clinical Excellence, 2008. http://www.nice.org.uk/nicemedia/live/11924/39687/39687.pdf (accessed 5 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"London: National Institute for Clinical Excellence, 2004. https://www.nice.org.uk/guidance/csgsp/evidence/supportive-and-palliative-care-the-manual-2 (accessed 5 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"Department of Health, 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213785/dh_123394.pdf (accessed 20 Feb2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"NHS Wales, 2012. http://wales.gov.uk/topics/health/publications/health/strategies/cancer/?lang=en (accessed 3 Nov 2014).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
http://www.1000livesplus.wales.nhs.uk/sitesplus/documents/1011/Bevan%20Commission%20Simply%20Prudent%20Healthcare%20v1%2004122013.pdf (accessed 5 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"Cardiff: Welsh Cancer Intelligence and Surveillance Unit (WCISU), 2010. http://www.wcisu.wales.nhs.uk/opendoc/226106 (accessed 20 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
2013. http://www.ncsi.org.uk/wp-content/uploads/ course-outline-2013PDF.pdf (accessed 5 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
2012. http://www.ncsi.org.uk/wp-content/uploads/Holistic-Needs- Assessment-practical-guide.pdf (accessed 5 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
http://www.wales.nhs.uk/nwis/page/52601 (accessed 3 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
2004. http://www.ces-asso.org/sites/default/files/H5-Edwards.,OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
"Kent: Personal Social Services Research Unit, 2014. http://www.pssru.ac.uk/project-pages/unit-costs/2014/ (accessed 2 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/48/63/bmjopen-2015-008470.PMC4486944.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007025).,Non-OADS,/arxiv_data1/oa_pdf/cd/85/bmjopen-2014-007025.PMC4486945.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007014).,Non-OADS,/arxiv_data1/oa_pdf/4c/8b/bmjopen-2014-007014.PMC4486946.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/8b/bmjopen-2014-007014.PMC4486946.pdf
http://www.nivel.nl/sites/default/files/bestanden/INT-IPA-Manual.pdf (accessed 18 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/4c/8b/bmjopen-2014-007014.PMC4486946.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006665).,Non-OADS,/arxiv_data1/oa_pdf/a4/76/bmjopen-2014-006665.PMC4486947.pdf
Part 5. http://norden.diva-portal.org/smash/record.jsf?pid=diva2%3A745817&dswid=8635(accessed 6 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/a4/76/bmjopen-2014-006665.PMC4486947.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007492).,Non-OADS,/arxiv_data1/oa_pdf/d3/25/bmjopen-2014-007492.PMC4486948.pdf
